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ABSTRACT OF THE DISSERTATION 
Cognitive Recovery in the Post Infectious CNS 
by 
Charise Garber 
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Neuroinflammation plays a pivotal role in a variety of diseases of the CNS associated 
with cognitive impairment, including Alzheimer’s Disease, Parkinson’s Disease with dementia, 
Multiple Sclerosis, anti-NMDA receptor encephalitis, and West Nile Virus Neuroinvasive 
disease (WNND). Despite strong evidence that infiltration of peripheral immune cells and 
activation of resident microglia and astrocytes occurs in these various diseases, very little is 
known about how this altered immune environment may influence normal cognitive function. 
Given that communication between the nervous and immune system is essential for normal 
cognitive function, the central motivation of my thesis work is to understand the mechanisms by 
which immune activation, which is vital for pathogen control, may influence cognitive recovery 
in the setting of viral infection of the CNS. 
First, using a recovery model of WNND in which intracranial infection of adult mice 
with an attenuated strain of West Nile Virus leads to spatial learning deficits on the Barnes Maze 
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behavioral task, we demonstrate that following viral clearance activated astrocytes express the 
cytokine interleukin-1 (IL-1) which decreases neurogenesis and increases the generation of 
astrocytes. Animals deficient in the receptor for IL-1 (IL1R1-/-) are protected from this decrease 
in neurogenesis and display early recovery of synaptic terminals and protection from virus-
induced spatial learning deficits. In addition, treatment of mice with Anakinra, an FDA-approved 
IL-1R antagonist, during acute disease similarly led to protection from spatial learning deficits.   
Next, using the same recovery model of WNND, we demonstrate that T cells persist in 
the hippocampus for weeks following viral clearance and continue to express the cytokine 
interferon-gamma (IFNg) leading to persistent activation of microglia. Animals deficient in the 
receptor for IFNg (IFNgR-/-) are protected from microglial activation and spatial learning 
deficits, despite delayed viral clearance and increased persistence of viral RNA in the 
hippocampus compared to wildtype controls. Conditional deletion of IFNgR from microglia 
upon tamoxifen administration to Cx3CR1-CreER x IFNgR-fl/fl mice was sufficient to protect 
animals from spatial learning deficits. These results were confirmed in animals infected with 
Zika-virus (ZIKV), a related flavivirus with different neural tropism, suggesting a common 
mechanism by which altered immune activation in the CNS leads to long term cognitive deficits. 
These studies provide valuable insights into the neuroimmune processes that influence tissue 
repair and cognitive recovery in the hippocampus following viral encephalitis, and identify IFNg 




Chapter 1: Introduction to neuroimmunity 
and cognitive function 
 
1.1 Overview of neuroimmunology and CNS function 
Neuroinflammation is a hallmark of many diseases associated with cognitive impairment 
including Alzheimer’s disease, Parkinson’s disease with dementia, multiple sclerosis, anti-
NMDA receptor encephalitis and viral encephalitis. However, even under homeostatic, disease-
free conditions, communication between the nervous and immune systems is essential for proper 
brain function. This includes a role for microglia, the resident immune cells of the CNS, which 
actively extend and retract their processes to remodel their local environment by engulfment of 
synapses1–3 or newborn neurons4–6, and for T cells, non-resident adaptive immune cells, which 
continuously patrol the CNS and influence cognitive processing through the secretion of 
cytokines7–10. Thus, the neuroprotective or pathological effect of inflammation may depend on 
specific cytokine expression induced in regionally distinct ways. 
1.2  Microglia 
1.2.1  Neurodevelopment 
The Microglia arise from erythromyeloid progenitors (EMP) of the fetal yolk sac during 
primitive hematopoiesis and begin seeding the CNS around E9.5 in mice11,12.  In addition to 
microglia, other myeloid cells of the CNS including perivascular, meningeal, and choroid plexus 
macrophages also derive from EMPs of the fetal yolk sac and seed the CNS between E9.5-12.513. 
The kinetics of microglial seeding into the CNS, coincident with angiogenesis and neurogenesis, 
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and prior to astrocyte and oligodendrocyte genesis, provides a unique opportunity for microglia 
to influence neurodevelopment14. Indeed, ingenuity pathway analysis (IPA) of microglial gene 
expression identified many functions associated with nervous system development15.  
 Several signaling pathways have been described which are important for microglial 
development and maintenance in the adult brain including transforming growth factor (TGF)-
beta, the transcription factor Pu.1, interferon regulatory factor (IRF)-8 and colony stimulating 
factor 1 receptor (CSF1R)11,15–18. CSF1R signaling is required for proliferation of yolk sac 
macrophages, as such CSF1R-/- mice do not have microglia although microglia are present in the 
CNS of animals lacking the ligand CSF1, which suggested an alternate CSF1R ligand is 
important for maintenance of microglia in the CNS. IL-34 can also signal through CSF1R, and is 
expressed by neurons in the cortex and hippocampus, but not the cerebellum of adult mice. 
Accordingly, animals deficient in IL-34 show decreased numbers of microglia in the cortex and 
hippocampus, with no changes observed in the cerebellum17,18. 
 Pioneering in vivo imaging studies revealed that microglia in the adult brain are highly 
dynamic, constantly extending and retracting processes to sample the surrounding environment, 
contacting neuronal cell bodies, astrocytes, blood vessels and synapses1,19,20. Transcriptome 
analysis revealed that microglia in the adult brain express many genes involved in sensing the 
environment, and the majority of these recognize intrinsic CNS antigens while a much smaller 
percentage recognized bacterial or other pathogen associated products21, suggesting that 
surveillance of the local environment represents an important microglial function. 
1.2.2  Homeostatic function 
During development, microglia play a crucial role in refining circuits by pruning excess 
synapses2,3, or promoting the formation of new ones22,23. In the lateral geniculate nucleus of the 
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thalamus, visual circuits are modified through activity dependent synaptic pruning via 
complement3. A recent report has also suggested a role for astrocyte derived IL-33, an IL-1 
family member, in signaling to microglia to promote synapse pruning in the thalamus and spinal 
cord during postnatal synapse maturation24. During adulthood, microglia contribute to learning-
dependent spine formation23. 
 As the specialized tissue-resident macrophage in the CNS, microglia have multiple 
functions during development and adulthood related to phagocytosis of debris. In addition to the 
pruning of synapses mentioned above, microglia also remove apoptotic purkinje cell neurons in 
the developing cerebellum4, apoptotic newborn cells in the neurogenic niche of the 
hippocampus5, and non-apoptotic tbr2+ neural progenitors in the developing cerebral cortex6. 
1.2.3  Role in disease 
Under homeostatic conditions, microglia, and other myeloid cells of the CNS derived from 
EMPs of the yolk sac are long lived and are not replaced by circulating monocytes, with the 
exception of choroid plexus macrophages which have more frequent turnover13. However, during 
blood brain barrier disruption in the setting of disease, peripheral monocytes can be recruited 
into the CNS parenchyma and contribute to the pathogenesis or resolution of disease. There 
continues to be a strong debate over the relative contributions of peripheral-derived macrophages 
and resident microglia in CNS diseases; in particular the ability of the former to enter and engraft 
in the CNS and the ability of the latter to proliferate and expand in response to disease. 
Following facial nerve axotomy, in which microgliosis is observed in the absence of blood brain 
barrier breakdown, microglia seem to proliferate locally in response to the injury25. Single-cell 
tracking by in vivo imaging confirmed the long-lived nature of microglial cells in the cortex, and 
suggested that in the setting of Alzheimer’s disease the increased density of microglia around 
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plaques is most likely due to proliferation of neighboring microglia whose daughter cells migrate 
towards the plaque26. These studies suggest that microglia can proliferate in response to disease. 
1.2.4  Role in disease 
Microglia isolated from different regions of the brain express unique genetic signatures27. 
Cortical and striatal microglia cluster distinctly from cerebellar microglia, with hippocampal 
microglial demonstrating an intermediate expression profile. Some of the most regionally distinct 
pathways include those involved in immune function and energy metabolism, which are 
increased in hippocampal and cerebellar microglia. Interestingly, hippocampal microglia show 
particular variability in aging, acquiring a profile that more closely resembles cortical microglia. 
In contrast, cerebellar microglia show increased expression of immune-related genes, consistent 
with the immune vigilant status of the hindbrain (see section 1.4.4)27. Baseline differences in the 
transcriptional profile of microglia suggest that microglia from distinct brain regions may 
respond differently to infection or injury, providing an exciting new area of research to be 
explored. 
1.3  Astrocytes 
1.3.1  Neurodevelopment 
In the developing CNS, neurogenesis precedes astrogenesis. Astrocytes develop from the neural 
stem cells, although the precise transcriptional cues regulating this “gliogenic switch” remain 
unknown. Activation of the Janus kinase-signal transducer and activator of transcription (JAK-
STAT) signaling pathway promotes astrocyte differentiation28,29. Fate-mapping revealed that 
astrocytes proliferate in the ventricular zone and early astrocyte-restricted precursors migrate to 
specific regions of the CNS according to their initial site of origin in the ventricular zone30,31. In 
vivo imaging studies demonstrated that differentiated astrocytes in the cortex then divide 
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postnatally to expand and functionally integrate with other CNS cell types32. Thus both 
asymmetric division occurring in germinal centers in late embryogenesis and symmetric division 
occurring in the final brain region where they will reside accounts for the 6-8 fold increase in 
astrocyte numbers observed in the first thee postnatal weeks33t.  
1.3.2  Homeostatic function 
Astrocytes perform a diverse array of functions in the developing and adult CNS. Astrocyte end-
feet surround cerebrovascular endothelial cells to form the blood brain barrier which regulates 
entry of molecules and cells into the CNS parenchyma34. Astrocytes also send processes toward 
synaptic connections between neurons to regulate synapse formation and neurotransmitter 
recycling35. Neighboring astrocytes are coupled electrically by gap junctions and buffer 
extracellular ions, in particular potassium, through expression of the potassium channel Kir4.136. 
Recent studies have identified unique roles for astrocytes in more complex behaviors. Astrocytes 
located in the chemoreceptor areas of the brainstem, respond rapidly to changes in pH and 
release ATP which triggered breathing in mice37. Astrocytes from other brain regions were not 
sensitive to changes in pH, suggesting that astrocytes may acquire regionally distinct functions as 
they integrate into CNS circuits37.   Indeed, an early study found that astrocytes from the 
hippocampus promote neurogenesis when cultured with neural stem cells, but astrocytes from 
the spinal cord do not38.  More recent studies have shown that astrocytes in the ventral (motor) 
and dorsal (sensory) regions of the spinal cord display unique genetic signatures, which influence 
axon orientation and synapse formation during development39 and astrocytes in the trigeminal 
nucleus induce bursting in rhythmogenic neurons by secretion of the calcium binding protein 
S100b40. Collectively, these studies demonstrate that astrocytes perform a wide range of 




1.3.3 Role in disease 
Astrocytes have long been known to react to injury, however the extent to which this reaction is 
neuroprotective or pathological has become a recent focus in the field of glial biology. In a 
pioneering study, Zamanian et al purified astrocytes from the CNS following two different types 
of injury: ischemic injury by middle cerebral artery occlusion (MCAO) and neuroinflammation 
by a single i.p. injection of LPS41. Transcriptional profiling revealed a set of genes which showed 
increased expression after both MCAO and LPS, as well as genetic signatures that were unique 
to one injury or the other41. A follow up study further refined the expression profile to define a 
set of genes coined “pan-reactive” (upregulated in both MCAO and LPS), “A1” (upregulated 
after LPS) and “A2” (upregulated after MCAO)42. Although the nomenclature has sparked some 
criticism, in part due to controversy surrounding the M1/M2 designation for reactive microglia43, 
these studies made important advances by identifying patterns of gene expression associated with 
neuroprotective or neurotoxic responses.  
Astrocytes can serve neuroprotective roles after CNS injury. Recent work has provided 
evidence to challenge the prevailing the dogma that glial scar formation after spinal cord injury 
prevents axonal regrowth. In an elegant series of experiments, Anderson et al prevented or 
removed glial scars and did not see spontaneous regrowth of axons. However, delivery of growth 
factors via synthetic hydrogel depots in the lesion led to robust regrowth of axons, and this 
regrowth was significantly blunted in the absence of glial scar formation44. Another study 
identified a unique mechanism of astrocyte-derived mitochondria to neurons to promote survival 
following stroke45. Astrocytes can also serve neurotoxic roles after CNS injury or prevent 
recovery. LPS reactive astrocytes release a neurotoxic factor, the identity of which is currently 
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unknown, which kills alpha motor neurons in vitro42.  In a mouse model of Alzheimer’s disease, 
plaque associated astrocytes produced increased levels of the inhibitory neurotransmitter GABA 
which impaired synaptic plasticity and learning and memory46. These studies suggest a 
functional diversity in the reaction of astrocytes to various types of CNS damage which may 
promote or prevent recovery. 
1.3.4 Enhanced innate immune responses of hindbrain neurons and 
astrocytes 
*The following section is adapted from a box I wrote for our published review47 
Astrocytes from different brain regions display distinct immune signatures at baseline and in 
response to an inflammatory stimulus. Early in vitro experiments demonstrated that brain stem 
astrocytes had elevated MHC-II and ICAM-I expression compared to various forebrain 
structures48. Cerebellar and spinal cord astrocytes additionally released higher basal levels of 
many chemokines/cytokines in vitro compared to cortical astrocytes including IL-1B, CCL2, IL-
6, and IL-9, and brain region had specific effects on chemokine/cytokine levels following 
exposure to HIV proteins49.  
Neurons also display regional heterogeneity of innate immune response at baseline and in 
response to infection.  In situ hybridization studies demonstrate that ISG-49 (IFIT-3) is highly 
expressed in the Purkinje cell layer of the cerebellum, corpus callosum, and choroid plexus 
following LCMV infection. In contrast, ISG-56 (IFIT-1) is most highly expressed in the 
olfactory bulb and olfactory neurons. Striking differences in ISG expression occurs even in 
neuronal subpopulations within a given region. For example, while ISG-49 was resent at high 
levels in Purkinje cell, molecular, and granule neurons of the cerebellum, ISG-56 was primarily 
restricted to granule neuron layer while ISG-54 (IFIT-2) was found in the Purkinje cell layer. 
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Granule cell neurons also expressed high levels of ISG-49 and ISG-56 following WNV 
infection50. In fact, differences in expression of innate immune genes can be seen at baseline.  
Microarray analysis comparing granule cell neurons of the cerebellum to cortical neurons of the 
cerebral cortex revealed that IFN related genes including Ifit1, Irf7, Stat1 and OasI were higher 
in cerebellar granule cell neurons. Granule cell neurons displayed increased resistance to viral 
infection at baseline and in response to IFN-b treatment.  Indeed, even the kinetics response to 
IFN-b treatment was increased in cerebellar granule cell neurons peak expression levels of 
several genes including Ifit1, Rsad2, and Oas reached peak expression levels at an earlier time 
point compared to cortical neurons51. 
1.4  T cells 
1.4.1  Meningeal Immunity 
A growing body of literature has demonstrated the important role of meningeal T cells in 
influencing spatial learning in mice52. Early experiments demonstrated that SCID mice, which 
lack functional B and T cells, have impaired performance on the Morris Water Maze53. This 
impairment in spatial learning was not due to differences in motor function or baseline 
psychomotor abnormalities, and could be reversed with CD3 T cell replenishment54. Mice 
undergoing a spatial learning task demonstrated an increase in CD4+ T cells in the meninges 
relative to naïve mice which did not undergo cognitive testing8, and further studies demonstrated 
a critical role for CD4+ T cells in spatial learning7,9. Importantly, surgical resection of deep 
cervical lymph nodes led to an increase of CD4+ T cells in the meninges and was correlated with 
deficits in spatial learning relative to sham operated controls55, suggesting that spatial learning 
depends in part on maintenance of particular T cell subsets in the meninges9,55,56. The discovery 
of meningeal lymphatics, which demonstrated a structural route for recirculation of meningeal 
9 
 
lymphocytes and drainage of cerebral spinal fluid (CSF), provides an important advance in 
understanding the interchange between peripheral immune compartments and the CNS10,57. 
1.4.2  Response to RNA virus infection 
T cells play a critical role in viral clearance from the CNS, although the response must be 
carefully controlled to limit immunopathology in an organ with limited capacity for repair. T cell 
recruitment to the CNS occurs primarily via chemokine signaling pathways. During WNV 
infection, neuronal production of CXCL10 leads to the recruitment of CXCR3+ T cells to the 
CNS to control viral infection and promote survival58. Reactivation of recruited T cells occurs 
via interaction with CD11c+ dendritic cells in an IL1R1 dependent manner59, and release of T 
cells from the perivascular space into the parenchyma is in part mediated via alterations in 
polarity of CXCL12 expression at the endothelium60. Recent work in a model of neurotropic 
coronavirus infection highlights the importance of CD8+ T cell reactivation in perivascular 
spaces of the CNS for viral control and survival. In this work, expression of CCL19 and 21 by 
stromal endothelial and fibroblast reticular like cells in the perivascular spaces of the CNS was 
shown to be important for coordinating recruitment and reactivation of antiviral CD8+ T cells to 
the CNS via CCR7 signaling61. The specific chemokine milieu in the infected CNS appears to 
also influence T cell activity and antiviral response. During acute infection with LCMV, 
cytotoxic T lymphocytes express chemokines which leads to peripheral myeloid cell recruitment, 
severe immunopathology and death62. However, during chronic LCMV infection, therapeutic 
administration of virus specific T cells can lead to non-cytopathic clearance of virus63. 
T cells can persist in the CNS for months to years following neurotropic infection with 
dengue64, VSV65, WNV66,67 and influenza68, however the functional implications of this 
persistence are relatively unknown. Tissue resident memory T cells (TRM cells) are a recently 
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described class of long lived memory T cells which reside in non-lymphoid tissues at sites of 
prior antigen exposure and coordinate a rapid recall response to re-challenge69,70. TRM cells are 
classically defined by the expression of the integrin aE (CD103) and the early activation marker 
CD69, however expression of these two markers is not uniform across all circulation-
independent TRM cells in non-lymphoid tissues. CD69 is rapidly upregulated upon activation 
through TCR signaling and exposure to type I interferons, and interferes with signaling through 
the sphingosine 1 phosphate 1 receptor S1P1, preventing T cell egress from the tissue71,72. In the 
CNS, generation of TRM cells appears to be antigen dependent65,73. However, persistent antigen 
exposure was not required for TRM persistence in the CNS65,68. CD69+ brain TRM cells also 
express high levels of the pro-survival molecule Bcl-274, which may explain their long term 
survival despite lack of continuous antigen exposure.   
Consistent with studies of TRM cells in other tissues, brain TRM cells are poised to provide 
enhanced protection against returning pathogens. An early study identified CD69+ CD8+ T cells 
persisting in the CNS to 320 days post infection (the latest time point analyzed) which retained 
killing function when exposed to peptide or virus loaded cells ex vivo68. More recent studies have 
demonstrated that brain TRM cells can provide enhanced protection and survival in mice upon re-
challenge74,75. This protection could occur despite depletion of peripheral CD4 and CD8 cells, 
and was dependent on interferon-gamma and perforin production by the brain TRM cells74.  While 
these studies demonstrate the existence of brain TRM cells, and the capacity to provide functional 
pathogen control upon re-exposure, very little is known about how the presence and activity of 
persistent T cells may influence activity of resident CNS cells including microglia, astrocytes, 
and neurons in the absence of overt infection. 
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1.5  Hippocampal function in learning and memory 
1.5.1  Hippocampal circuitry 
The hippocampus plays a critical role in the processing, storage and retrieval of different types of 
memory, in particular spatial memory. Memory is encoded through a feedforward circuit loop 
that centers around the CA3 region of the hippocampus76. The CA3 receives input from the 
entorhinal cortex either directly through the perforant path, or indirectly through the dentate 
gyrus (DG). There are excitatory connections between CA3 pyramidal cells, as well as inhibitory 
input from CA3 interneurons. The primary output of the CA3 is through axons which synapse on 
CA1 pyramidal cells and interneurons76. Different sub-regions of the hippocampus have distinct 
functions in computational memory processing. In particular, the dentate gyrus, which receives 
numerous connections from the entorhinal cortex but sends sparse input to the CA3, is 
responsible for pattern separation77. The excitatory connections between CA3 pyramidal cells 
allow for pattern completion to integrate new spatial memory information into the pattern of 
what was previously experienced77. Elegant studies using a multi-electrode approach to 
simultaneously record neurons in the DG and CA3 during a spatial processing task in which 
local and global cues were spatially rotated at distinct angles provided experimental and 
computational evidence for this long-standing, anatomically-based, hypothesis78. 
1.5.2  Hippocampal circuitry 
Neurogenesis occurs in two distinct brain regions in adult animals: the subgranular zone (SGZ) 
of the dentate gyrus (DG), and the subventricular zone (SVZ) of the lateral ventricles79. Genetic 
labeling studies demonstrated that SVZ neurogenesis contributes to the replacement of olfactory 
bulb neurons without a change in overall number80. In contrast, neurogenesis in the SGZ appears 
to account for the increase in the number of DG neurons observed as animals age80. Blockade of 
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neurogenesis by radiation or anti-mitotic drugs has led to mixed results over the requirement of 
adult neurogenesis for spatial learning in adult mice81. However, specific targeting of neural 
precursor cells by genetic ablation in C57BL/6 mice demonstrated that adult neurogenesis is 
important for spatial learning and memory recall on the Barnes Maze behavioral task80. More 
specifically, hippocampal neurogenesis appears to be important for pattern separation, or the 
ability to encode and recall small changes between similar inputs, in the dentate gyrus. Ablation 
of neurogenesis in the SGZ prevented animals from correctly distinguishing between spatially 
similar reward arms during a modified radial arm maze designed to test pattern separation. 
Performance of depleted animals was similar to sham-operated controls if the arms were 
separated by a greater distance82. Exercise induced increases in neurogenesis was recently shown 
to improve spatial pattern separation in adult mice, and aged animals which were exposed to 
exercise but resistant to increases in neurogenesis were subsequently resistant to exercise-
induced benefits in spatial memory83.  These studies suggest that neurogenesis in the adult rodent 
hippocampus contributes to spatial memory encoding. 
1.5.3  Synaptic plasticity 
Long-term potentiation, the ability of repeated afferent stimulation to produce a long-term 
enhancement of synaptic transmission, has long been the leading hypothesis to explain how 
synaptic plasticity influences hippocampal encoding of spatial memory84. This phenomenon was 
first observed in the dentate gyrus anesthetized rabbits85 and has since been validated in other 
model systems including mice84. One of the first studies using the cre-lox system for conditional 
gene expression, specifically deleted N-methyl-D-aspartate receptors (NMDARs), which are 
important mediators of LTP, in CA1 neurons to demonstrate that loss of LTP in the CA1 
impaired spatial learning on the morris water maze86. A seminal study using an inhibitory 
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avoidance paradigm, which creates a stable memory in rats after one trial, provided experimental 
evidence that learning induces LTP in the hippocampus87. 
1.6  Inflammation-induced CNS dysfunction in parenchyma 
infection 
*The following sections are adapted from material I wrote for our published review47 
1.6.1  Viruses 
Both DNA and RNA viruses of different families can infect the CNS, leading to the clinical 
syndromes of meningitis, encephalitis, or meningoencephalitis. Many DNA viruses and few 
RNA viruses replicate in the nucleus, establishing latency by integrating into the cellular DNA, 
while most RNA viruses primarily replicate in the cytosol, and generally do not establish 
latency88. Herpes simplex encephalitis (HSE), caused by the DNA virus herpes simplex virus 
(HSV)-1, is the most common acute, sporadic encephalitis in the US and worldwide89. 
Arthropod-born viruses, or arboviruses, are another important cause of encephalitis (Reviewed 
in90). West Nile virus (WNV), a positive sense RNA flavivirus, is the most widely distributed 
arbovirus worldwide, with cases reported on every continent but Antarctica91.  The 
pathophysiology, diagnosis, and management of acute HSE and WNV have been recently 
reviewed92. Patients with viral encephalitis of any etiology typically present with fever, 
headache, confusion and altered mental status but may also present with seizures or focal 
neurological signs. Animal and human studies have demonstrated that both innate immune 
responses and lymphocyte trafficking to the CNS are important mechanisms of virologic 
control93,94. Neurological and neuropsychiatric sequelae can persist or develop following 
encephalitis due to a variety of neurotropic pathogens, which has become a prioritized area of 
research95. Patients surviving HSE or WNV encephalitis experience high rates of neurological 
sequelae including memory impairment (60%), speech disorders (35%) and cognitive 
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impairment (29%)96. Of the 90% of patients who survive WNV, about 50% experience cognitive 
sequelae deficits including depression, fatigue, memory impairment or changes in executive 
function that may persist for years97,98. Here, we will focus on mechanisms underlying 
neurological sequelae in HSE and WNV encephalitis in individuals with intact immunity.  
Increasing evidence suggests that developmental pathways regulating synaptic plasticity 
by microglia and astrocytes can be reactivated during disease states. Alterations in synapse 
homeostasis resulting from aberrant activation of glia may contribute to the cognitive 
dysfunction seen in many neurocognitive disorders, including Autism Spectrum Disorders and a 
variety of dementias including Alzheimer’s Disease (AD)99,100. The complement system, part of 
innate immunity that initiates adaptive responses to clear virus peripherally101, influences 
synapse homeostasis during development20,102 and can promote synapse elimination during 
neurodegenerative and neuroinfectious diseases103,104. In a model of AD using J20 transgenic 
mice which harbor a familial AD-mutant of human amyloid precursor protein105, C1q deposition 
preceded synapse elimination and plaque formation, and mice deficient in complement signaling 
had fewer phagocytic microglia and reduced synaptic elimination104. Loss of C1q also protected 
animals from synaptic elimination and downstream behavioral phenotypes in a model of 
dementia caused by deficiency of progranulin, a pleotropic protein that plays a major role in 
genetic causes of frontotemporal dementia106.  Progranulin-deficient microglia exhibit increased 
lysosomal activity and complement production, leading to preferential elimination of inhibitory 
neurons107. In a model of WNV-induced memory impairment, phagocytic microglia persisted for 
weeks after viral clearance, and gene signatures associated with complement-mediated synapse 
remodeling were elevated in the hippocampus, a CNS region responsible for memory103. Delayed 
recovery from acute synapse loss correlated with poor spatial learning, and mice with fewer 
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microglia (Il34–/–) or complement deficiency (C3–/– or C3ar–/–) were protected from virus-
induced synaptic elimination103, suggesting aberrant microglial activation and complement-
mediated deletion of neuronal communication following viral encephalitis may result in 
neurological sequelae seen in neurotropic virus-infected survivors. 
While instituting intravenous acyclovir as the standard of care for HSE has greatly improved 
survival rates108, patients surviving acute infection are at risk for clinical neurologic relapse and 
the development of new neuropsychiatric symptoms including memory loss and epilepsy109. PCR 
analysis of the CSF during relapse at times reveal an absence of CNS viral replication, leading to 
the hypothesis that these relapses are in fact immune-mediated110. In recent years, numerous 
studies and case reports have linked clinical relapses to the development of autoimmune 
encephalitis, and in particular to anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis 
(Reviewed in111). Administration of patient, but not control, CSF to hippocampal cultures leads 
to a titer-dependent but reversible decrease in NMDAR density without altering the number of 
synapses or the density of other synaptic proteins like PSD-95, GluR1, GluR2 receptor clusters 
or GABA receptor112. Intracerebral infusion of patient CSF or purified IgG similarly increases 
NMDAR internalization in vivo and alteration in glutamate homeostasis and signaling112,113. 
Furthermore, these autoantibodies inhibited the development of long-term synaptic plasticity in 
vitro114. The recent development of a rodent model for anti-NMDAR encephalitis demonstrates 
that continuous infusion of patient autoantibodies can lead to behavioral deficits, providing a 
platform for preclinical testing113. Whether autoantibodies develop due to molecular mimicry, 
secondary to release of antigens following neuronal lysis, or as a primary mechanism of 
neuroprotection by the immune system requires further study. 
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1.6.2  Neurotropic parasites 
CNS infections with certain neurotropic parasites are also known to cause alterations in host 
behavior. Among the most well-known is Toxoplasma gondii, a common zoonotic parasite with 
a worldwide seroprevalance between 30-70%. T. gondii, causes chronic CNS infection and 
neuroinflammation after ingestion of oocysts in contaminated food or water115. Ingested oocysts 
develop into fast-dividing tachyzoites that invade the gut epithelium and lamina propria, 
replicate asexually through a process called endodyogeny, and then exit and infect myeloid cells, 
which allow dissemination to multiple tissue sites in the body (including the eye, heart, liver, 
lung, lymph nodes, muscles and CNS (Reviewed in116). The life cycle of T. gondii requires 
infection of feline prey intermediate hosts whose ingestion leads to infection of feline definitive 
hosts (Reviewed in117). Infection of intermediate host CNS appears to be a critical stage of the T. 
gondii life cycle, ensuring successful predation via modifications in prey’s olfactory preferences 
that reduce predator avoidance118,119. Epidemiologic studies of T. gondii infection in humans, 
which may have evolved when human ancestors were still under feline predation120, similarly 
link parasite seropositivity with alterations in olfactory preference and behavioral abnormalities 
in immunocompetent individuals, the latter of which include those associated with 
neurodegenerative and psychiatric diseases.  
CNS invasion by T. gondii (Reviewed in121), leads to infection of all neural cell types, 
most of which are promptly cleared of parasite via astrocyte and microglial expression of T cell 
chemoattractants CCL5, CXCL9 and CXCL10, that recruit IFN-γ-expressing CD4+ and CD8+ T 
cells directed at T. gondii antigens122. Neurons remain latently infected with slowly replicating 
bradyzoites for the life of the host. In murine studies, behavioral effects of T. gondii are 
associated with direct infection of cortical neurons and astrocytes with modification in their 
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functions, including those that impact innate immunity and dopaminergic and glutamate 
signaling123,124. Direct effects of T. gondii on neuronal function, including derailments of 
neurotransmitter expression, modulation of calcium signaling, and loss of myelinated fibers, 
MAP-2+ neurites and NeuN+ cells are all suggestive of parasite-mediated impairment or injury 
(Reviewed in125). These effects are proposed to underlie a variety of behavioral alterations, 
psychiatric diseases and certain neurodegenerative disorders observed in T. gondii–infected 
hosts. However, aversion to cat urine is also observed in rodents after clearance of cysts126, and 
low total cyst burdens and lack of specific neuronal tropism observed in infected brain regions 
raise the important possibility that chronic T. gondii infection induces inflammatory-mediated 
dysfunction that does not require the persistence of parasite.  
 The T. gondii-infected CNS exhibits increased astrocyte expression of TNF, IL-1a, and 
IL-6127, each of which have been implicated in the regulation of neural correlates of memory 
including adult neurogenesis, synaptic plasticity and modulation of long-term potentiation128–130. 
Molecular interactions between dopaminergic and inflammatory cascades within neurons may 
underlie behavioral alterations during chronic infection with T. gondii. NR4A transcription 
factors NR4A1, NR4A2, and NR4A3 (also known as Nur77, Nurr1, and Nor1, respectively) 
share similar DNA-binding properties and have been implicated in regulation of dopamine 
neurotransmission genes131. Nurr1, in particular, induces tyrosine hydroxylase (TH) expression 
during differentiation of dopaminergic neurons and plays a key role in the maintenance of the 
dopaminergic system of the adult brain. Consistent with this, NR4A2 polymorphisms are 
associated with a variety of neurologic and psychiatric disorders including Parkinson’s disease, 
Lewy body dementia, addiction and attention deficit disorder132. Nurr1 and its co-regulating 
factor, glycogen synthase kinase 3, recruits CoREST, a complex made of several proteins that 
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assembles chromatin-modifying enzymes, also interacts with the transcription factor complex 
NF-kB-p65, protecting dopaminergic neurons during LPS-induced inflammation by reducing 
expression of inflammatory genes, including Tnf, NO and Il1b, in microglia and astrocytes133. 
Nurr1-heterozygous mice show increased exploratory behavior and reduced anxiety that is 
exacerbated by chronic infection with T. gondii compared with similarly infected wild-type 
animals134. While there are no studies examining NR4A2 polymorphisms in psychiatric patients 
chronically infected with T. gondii, cognitive deterioration among bipolar disorder patients 
infected by T. gondii has been reported135. Genome-wide analyses may be a useful approach to 
identify susceptibility genes that predispose individuals to development or worsening of affective 
disorders after infection with T. gondii. 
1.7  West Nile virus 
1.7.1  Virology 
West Nile virus (WNV) is a neurotropic, mosquito-borne flavivirus that cycles primarily 
between birds and rodents. Humans and horses can incidentally serve as dead-end hosts when 
bitten by an infected mosquito, but due to low levels of viremia do not contribute to the 
transmission cycle for the virus. WNV is a member of the Flaviviridae family which includes 
other viruses that cause a significant burden of disease worldwide including Dengue virus 
(DENV)136, Japanese Encephalitis virus (JEV), Tick-borne encephalitis virus (TBEV) and Zika 
virus (ZIKV, see section 1.9). Like other flaviviruses, WNV is a single-stranded positive-sense 
RNA virus containing a single open reading frame. The translated polyprotein is cleaved by viral 
and host proteases to generate three structural proteins (C, prM, and E) and seven non-structural 
proteins (NS1, NS2A, NS2B, NS3, NS4a, NS4b)137. 
19 
 
1.7.2  Epidemiology and clinical presentation 
WNV was first isolated from a febrile patient in Uganda in 1947138 and was introduced to the US 
in New York in 1999139. Since then the virus has spread across the US and is the leading cause of 
domestically acquired arboviral disease with about 2,000 cases reported to the CDC every 
year140. Most patients who become infected with WNV are asymptomatic or experience non-
specific flu-like symptoms that cause significant morbidity but remain undiagnosed141. A subset 
of patients may experience severe and potentially fatal neuroinvasive disease including 
encephalitis, meningitis, and/or flaccid paralysis142. Patients surviving West nile virus experience 
significant morbidity due to the presence of persistent neurological sequelae which can last for 
years98,143–150. A systematic review of the clinical literature revealed that muscle weakness, 
fatigue, memory loss and depression are among the most commonly reported symptoms150. 
Fatigue was present in 48-75% of patients after neuroinvasive disease and 48% of patients with 
WNV fever150. Memory loss was present in up to 59% of patients for up to 8 years following 
infection with WNV150. 
1.8  Zika virus 
1.8.1  Epidemiology and clinical presentation 
Zika virus was first isolated in 1947 from a rhesus monkey in the Zika forest of Uganda151. In 
2007 there was an outbreak in the Yap Island of Micronesia primarily characterized by rash, 
fever, arthralgia and conjunctivitis which represented the first occasion of spread outside of 
Africa and Asia152. In 2013 and 2014 another major outbreak of Zika virus occurred, this time 
associated with Guillain-Barre syndrome, an autoimmune flaccid paralysis153. In 2016 the Zika 
virus epidemic was named a Public Health Emergency of International Concern (PHEIC) due to 
the clustered reports of microcephaly and GBS cases in Brazil and other countries154.   
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The recent epidemic has revealed multiple outcomes of Zika virus infection causing 
human disease. Congenital ZIKV exposure can cause multiple abnormalities, now clinically 
defined as Congenital Zika Syndrome, including severe microcephaly, cortical malformation, 
subcortical or basal ganglia calcifications, and hypertonia155. In addition to Guillain-Barre 
Syndrome (GBS), which was associated with Zika virus infection in French Polynesia153, a range 
of other neurological complications in adults infected with Zika virus have been reported, and 
the long-term outcomes for patients surviving this emerging neurotropic virus remain 
unknown156–162. Animal studies have demonstrated increased neurotropism and neurovirulence of 
African lineage strains, particularly in the CNS. Some have suggested that outbreaks may have 
occurred, but went unnoticed due to the low capacity for detecting and reporting emerging 
threats in much of the continent163. Indeed, a retrospective cohort study in Nigeria in 2012 
identified 340 cases of microcephaly among 3196 infants enrolled (10.6%), which at the time 
was attributed to suspected CMV164. 
1.8.2  Neurotropism 
Zika virus can infect human neural progenitor cells derived from human induced pleuripotent 
stem cells (hiPSCs), leading to increased cell death and cell cycle disturbance165 which prevents 
neurosphere proliferation and brain organoid growth in vitro166. In triple knock out mice 
deficient in Irf3, Irf5, and Irf7, retro-orbital injection of a Cambodian isolate of ZIKV led to 
infection of adult neural progenitor cells in neurogenic zones leading to caspase-3 activation and 
apoptosis167. Another study found early infection of GFAP+ astrocytes and mature neurons in the 
CNS after intraperitoneal (ip) injection of wildtype pups with a Cambodian isolate on the day of 
birth (P0), with sparse infection of neural progenitor cells at this developmental stage168. Another 
group infected WT mice at P7 or P21 by intracranial injection with ZIKV MR766 and found 
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immunoreactivity for the apoptotic marker cleaved caspase 3 (CC3) to colocalize with NeuN, a 
marker of mature neurons169. Finally, a recent study of congenital Zika virus infection in pigtail 
macaques found decreased numbers of neural progenitors in the neurogenic SGZ and SVZ as 
well as increases in astrocytes in virus-exposed fetal tissue harvested by caesarean section within 
one month of their due date170.   
High levels of ZIKV RNA and infectious virus were detected in the spinal cord and 
brains of 4-6 week old Ifnar1-/- mice infected with a ZIKV isolate from French Polynesia171. 
ZIKV non-structural protein 5 (NS5) targets human STAT2 for proteasome-dependent 
degradation, which allows it to evade the Type I interferon response and cause disease172,173. NS5 
does not bind mouse STAT2, which could explain the lack of disease in wild-type mice173. 
Indeed, in Stat2-/- mice, subcutaneous infection with African lineage strains (Uganda MR766 
and Dakar 41519) led to high levels of virus in the brain, robust induction of chemokines and 
cytokines, and lethality by 7 days post infection. WT animals infected with the same strains did 
not lose weight or succumb to the infection174. 
1.9  References 
1.  Davalos D, Grutzendler J, Yang G, et al. ATP mediates rapid microglial response to local 
brain injury in vivo. Nat Neurosci. 2005;8(6):752-758. doi:10.1038/nn1472. 
2.  Paolicelli RC, Bolasco G, Pagani F, et al. Synaptic pruning by microglia is necessary for 
normal brain development. Science. 2011;333(6048):1456-1458. 
doi:10.1126/science.1202529. 
3.  Schafer DP, Lehrman EK, Kautzman AG, et al. Microglia Sculpt Postnatal Neural Circuits 
in an Activity and Complement-Dependent Manner. Neuron. 2012;74(4):691-705. 
doi:10.1016/j.neuron.2012.03.026. 
4.  Marı́n-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, Mallat M. Microglia 
Promote the Death of Developing Purkinje Cells. Neuron. 2004;41(4):535-547. 
doi:10.1016/S0896-6273(04)00069-8. 
5.  Sierra A, Encinas JM, Deudero JJP, et al. Microglia Shape Adult Hippocampal 
Neurogenesis through Apoptosis-Coupled Phagocytosis. Cell Stem Cell. 2010;7(4):483-
495. doi:10.1016/J.STEM.2010.08.014. 
6.  Cunningham CL, Martínez-Cerdeño V, Noctor SC. Microglia regulate the number of 
22 
 
neural precursor cells in the developing cerebral cortex. J Neurosci. 2013;33(10):4216-
4233. doi:10.1523/JNEUROSCI.3441-12.2013. 
7.  Wolf SA, Steiner B, Akpinarli A, et al. CD4-positive T lymphocytes provide a 
neuroimmunological link in the control of adult hippocampal neurogenesis. J Immunol. 
2009;182(7):3979-3984. doi:10.4049/jimmunol.0801218. 
8.  Derecki NC, Cardani AN, Yang CH, et al. Regulation of learning and memory by 
meningeal immunity: a key role for IL-4. J Exp Med. 2010;207(5):1067-1080. 
doi:10.1084/jem.20091419. 
9.  Radjavi A, Smirnov I, Kipnis J. Brain antigen-reactive CD4+ T cells are sufficient to 
support learning behavior in mice with limited T cell repertoire. Brain Behav Immun. 
2014;35:58-63. doi:10.1016/J.BBI.2013.08.013. 
10.  Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central 
nervous system lymphatic vessels. Nature. 2015;523(7560):337-341. 
doi:10.1038/nature14432. 
11.  Ginhoux F, Greter M, Leboeuf M, et al. Fate mapping analysis reveals that adult microglia 
derive from primitive macrophages. Science. 2010;330(6005):841-845. 
doi:10.1126/science.1194637. 
12.  Gomez Perdiguero E, Klapproth K, Schulz C, et al. Tissue-resident macrophages originate 
from yolk-sac-derived erythro-myeloid progenitors. Nature. 2015;518(7540):547-551. 
doi:10.1038/nature13989. 
13.  Goldmann T, Wieghofer P, Jordão MJC, et al. Origin, fate and dynamics of macrophages 
at central nervous system interfaces. Nat Immunol. 2016;17(7):797-805. 
doi:10.1038/ni.3423. 
14.  Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev 
Immunol. 2017;18(4):225-242. doi:10.1038/nri.2017.125. 
15.  Butovsky O, Jedrychowski MP, Moore CS, et al. Identification of a unique TGF-β–
dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17(1):131-
143. doi:10.1038/nn.3599. 
16.  Goldmann T, Wieghofer P, Jordão MJC, et al. Origin, fate and dynamics of macrophages 
at central nervous system interfaces. Nat Immunol. 2016;17(7):797-805. 
doi:10.1038/ni.3423. 
17.  Greter M, Lelios I, Pelczar P, et al. Stroma-derived interleukin-34 controls the 
development and maintenance of langerhans cells and the maintenance of microglia. 
Immunity. 2012;37(6):1050-1060. doi:10.1016/j.immuni.2012.11.001. 
18.  Wang Y, Szretter KJ, Vermi W, et al. IL-34 is a tissue-restricted ligand of CSF1R 
required for the development of Langerhans cells and microglia. Nat Immunol. 
2012;13(8):753-760. doi:10.1038/ni.2360. 
19.  Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic 
surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314-1318. 
doi:10.1126/science.1110647. 
20.  Tremblay M-È, Lowery RL, Majewska AK. Microglial Interactions with Synapses Are 
Modulated by Visual Experience. Dalva M, ed. PLoS Biol. 2010;8(11):e1000527. 
doi:10.1371/journal.pbio.1000527. 
21.  Hickman SE, Kingery ND, Ohsumi TK, et al. The microglial sensome revealed by direct 
RNA sequencing. Nat Neurosci. 2013;16(12):1896-1905. doi:10.1038/nn.3554. 
22.  Miyamoto A, Wake H, Ishikawa AW, et al. Microglia contact induces synapse formation 
23 
 
in developing somatosensory cortex. Nat Commun. 2016;7:12540. 
doi:10.1038/ncomms12540. 
23.  Parkhurst CN, Yang G, Ninan I, et al. Microglia promote learning-dependent synapse 
formation through brain-derived neurotrophic factor. Cell. 2013;155(7):1596-1609. 
doi:10.1016/j.cell.2013.11.030. 
24.  Vainchtein ID, Chin G, Cho FS, et al. Astrocyte-derived interleukin-33 promotes 
microglial synapse engulfment and neural circuit development. Science. 
2018;359(6381):1269-1273. doi:10.1126/science.aal3589. 
25.  Tay TL, Mai D, Dautzenberg J, et al. A new fate mapping system reveals context-
dependent random or clonal expansion of microglia. Nat Neurosci. 2017;20(6):793-803. 
doi:10.1038/nn.4547. 
26.  Füger P, Hefendehl JK, Veeraraghavalu K, et al. Microglia turnover with aging and in an 
Alzheimer’s model via long-term in vivo single-cell imaging. Nat Neurosci. 
2017;20(10):1371-1376. doi:10.1038/nn.4631. 
27.  Grabert K, Michoel T, Karavolos MH, et al. Microglial brain region−dependent diversity 
and selective regional sensitivities to aging. Nat Neurosci. 2016;19(3):504-516. 
doi:10.1038/nn.4222. 
28.  Bonni A, Sun Y, Nadal-Vicens M, et al. Regulation of gilogenesis in the central nervous 
system by the jak-stat signaling pathway. Science (80- ). 1997;278(October):477-483. 
29.  He F, Ge W, Martinowich K, et al. A positive autoregulatory loop of Jak-STAT signaling 
controls the onset of astrogliogenesis. Nat Neurosci. 2005;8(5):616-625. 
doi:10.1038/nn1440. 
30.  Tien A-C, Tsai H-H, Molofsky A V., et al. Regulated temporal-spatial astrocyte precursor 
cell proliferation involves BRAF signalling in mammalian spinal cord. Development. 
2012;139(14):2477-2487. doi:10.1242/dev.077214. 
31.  Tsai HH, Li H, Fuentealba LC, et al. Regional astrocyte allocation regulates CNS 
synaptogenesis and repair. Science (80- ). 2012;337(6092):358-362. 
doi:10.1126/science.1222381. 
32.  Ge W-P, Miyawaki A, Gage FH, Jan YN, Jan LY. Local generation of glia is a major 
astrocyte source in postnatal cortex. Nature. 2012;484(7394):376-380. 
doi:10.1038/nature10959. 
33.  Bandeira F, Lent R, Herculano-Houzel S. Changing numbers of neuronal and non-
neuronal cells underlie postnatal brain growth in the rat. Proc Natl Acad Sci U S A. 
2009;106(33):14108-14113. doi:10.1073/pnas.0804650106. 
34.  Abbott NJ, Rönnbäck L, Hansson E. Astrocyte–endothelial interactions at the blood–brain 
barrier. Nat Rev Neurosci. 2006;7(1):41-53. doi:10.1038/nrn1824. 
35.  Clarke LE, Barres BA. Emerging roles of astrocytes in neural circuit development. Nat 
Rev Neurosci. 2013;14(5):311-321. doi:10.1038/nrn3484. 
36.  Seifert G, Huttmann K, Binder DK, et al. Analysis of Astroglial K+ Channel Expression 
in the Developing Hippocampus Reveals a Predominant Role of the Kir4.1 Subunit. J 
Neurosci. 2009;29(23):7474-7488. doi:10.1523/JNEUROSCI.3790-08.2009. 
37.  Gourine A V, Kasymov V, Marina N, et al. Astrocytes control breathing through pH-
dependent release of ATP. Science. 2010;329(5991):571-575. 
doi:10.1126/science.1190721. 
38.  Song H, Stevens CF, Gage FH. Astroglia induce neurogenesis from adult neural stem 
cells. Nature. 2002;417(6884):39-44. doi:10.1038/417039a. 
24 
 
39.  Molofsky A V., Kelley KW, Tsai H-H, et al. Astrocyte-encoded positional cues maintain 
sensorimotor circuit integrity. Nature. 2014;509(7499):189-194. doi:10.1038/nature13161. 
40.  Morquette P, Verdier D, Kadala A, et al. An astrocyte-dependent mechanism for neuronal 
rhythmogenesis. Nat Neurosci. 2015;18(6):844-854. doi:10.1038/nn.4013. 
41.  Zamanian JL, Xu L, Foo LC, et al. Genomic analysis of reactive astrogliosis. J Neurosci. 
2012;32(18):6391-6410. doi:10.1523/JNEUROSCI.6221-11.2012. 
42.  Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are 
induced by activated microglia. Nature. 2017;541(7638):481-487. 
doi:10.1038/nature21029. 
43.  Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 
2016;19(8):987-991. doi:10.1038/nn.4338. 
44.  Anderson MA, Burda JE, Ren Y, et al. Astrocyte scar formation aids central nervous 
system axon regeneration. Nature. 2016;532(7598):195-200. doi:10.1038/nature17623. 
45.  Hayakawa K, Esposito E, Wang X, et al. Transfer of mitochondria from astrocytes to 
neurons after stroke. Nature. 2016;535(7613):551-555. doi:10.1038/nature18928. 
46.  Jo S, Yarishkin O, Hwang YJ, et al. GABA from reactive astrocytes impairs memory in 
mouse models of Alzheimer’s disease. Nat Med. 2014;20(8):886-896. 
doi:10.1038/nm.3639. 
47.  Klein RS, Garber C, Howard N. Infectious immunity in the central nervous system and 
brain function. Nat Immunol 2017 182. 2017;18(2):132. doi:10.1038/ni.3656. 
48.  Morga E, Faber C, Heuschling P. Cultured astrocytes express regional heterogeneity of 
the immunoreactive phenotype under basal conditions and after γ-IFN induction. J 
Neuroimmunol. 1998;87(1):179-184. doi:10.1016/S0165-5728(98)00099-X. 
49.  Fitting S, Zou S, Chen W, Vo P, Hauser KF, Knapp PE. Regional Heterogeneity and 
Diversity in Cytokine and Chemokine Production by Astroglia: Differential Responses to 
HIV-1 Tat, gp120 and Morphine Revealed by Multiplex Analysis. J Proteome Res J 
Proteome Res April. 2010;5(94):1795-1804. doi:10.1021/pr900926n. 
50.  Wacher C, Müller M, Hofer MJ, et al. Coordinated regulation and widespread cellular 
expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the 
central nervous system after infection with distinct viruses. J Virol. 2007;81(2):860-871. 
doi:10.1128/JVI.01167-06. 
51.  Cho H, Proll SC, Szretter KJ, Katze MG, Gale M, Diamond MS. Differential innate 
immune response programs in neuronal subtypes determine susceptibility to infection in 
the brain by positive-stranded RNA viruses. Nat Med. 2013;19(4):458-464. 
doi:10.1038/nm.3108. 
52.  Kipnis J. Multifaceted interactions between adaptive immunity and the central nervous 
system. Science. 2016;353(6301):766-771. doi:10.1126/science.aag2638. 
53.  Kipnis J, Cohen H, Cardon M, Ziv Y, Schwartz M. T cell deficiency leads to cognitive 
dysfunction: Implications for therapeutic vaccination for schizophrenia and other 
psychiatric conditions. 2004;101(21):8180-8185. 
54.  Brynskikh A, Warren T, Zhu J, Kipnis J. Adaptive immunity affects learning behavior in 
mice. Brain Behav Immun. 2008;22(6):861-869. doi:10.1016/J.BBI.2007.12.008. 
55.  Radjavi A, Smirnov I, Derecki N, Kipnis J. Dynamics of the meningeal CD4+ T-cell 
repertoire are defined by the cervical lymph nodes and facilitate cognitive task 
performance in mice. Mol Psychiatry. 2014;19(5):531-532. doi:10.1038/mp.2013.79. 
56.  Ziv Y, Ron N, Butovsky O, et al. Immune cells contribute to the maintenance of 
25 
 
neurogenesis and spatial learning abilities in adulthood. Nat Neurosci. 2006;9(2):268-275. 
doi:10.1038/nn1629. 
57.  Aspelund A, Antila S, Proulx ST, et al. A dural lymphatic vascular system that drains 
brain interstitial fluid and macromolecules. J Exp Med. 2015;212(7):991-999. 
doi:10.1084/jem.20142290. 
58.  Klein RS, Lin E, Zhang B, et al. Neuronal CXCL10 directs CD8+ T-cell recruitment and 
control of West Nile virus encephalitis. J Virol. 2005;79(17):11457-11466. 
doi:10.1128/JVI.79.17.11457-11466.2005. 
59.  Durrant DM, Robinette ML, Klein RS. IL-1R1 is required for dendritic cell-mediated T 
cell reactivation within the CNS during West Nile virus encephalitis. J Exp Med. 
2013;210(3):503-516. doi:10.1084/jem.20121897. 
60.  McCandless EE, Zhang B, Diamond MS, Klein RS. CXCR4 antagonism increases T cell 
trafficking in the central nervous system and improves survival from West Nile virus 
encephalitis. Proc Natl Acad Sci U S A. 2008;105(32):11270-11275. 
doi:10.1073/pnas.0800898105. 
61.  Cupovic J, Onder L, Gil-Cruz C, et al. Central Nervous System Stromal Cells Control 
Local CD8(+) T Cell Responses during Virus-Induced Neuroinflammation. Immunity. 
2016;44(3):622-633. doi:10.1016/j.immuni.2015.12.022. 
62.  Kim J V., Kang SS, Dustin ML, McGavern DB. Myelomonocytic cell recruitment causes 
fatal CNS vascular injury during acute viral meningitis. Nature. 2009;457(7226):191-195. 
doi:10.1038/nature07591. 
63.  Herz J, Johnson KR, McGavern DB. Therapeutic antiviral T cells noncytopathically clear 
persistently infected microglia after conversion into antigen-presenting cells. J Exp Med. 
2015;212(8):1153-1169. doi:10.1084/jem.20142047. 
64.  Most RG v. d. Prolonged presence of effector-memory CD8 T cells in the central nervous 
system after dengue virus encephalitis. Int Immunol. 2003;15(1):119-125. 
doi:10.1093/intimm/dxg009. 
65.  Wakim LM, Woodward-davis A, Bevan MJ. Memory T cells persisting within the brain 
after local infection show functional adaptations to their tissue of residence. 2010. 
doi:10.1073/pnas.1010201107/-
/DCSupplemental.www.pnas.org/cgi/doi/10.1073/pnas.1010201107. 
66.  Graham JB, Da Costa A, Lund JM. Regulatory T cells shape the resident memory T cell 
response to virus infection in the tissues. J Immunol. 2014;192(2):683-690. 
doi:10.4049/jimmunol.1202153. 
67.  Stewart BS, Demarest VL, Wong SJ, Green S, Bernard KA. Persistence of virus-specific 
immune responses in the central nervous system of mice after West Nile virus infection. 
BMC Immunol. 2011;12(1):6. doi:10.1186/1471-2172-12-6. 
68.  Hawke S, Stevenson PG, Freeman S, Bangham CR. Long-term persistence of activated 
cytotoxic T lymphocytes after viral infection of the central nervous system. J Exp Med. 
1998;187(10):1575-1582. doi:10.1084/JEM.187.10.1575. 
69.  Mueller SN, Mackay LK. Tissue-resident memory T cells: local specialists in immune 
defence. Nat Rev Immunol. 2016;16(2):79-89. doi:10.1038/nri.2015.3. 
70.  Schenkel JM, Fraser K a, Beura LK, Pauken KE, Vezys V, Masopust D. Resident memory 
CD8 T cells trigger protective innate and adaptive immune responses. Science (80- ). 
2014;346(6205):98-101. doi:10.1126/science.1254536. 
71.  Shiow LR, Rosen DB, Brdičková N, et al. CD69 acts downstream of interferon-α/β to 
26 
 
inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature. 2006;440(7083):540-
544. doi:10.1038/nature04606. 
72.  Mackay LK, Braun A, Macleod BL, et al. Cutting edge: CD69 interference with 
sphingosine-1-phosphate receptor function regulates peripheral T cell retention. J 
Immunol. 2015;194(5):2059-2063. doi:10.4049/jimmunol.1402256. 
73.  Casey KA, Fraser KA, Schenkel JM, et al. Antigen-independent differentiation and 
maintenance of effector-like resident memory T cells in tissues. J Immunol. 
2012;188(10):4866-4875. doi:10.4049/jimmunol.1200402. 
74.  Steinbach K, Vincenti I, Kreutzfeldt M, et al. Brain-resident memory T cells represent an 
autonomous cytotoxic barrier to viral infection. J Exp Med. 2016;213(8):1571-1587. 
doi:10.1084/jem.20151916. 
75.  Wakim LM, Woodward-Davis A, Liu R, et al. The molecular signature of tissue resident 
memory CD8 T cells isolated from the brain. J Immunol. 2012;189(7):3462-3471. 
doi:10.4049/jimmunol.1201305. 
76.  Rebola N, Carta M, Mulle C. Operation and plasticity of hippocampal CA3 circuits: 
implications for memory encoding. Nat Rev Neurosci. 2017;18(4):208-220. 
doi:10.1038/nrn.2017.10. 
77.  Newman EL, Hasselmo ME. CA3 Sees the Big Picture while Dentate Gyrus Splits Hairs. 
Neuron. 2014;81(2):226-228. doi:10.1016/J.NEURON.2014.01.004. 
78.  Neunuebel JP, Knierim JJ. CA3 Retrieves Coherent Representations from Degraded Input: 
Direct Evidence for CA3 Pattern Completion and Dentate Gyrus Pattern Separation. 
Neuron. 2014;81(2):416-427. doi:10.1016/J.NEURON.2013.11.017. 
79.  Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult 
hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci. 
2010;11(5):339-350. doi:10.1038/nrn2822. 
80.  Imayoshi I, Sakamoto M, Ohtsuka T, et al. Roles of continuous neurogenesis in the 
structural and functional integrity of the adult forebrain. Nat Neurosci. 2008;11(10):1153-
1161. doi:10.1038/nn.2185. 
81.  Yau S, Li A, So K-F. Involvement of Adult Hippocampal Neurogenesis in Learning and 
Forgetting. Neural Plast. 2015;2015:717958. doi:10.1155/2015/717958. 
82.  Clelland CD, Choi M, Romberg C, et al. A functional role for adult hippocampal 
neurogenesis in spatial pattern separation. Science. 2009;325(5937):210-213. 
doi:10.1126/science.1173215. 
83.  Creer DJ, Romberg C, Saksida LM, van Praag H, Bussey TJ. Running enhances spatial 
pattern separation in mice. Proc Natl Acad Sci U S A. 2010;107(5):2367-2372. 
doi:10.1073/pnas.0911725107. 
84.  Neves G, Cooke SF, Bliss TVP. Synaptic plasticity, memory and the hippocampus: a 
neural network approach to causality. Nat Rev Neurosci. 2008;9(1):65-75. 
doi:10.1038/nrn2303. 
85.  Bliss TVP, Lømo T. Long-lasting potentiation of synaptic transmission in the dentate area 
of the anaesthetized rabbit following stimulation of the perforant path. J Physiol. 
1973;232(2):331-356. doi:10.1113/jphysiol.1973.sp010273. 
86.  Tsien JZ, Huerta PT, Tonegawa S. The Essential Role of Hippocampal CA1 NMDA 
Receptor–Dependent Synaptic Plasticity in Spatial Memory. Cell. 1996;87(7):1327-1338. 
doi:10.1016/S0092-8674(00)81827-9. 
87.  Whitlock JR, Heynen AJ, Shuler MG, Bear MF. Learning induces long-term potentiation 
27 
 
in the hippocampus. Science. 2006;313(5790):1093-1097. doi:10.1126/science.1128134. 
88.  Mettenleiter TC. Breaching the Barrier—The Nuclear Envelope in Virus Infection. J Mol 
Biol. 2016;428(10):1949-1961. doi:10.1016/J.JMB.2015.10.001. 
89.  Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in 
their clinical presentations in England: a multicentre, population-based prospective study. 
Lancet Infect Dis. 2010;10(12):835-844. doi:10.1016/S1473-3099(10)70222-X. 
90.  Salimi H, Cain MD, Klein RS. Encephalitic Arboviruses: Emergence, Clinical 
Presentation, and Neuropathogenesis. Neurotherapeutics. 2016;13(3):514-534. 
doi:10.1007/s13311-016-0443-5. 
91.  Kramer LD, Styer LM, Ebel GD. A Global Perspective on the Epidemiology of West Nile 
Virus. Annu Rev Entomol. 2008;53(1):61-81. 
doi:10.1146/annurev.ento.53.103106.093258. 
92.  Bradshaw MJ, Venkatesan A. Herpes Simplex Virus-1 Encephalitis in Adults: 
Pathophysiology, Diagnosis, and Management. Neurotherapeutics. 2016;13(3):493-508. 
doi:10.1007/s13311-016-0433-7. 
93.  Altfeld M, Gale Jr M. Innate immunity against HIV-1 infection. Nat Immunol. 
2015;16(6):554-562. doi:10.1038/ni.3157. 
94.  Armangue T, Moris G, Cantarín-Extremera V, et al. Autoimmune post-herpes simplex 
encephalitis of adults and teenagers. Neurology. 2015;85(20):1736-1743. 
doi:10.1212/WNL.0000000000002125. 
95.  John CC, Carabin H, Montano SM, Bangirana P, Zunt JR, Peterson PK. Global research 
priorities for infections that affect the nervous system. Nature. 2015;527(7578):S178-
S186. doi:10.1038/nature16033. 
96.  STAHL JP, MAILLES A, De BROUCKER T, Group  the SC and I. Herpes simplex 
encephalitis and management of acyclovir in encephalitis patients in France. Epidemiol 
Infect. 2012;140(2):372-381. doi:10.1017/S0950268811000483. 
97.  Garcia MN, Hause AM, Walker CM, Orange JS, Hasbun R, Murray KO. Evaluation of 
Prolonged Fatigue Post–West Nile Virus Infection and Association of Fatigue with 
Elevated Antiviral and Proinflammatory Cytokines. Viral Immunol. 2014;27(7):327-333. 
doi:10.1089/vim.2014.0035. 
98.  Sadek JR, Pergam S a, Harrington J a, et al. Persistent neuropsychological impairment 
associated with West Nile virus infection. J Clin Exp Neuropsychol. 2010;32(1):81-87. 
doi:10.1080/13803390902881918. 
99.  Guerreiro R, Wojtas A, Bras J, et al. TREM2 Variants in Alzheimer’s Disease. N Engl J 
Med. 2013;368(2):117-127. doi:10.1056/NEJMoa1211851. 
100.  Chung W-S, Welsh CA, Barres BA, Stevens B. Do glia drive synaptic and cognitive 
impairment in disease? Nat Neurosci. 2015;18(11):1539-1545. doi:10.1038/nn.4142. 
101.  Mehlhop E, Diamond MS. Protective immune responses against West Nile virus are 
primed by distinct complement activation pathways. J Exp Med. 2006;203(5):1371-1381. 
doi:10.1084/jem.20052388. 
102.  Schafer DP, Lehrman EK, Kautzman AG, et al. Microglia Sculpt Postnatal Neural Circuits 
in an Activity and Complement-Dependent Manner. Neuron. 2012;74(4):691-705. 
doi:10.1016/J.NEURON.2012.03.026. 
103.  Vasek MJ, Garber C, Dorsey D, et al. A complement–microglial axis drives synapse loss 




104.  Hong S, Beja-Glasser VF, Nfonoyim BM, et al. Complement and microglia mediate early 
synapse loss in Alzheimer mouse models. Science. 2016;352(6286):712-716. 
doi:10.1126/science.aad8373. 
105.  Mucke L, Masliah E, Yu GQ, et al. High-level neuronal expression of abeta 1-42 in wild-
type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque 
formation. J Neurosci. 2000;20(11):4050-4058. doi:10.1523/JNEUROSCI.20-11-
04050.2000. 
106.  Woollacott IOC, Rohrer JD. The clinical spectrum of sporadic and familial forms of 
frontotemporal dementia. J Neurochem. 2016;138:6-31. doi:10.1111/jnc.13654. 
107.  Lui H, Zhang J, Makinson SR, et al. Progranulin Deficiency Promotes Circuit-Specific 
Synaptic Pruning by Microglia via Complement Activation. Cell. 2016;165(4):921-935. 
doi:10.1016/j.cell.2016.04.001. 
108.  Sköldenberg B, Alestig K, Burman L, et al. ACYCLOVIR VERSUS VIDARABINE IN 
HERPES SIMPLEX ENCEPHALITIS. Lancet. 1984;324(8405):707-711. 
doi:10.1016/S0140-6736(84)92623-0. 
109.  Sili U, Kaya A, Mert A, et al. Herpes simplex virus encephalitis: clinical manifestations, 
diagnosis and outcome in 106 adult patients. J Clin Virol. 2014;60(2):112-118. 
doi:10.1016/j.jcv.2014.03.010. 
110.  De Tiege X, Rozenberg F, Des Portes V, et al. Herpes simplex encephalitis relapses in 
children: Differentiation of two neurologic entities. Neurology. 2003;61(2):241-243. 
doi:10.1212/01.WNL.0000073985.71759.7C. 
111.  Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci. 
2015;1338(1):94-114. doi:10.1111/nyas.12553. 
112.  Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-
NMDA receptor encephalitis. J Neurosci. 2010;30(17):5866-5875. 
doi:10.1523/JNEUROSCI.0167-10.2010. 
113.  Planagumà J, Leypoldt F, Mannara F, et al. Human N-methyl D-aspartate receptor 
antibodies alter memory and behaviour in mice. Brain. 2015;138(Pt 1):94-109. 
doi:10.1093/brain/awu310. 
114.  Mikasova L, De Rossi P, Bouchet D, et al. Disrupted surface cross-talk between NMDA 
and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain. 2012;135(Pt 5):1606-1621. 
doi:10.1093/brain/aws092. 
115.  Guo M, Mishra A, Buchanan RL, et al. A Systematic Meta-Analysis of Toxoplasma 
gondii Prevalence in Food Animals in the United States. Foodborne Pathog Dis. 
2016;13(3):109-118. doi:10.1089/fpd.2015.2070. 
116.  Ueno N, Lodoen MB. From the blood to the brain: avenues of eukaryotic pathogen 
dissemination to the central nervous system. Curr Opin Microbiol. 2015;26:53-59. 
doi:10.1016/J.MIB.2015.05.006. 
117.  White MW, Radke JR, Radke JB. T oxoplasma development - turn the switch on or off? 
Cell Microbiol. 2014;16(4):466-472. doi:10.1111/cmi.12267. 
118.  Flegr J, Lenochová P, Hodný Z, Vondrová M. Fatal Attraction Phenomenon in Humans – 
Cat Odour Attractiveness Increased for Toxoplasma-Infected Men While Decreased for 
Infected Women. Webster JP, ed. PLoS Negl Trop Dis. 2011;5(11):e1389. 
doi:10.1371/journal.pntd.0001389. 
119.  Vyas A, Kim S-K, Giacomini N, Boothroyd JC, Sapolsky RM. Behavioral changes 
induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. 
29 
 
Proc Natl Acad Sci U S A. 2007;104(15):6442-6447. doi:10.1073/pnas.0608310104. 
120.  Poirotte C, Kappeler PM, Ngoubangoye B, Bourgeois S, Moussodji M, Charpentier MJE. 
Morbid attraction to leopard urine in Toxoplasma-infected chimpanzees. Curr Biol. 
2016;26(3):R98-R99. doi:10.1016/J.CUB.2015.12.020. 
121.  Blanchard N, Dunay IR, Schlüter D. Persistence of Toxoplasma gondii in the central 
nervous system: a fine-tuned balance between the parasite, the brain and the immune 
system. Parasite Immunol. 2015;37(3):150-158. doi:10.1111/pim.12173. 
122.  Landrith TA, Harris TH, Wilson EH. Characteristics and critical function of CD8+ T cells 
in the Toxoplasma-infected brain. Semin Immunopathol. 2015;37(3):261-270. 
doi:10.1007/s00281-015-0487-3. 
123.  Cabral CM, Tuladhar S, Dietrich HK, et al. Neurons are the Primary Target Cell for the 
Brain-Tropic Intracellular Parasite Toxoplasma gondii. Denkers EY, ed. PLOS Pathog. 
2016;12(2):e1005447. doi:10.1371/journal.ppat.1005447. 
124.  David CN, Frias ES, Szu JI, et al. GLT-1-Dependent Disruption of CNS Glutamate 
Homeostasis and Neuronal Function by the Protozoan Parasite Toxoplasma gondii. 
Pletnikov M, ed. PLOS Pathog. 2016;12(6):e1005643. doi:10.1371/journal.ppat.1005643. 
125.  Parlog A, Schlüter D, Dunay IR. Toxoplasma gondii -induced neuronal alterations. 
Parasite Immunol. 2015;37(3):159-170. doi:10.1111/pim.12157. 
126.  Ingram WM, Goodrich LM, Robey EA, Eisen MB. Mice Infected with Low-Virulence 
Strains of Toxoplasma gondii Lose Their Innate Aversion to Cat Urine, Even after 
Extensive Parasite Clearance. Wilson EH, ed. PLoS One. 2013;8(9):e75246. 
doi:10.1371/journal.pone.0075246. 
127.  Mahmoudvand H, Ziaali N, Ghazvini H, et al. Toxoplasma gondii Infection Promotes 
Neuroinflammation Through Cytokine Networks and Induced Hyperalgesia in BALB/c 
Mice. Inflammation. 2016;39(1):405-412. doi:10.1007/s10753-015-0262-6. 
128.  Riazi K, Galic MA, Kentner AC, Reid AY, Sharkey KA, Pittman QJ. Microglia-
dependent alteration of glutamatergic synaptic transmission and plasticity in the 
hippocampus during peripheral inflammation. J Neurosci. 2015;35(12):4942-4952. 
doi:10.1523/JNEUROSCI.4485-14.2015. 
129.  Wu MD, Montgomery SL, Rivera-Escalera F, Olschowka JA, O’Banion MK. Sustained 
IL-1β expression impairs adult hippocampal neurogenesis independent of IL-1 signaling 
in nestin+ neural precursor cells. Brain Behav Immun. 2013;32:9-18. 
doi:10.1016/J.BBI.2013.03.003. 
130.  del Rey A, Balschun D, Wetzel W, Randolf A, Besedovsky HO. A cytokine network 
involving brain-borne IL-1β, IL-1ra, IL-18, IL-6, and TNFα operates during long-term 
potentiation and learning. Brain Behav Immun. 2013;33:15-23. 
doi:10.1016/J.BBI.2013.05.011. 
131.  Eells JB, Wilcots J, Sisk S, Guo-Ross SX. NR4A Gene Expression Is Dynamically 
Regulated in the Ventral Tegmental Area Dopamine Neurons and Is Related to Expression 
of Dopamine Neurotransmission Genes. J Mol Neurosci. 2012;46(3):545-553. 
doi:10.1007/s12031-011-9642-z. 
132.  Grimes DA, Han F, Panisset M, et al. Translated mutation in the Nurr1 gene as a cause for 
Parkinson’s disease. Mov Disord. 2006;21(7):906-909. doi:10.1002/mds.20820. 
133.  Lallier SW, Graf AE, Waidyarante GR, Rogers LK. Nurr1 expression is modified by 




134.  Eells JB, Varela-Stokes A, Guo-Ross SX, et al. Chronic Toxoplasma gondii in Nurr1-Null 
Heterozygous Mice Exacerbates Elevated Open Field Activity. Wilson EH, ed. PLoS One. 
2015;10(4):e0119280. doi:10.1371/journal.pone.0119280. 
135.  Hamdani N, Daban-Huard C, Lajnef M, et al. Cognitive deterioration among bipolar 
disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels. J 
Affect Disord. 2015;179:161-166. doi:10.1016/J.JAD.2015.03.038. 
136.  Stanaway JD, Shepard DS, Undurraga EA, et al. The global burden of dengue: an analysis 
from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(6):712-723. 
doi:10.1016/S1473-3099(16)00026-8. 
137.  Brinton MA. The Molecular Biology of West Nile Virus: A New Invader of the Western 
Hemisphere. Annu Rev Microbiol. 2002;56(1):371-402. 
doi:10.1146/annurev.micro.56.012302.160654. 
138.  Hughes TP, Paul JH, Smithburn KC, Burke AW. A Neurotropic Virus Isolated from the 
Blood of a Native of Uganda 1. Am J Trop Med Hyg. 1940;s1-20(4):471-492. 
doi:10.4269/ajtmh.1940.s1-20.471. 
139.  Nash D, Mostashari F, Fine A, et al. The Outbreak of West Nile Virus Infection in the 
New York City Area in 1999. N Engl J Med. 2001;344(24):1807-1814. 
doi:10.1056/NEJM200106143442401. 
140.  Burakoff A, Lehman J, Fischer M, Staples JE, Lindsey NP. West Nile Virus and Other 
Nationally Notifiable Arboviral Diseases — United States, 2016. MMWR Morb Mortal 
Wkly Rep. 2018;67(1):13-17. doi:10.15585/mmwr.mm6701a3. 
141.  Zou S, Foster GA, Dodd RY, Petersen LR, Stramer SL. West Nile Fever Characteristics 
among Viremic Persons Identified through Blood Donor Screening. J Infect Dis. 
2010;202(9):1354-1361. doi:10.1086/656602. 
142.  Davis LE, DeBiasi R, Goade DE, et al. West Nile virus neuroinvasive disease. Ann 
Neurol. 2006;60(3):286-300. doi:10.1002/ana.20959. 
143.  Carson PJ, Konewko P, Wold KS, et al. Long-term clinical and neuropsychological 
outcomes of West Nile virus infection. Clin Infect Dis. 2006;43(6):723-730. 
doi:10.1086/506939. 
144.  Loeb M. Prognosis after West Nile Virus Infection. Ann Intern Med. 2008;149(4):232. 
doi:10.7326/0003-4819-149-4-200808190-00004. 
145.  Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West 
Nile virus infection. JAMA. 2003;290(4):511-515. doi:10.1001/jama.290.4.511. 
146.  Klee AL, Maldin B, Edwin B, et al. Long-Term Prognosis for Clinical West Nile Virus 
Infection. 2004;10(8):8-14. 
147.  Patnaik JL, Harmon H, Vogt RL. Human West Nile Virus Infections ,. 2006;12(7):1129-
1131. 
148.  Haaland KY, Sadek J, Pergam S, et al. Mental status after West Nile virus infection. 
Emerg Infect Dis. 2006;12(8):1260-1262. doi:10.3201/eid1208.060097. 
149.  Murray K, Walker C, Herrington E, et al. Persistent Infection with West Nile Virus Years 
after Initial Infection. J Infect Dis. 2010;201(1):2-4. doi:10.1086/648731. 
150.  Patel H, Sander B, Nelder MP. Long-term sequelae of West Nile virus-related illness: a 
systematic review. Lancet Infect Dis. 2015;15(8):951-959. doi:10.1016/S1473-
3099(15)00134-6. 
151.  Dick GW., Kitchen S., Haddow A. Zika Virus (I). Isolations and serological specificity. 
Trans R Soc Trop Med Hyg. 1952;46(5):509-520. doi:10.1016/0035-9203(52)90042-4. 
31 
 
152.  Duffy MR, Chen T-H, Hancock WT, et al. Zika Virus Outbreak on Yap Island, Federated 
States of Micronesia. N Engl J Med. 2009;360(24):2536-2543. 
doi:10.1056/NEJMoa0805715. 
153.  Cao-Lormeau V-M, Blake A, Mons S, et al. Guillain-Barré Syndrome outbreak associated 
with Zika virus infection in French Polynesia: a case-control study. Lancet. 
2016;387(10027):1531-1539. doi:10.1016/S0140-6736(16)00562-6. 
154.  WHO | WHO statement on the first meeting of the International Health Regulations 
(2005) (IHR 2005) Emergency Committee on Zika virus and observed increase in 
neurological disorders and neonatal malformations. WHO. 2016. 
http://www.who.int/mediacentre/news/statements/2016/1st-emergency-committee-
zika/en/. Accessed April 18, 2018. 
155.  Moore CA, Staples JE, Dobyns WB, et al. Characterizing the Pattern of Anomalies in 
Congenital Zika Syndrome for Pediatric Clinicians. JAMA Pediatr. 2017;171(3):288. 
doi:10.1001/jamapediatrics.2016.3982. 
156.  Roth W, Tyshkov C, Thakur K, Vargas W. Encephalomyelitis Following Definitive Zika 
Virus Infection. Neurol Neuroimmunol neuroinflammation. 2017;4(4):e349. 
doi:10.1212/NXI.0000000000000349. 
157.  Rozé B, Najioullah F, Signate A, et al. Zika virus detection in cerebrospinal fluid from 
two patients with encephalopathy, Martinique, February 2016. Eurosurveillance. 
2016;21(16):30205. doi:10.2807/1560-7917.ES.2016.21.16.30205. 
158.  Carteaux G, Maquart M, Bedet A, et al. Zika Virus Associated with Meningoencephalitis. 
N Engl J Med. 2016;374(16):1595-1596. doi:10.1056/NEJMc1602964. 
159.  Soares CN, Brasil P, Carrera RM, et al. Fatal encephalitis associated with Zika virus 
infection in an adult. J Clin Virol. 2016;83:63-65. doi:10.1016/J.JCV.2016.08.297. 
160.  Mécharles S, Herrmann C, Poullain P, et al. Acute myelitis due to Zika virus infection. 
Lancet. 2016;387(10026):1481. doi:10.1016/S0140-6736(16)00644-9. 
161.  Muñoz LS, Parra B, Pardo CA. Neurological Implications of Zika Virus Infection in 
Adults. J Infect Dis. 2017;216(suppl_10):S897-S905. doi:10.1093/infdis/jix511. 
162.  Mehta R, Soares CN, Medialdea-Carrera R, et al. The spectrum of neurological disease 
associated with Zika and chikungunya viruses in adults in Rio de Janeiro, Brazil: A case 
series. Beasley DWC, ed. PLoS Negl Trop Dis. 2018;12(2):e0006212. 
doi:10.1371/journal.pntd.0006212. 
163.  Meda N, Salinas S, Kagoné T, Simonin Y, Van de Perre P. Zika virus epidemic: Africa 
should not be neglected. Lancet. 2016;388(10042):337-338. doi:10.1016/S0140-
6736(16)31103-5. 
164.  Olusanya BO. Full-term newborns with congenital microcephaly and macrocephaly in 
Southwest Nigeria. Int Health. 2012;4(2):128-134. doi:10.1016/J.INHE.2011.12.006. 
165.  Tang H, Hammack C, Ogden SC, et al. Zika virus infects human cortical neural 
progenitors and attenuates their growth. Cell Stem Cell. 2016;18(5):587-590. 
doi:10.1016/j.stem.2016.02.016. 
166.  Garcez PP, Loiola EC, Madeiro da Costa R, et al. Zika virus impairs growth in human 
neurospheres and brain organoids. Science. 2016;352(6287):816-818. 
doi:10.1126/science.aaf6116. 
167.  Li H, Saucedo-Cuevas L, Regla-Nava JA, et al. Zika Virus Infects Neural Progenitors in 




168.  van den Pol AN, Mao G, Yang Y, Ornaghi S, Davis JN. Zika Virus Targeting in the 
Developing Brain. J Neurosci. 2017;37(8):2161-2175. doi:10.1523/JNEUROSCI.3124-
16.2017. 
169.  Huang W-C, Abraham R, Shim B-S, Choe H, Page DT. Zika virus infection during the 
period of maximal brain growth causes microcephaly and corticospinal neuron apoptosis 
in wild type mice. Sci Rep. 2016;6(1):34793. doi:10.1038/srep34793. 
170.  Adams Waldorf KM, Nelson BR, Stencel-Baerenwald JE, et al. Congenital Zika virus 
infection as a silent pathology with loss of neurogenic output in the fetal brain. Nat Med. 
2018;24(3):368-374. doi:10.1038/nm.4485. 
171.  Lazear HM, Govero J, Smith AM, et al. A Mouse Model of Zika Virus Pathogenesis. Cell 
Host Microbe. 2016;19(5):720-730. doi:10.1016/j.chom.2016.03.010. 
172.  Kumar A, Hou S, Airo AM, et al. Zika virus inhibits type-I interferon production and 
downstream signaling. EMBO Rep. 2016;17(12):1766-1775. 
doi:10.15252/embr.201642627. 
173.  Grant A, Ponia SS, Tripathi S, et al. Zika Virus Targets Human STAT2 to Inhibit Type I 
Interferon Signaling. Cell Host Microbe. 2016;19(6):882-890. 
doi:10.1016/J.CHOM.2016.05.009. 
174.  Tripathi S, Balasubramaniam VRMT, Brown JA, et al. A novel Zika virus mouse model 
reveals strain specific differences in virus pathogenesis and host inflammatory immune 







Chapter 2: Astrocytes decrease adult 
neurogenesis during memory dysfunction via 
Il-1 
 
This chapter is adapted from a manuscript published in Nature Immunology: 
Garber C, Vasek MJ, Vollmer LL, Sun T, Jiang X, Klein RS. Astrocytes decrease adult 
neurogenesis during virus-induced memory dysfunction via IL-1. Nat Immunol. 
2018;19(2):151-161. doi:10.1038/s41590-017-0021-y. 
 
C.G., M.J.V., and R.S.K. designed the experiments; C.G. and M.J.V. did most of the 
experiments, compiled and analyzed the data; C.G., M.J.V., and R.S.K. prepared the figures; 
L.L.V., T.S. and X.J. were involved in specific experiments; C.G., M.J.V., and R.S.K. analyzed 
the data and wrote the manuscript. 
 
2.1 Abstract 
Memory impairment following West Nile virus neuroinvasive disease (WNND) is associated 
with loss of hippocampal synapses with lack of recovery. Adult neurogenesis and synaptogenesis 
are fundamental features of hippocampal repair, suggesting viruses impact these processes. Here, 
using an established model of WNND-induced cognitive dysfunction, transcriptional profiling 
revealed alterations in gene expression that limit adult neurogenesis, including interleukin (IL)-1. 
WNND-recovered animals exhibit decreased neuroblasts and increased astrogenesis, without 
recovery of hippocampal neurogenesis at thirty days. Analysis of cytokine production in ex vivo 
isolated microglia and astrocytes revealed the latter to be the predominant source of IL-1. IL-
1R1-deficient, WNND-recovered mice exhibit normal neurogenesis, recovery of presynaptic 
termini, and resistance to spatial learning defects, the latter of which likewise occurred after 
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treatment with IL-1R1 antagonist. Thus, preferential generation of proinflammatory astrocytes 
impairs neuronal progenitor cell homeostasis via expression of IL-1, which may underlie long-
term cognitive consequences of WNND, but provides a therapeutic target. 
2.2 Introduction 
Members of the Flavivirus genus, which include West Nile (WNV), Japanese encephalitis (JEV), 
and Zika (ZIKV) viruses, are the most important arthropod-borne viruses causing encephalitis in 
humans1. Acutely, patients suffering from WNV neuroinvasive disease (WNND) can experience 
confusion, fatigue, loss of motor control, memory loss, coma, and a mortality rate of 5-10%1. WNV 
is a (+)-sense single-stranded RNA virus that targets fully differentiated neurons, but may be 
cleared by immune-mediated processes, even after infection of the central nervous system (CNS)2. 
However, approximately half of survivors experience debilitating, long-term cognitive sequelae, 
including defects in verbal and visuospatial learning, for months to years beyond the acute 
infectious event3,4. Animal studies have identified multiple cytokines that play critical roles in cell-
mediated antiviral immunity, including tumor necrosis factor (TNF)5, type I, II and III interferons 
(IFNs)6-9, and interleukin (IL)-110,11, which improve survival. Prior studies have determined that 
human and murine neurons are the target of WNV in vivo12-14. Importantly, studies in which critical 
cytokines have been deleted via genetic approaches have not led to expanded tropism of WNV to 
nonneuronal cells within the CNS10,15. While neuronal death is associated with high mortality in 
human and murine cases of WNV encephalitis16, survivors may exhibit limited neuronal loss14,17, 
suggesting inflammatory processes triggered acutely contribute to long-term memory dysfunction. 
That many patients recovering from WNND experience memory impairments for months to years 




In a murine model of recovery from WNND, in which intracranial inoculation of a mutant 
WNV (WNV-NS5-E218A) leads to high survival rates with visuospatial learning defects, 
hippocampi exhibit up-regulation of genes involved in microglial-mediated synaptic remodeling, 
including drivers of phagocytosis and the classical complement pathway, and decreased expression 
of synaptic scaffolding proteins and glutamate receptors14. Complement-mediated synapse 
elimination has been reported to occur in numerous neuroinflammatory diseases, including 
multiple sclerosis18, Alzheimer’s disease19, and schizophrenia20, suggesting this may be a general 
mechanism underlying inflammation-associated disruption of neural circuitry. The hippocampus, 
essential for spatial and contextual memory formation, receives input from the entorhinal cortex, 
which relays through the dentate gyrus, CA3, and CA121. WNV-NS5-E218A-recovered mice with 
poor spatial learning show persistence of phagocytic microglia engulfing presynaptic terminals 
within the hippocampal CA3 acutely, and during recovery14. While this provides molecular 
explanations for poor spatial learning in WNV-recovered animals, it does not explain why other 
hippocampal correlates of learning, such as adult neurogenesis, are not able to restore spatial 
learning.   
Adult neurogenesis occurs within the hippocampal dentate gyrus (DG) and the 
subventricular zone (SVZ)22. Within the DG, adult neural stem cells (NSCs) give rise to astrocytes 
and intermediate neuronal progenitors, the latter of which proliferate and differentiate into 
neuroblasts that mature into granule cell neurons and integrate into the hippocampal circuit over 
the course of a few weeks23. This process is regulated by intrinsic and extrinsic factors, including 
local signaling molecules, exercise, aging and inflammation24. A variety of endogenous factors 
play critical roles in the generation and integration of newly generated neurons in the adult 
hippocampus. These include morphogens, such as neurogenic locus notch homolog (Notch) 
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proteins, sonic hedgehog (Shh), wingless integrated signals (Wnts), and bone morphogenic 
proteins (BMPs), and neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), 
ciliary neurotrophic factor (CNTF), insulin-like growth factor-1 (IGF-1), and vascular 
endothelium growth factor (VEGF)25. Recently, proinflammatory pathways, including those 
triggered by systemic accumulations of TNF, interleukin (IL)-1b, and IL-6, and microglial 
activation have been implicated in the regulation of neural correlates of memory including adult 
neurogenesis, synaptic plasticity and modulation of long-term potentiation14,26-29.   
IL-1, in particular, has gained attention for its impact on cognitive function in the context 
of neuroinflammation. IL-1 signaling is mediated by a family of proteins comprised of IL-1a, IL-
1b, and IL-1 receptor antagonist (IL-1ra) primarily through type I IL-1 receptor (IL-1R1). IL-1b 
is generated via proteolytic cleavage of pro-IL-1b by Caspase 1 during inflammasome activation30. 
IL-1 is highly expressed in vivo by infiltrating myeloid cells during WNV encephalitis, where it 
critically regulates antiviral effector T cell responses10,11. While IL-1 is a key player in 
orchestrating CNS immune responses, including onset of fever27, it also plays a role in spatial 
learning and memory-related behavior28. Indeed, injection of IL-1b into the brain impairs spatial 
learning, contextual fear memory, and adult neurogenesis29–31. Although several studies have 
investigated impacts of IL-1 on hippocampal-based learning and behavior in neurologic diseases31-
35, none have done so in a setting of IL-1 induction during CNS viral infection.  
Here, using an established model of post-infectious cognitive dysfunction from WNND 
in which animals display defects in spatial learning, we investigated the regulation of 
neurogenesis during repair and recovery. We identified a novel feed forward mechanism in 
which IL-1 contributes to spatial learning defects via derailment of hippocampal neurogenesis to 
generate proinflammatory astrocytes, which exhibit a previously unidentified role in IL-1-
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mediated cognitive dysfunction, and that this pathway may be successfully targeted for the 
prevention of learning defects during recovery from viral encephalitis. 
2.3 Results 
WNND-recovered mice exhibit genetic signatures of derailed neurogenesis  
Our previous microarray study of hippocampal gene expression in WNV-NS5-E218A-recovered 
mice identified several significantly altered pathways in mice with impaired spatial memory 
including axon guidance, Wnt signaling, and p53 signaling14, which point to potential effects on 
adult neurogenesis. To further examine these pathways, we grouped the genes altered between 
Mock and WNV-NS5-E218A-recovered animals into those that promote or inhibit neurogenesis, 
here shown as gene expression heatmaps (Fig. 2.1a, b). Expression of genes associated with 
inflammation and/or prohibition of neurogenesis (Casp1, Il1a, Tnf, Tnfrsf1a) was higher in WNV-
NS5-E218A-recovered (Fig. 2.1a) compared with mock-infected mice, which exhibited higher 
expression of genes that promote proliferation and differentiation of neuroblasts (Epha5, Wnt2, 
Nrg3) and axon guidance (Robo2, Sema3) (Fig. 2.1b). Markers for recently identified subgroups 
of reactive astrocytes36 deemed A2 and A1, the latter of which are proposed to be induced by 
activated microglia and lose the ability to promote neuronal survival, outgrowth, were also 
significantly elevated (Fig. 2.1c, d). Alterations in genes that impact neurogenesis after infection 
with WNV-NS5-E218A and markers of reactive astrocytes, including additional panreactive 
astrocyte markers36 were validated in an independent set of hippocampal samples by qPCR (Fig. 
2.1e-h).  These data suggest that WNND might limit adult neurogenesis in favor of astrogenesis. 
 
WNND induces acute loss of adult neurogenesis in the hippocampus 
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Given that genetic signatures in the hippocampi of WNV-recovered mice are consistent with 
pathways that negatively impact adult neurogenesis, we evaluated the generation of new neurons 
during WNV encephalitis. We administered BrdU during the peak of WNV encephalitis for a 
period of 4 days (days 3-7), allowed mice to recover for 45 days and then evaluated numbers of 
newly generated neurons (Fig. 2.2a-d). WNV-recovered mice exhibited fewer BrdU-labeled 
neurons within the DG granule cell layer than mock-infected controls (Fig. 2.2a, c, d). To 
determine whether reduction in newly generated neurons in WNV-recovered mice is due to 
alteration in the rate of neuronal progenitor cell proliferation, mock-infected versus WNV-NY99-
infected or WNV-NS5-E218A-infected mice were administered BrdU during the peak of 
encephalitis, followed by either immunohistochemical (Fig. 2.3a, b) or flow cytometric (Fig. 2.8) 
evaluation of neuronal progenitors, which express doublecortin (DCX+), in the SVZ or 
hippocampi, as described previously37. Infections with wild-type WNV (NY-99) via either the 
peripheral footpad or intracranial route, or attenuated WNV-NS5-E218A all led to fewer BrdU-
labeled neuroblasts at 6-8 days post-infection (Fig. 2.3c). This reduction in generation of 
neuroblasts was assessed over the course of recovery from WNND, at days 6, 15, and 30 post-
infection (d.p.i.) as compared to age-matched mock-infected controls. This analysis revealed that 
significant deficits persist until day 30 in the hippocampus, with a trend towards recovery observed 
in the SVZ (Fig. 2.3d). Taken together, these data indicate that hippocampal neuronal repair is 
defective after WNND. 
 
WNV does not target NSCs or neuronal progenitors 
One possible explanation of fewer new neurons after the recovery period of WNV encephalitis is 
that neuroblasts are dying before reaching maturity. In agreement with previous studies, we 
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confirmed that neural stem cells and intermediate neuronal progenitors were not permissive to 
WNV infection36, and observed that less than 1% of DCX+ neuroblasts were infected in vivo in 
both the SVZ and DG (Fig. 2.9a). Furthermore, rates of neuroblast apoptosis during acute WNND 
were equivalent to mock-infected controls (data not shown). The few infected neuroblasts that 
were observed within the DG were located within the granule cell layer, suggesting that these may 
be late-stage DCX+ cells during their transition into immature neurons. Late-stage neuroblasts 
exhibit many of the same properties as neurons including, receptors, filament proteins, and cellular 
processes (e.g. axon and dendrite formation), thus potentially explaining the ability of WNV to 
infect them. Alterations in the proliferation rates of neural progenitors could result in changes to 
the overall pool of stem cells over time. Using mice expressing GFP under the Nestin promoter, 
we counted the numbers of Nestin and GFAP-double positive neural stem cells remaining within 
the hippocampal DG at 45 days post-infection, but found no differences in the numbers of these 
cells present in mock and WNV-NS5-E218A recovered mice (Fig. 2.9b). Thus, WNV does not 
target or alter the numbers of NSCs, nor does it infection neuroblasts.  
 
Astrocytes are the primary source of IL-1β in the recovering CNS 
To further investigate the potential for an alteration in cell fate of early stage progenitors, we 
determined whether fewer neuronal progenitors were produced in favor of more glial progenitors 
within the hippocampus of WNV-infected mice. To test this, mock- versus WNV-NY- or WNV-
NS5-E218A-infected mice were administered BrdU during the peak of encephalitis followed by 
flow cytometric evaluation of hippocampal neuronal progenitors and astrocytes 48 hours later (Fig. 
2.4a, b). Infections with either wild type WNV (NY-99) or WNV-NS5-E218A led to more BrdU-
labeled GFAP-expressing astrocytes in the hippocampus at 7 days post infection than mock-
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infected controls (Fig. 2.4b). Although GFAP expression varies among astrocyte subpopulations, 
recent work has demonstrated that GFAP is the most highly expressed transcript and protein in 
astrocytes isolated from the hippocampus38. Next, we determined whether an increase in astrocyte 
genesis during acute infection significantly contributes to alterations in the CNS immune profile 
after viral clearance. Analysis of ex vivo-isolated astrocytes at 25 d.p.i. demonstrated an increase 
in markers of A1, but not A2, reactive astrocyte markers, (Fig. 2.4c, c′). Thus, the slight increases 
in neuroprotective markers previously detected in whole hippocampal samples at the same time 
point (Fig. 2.1c-e) are likely contributed by other cell types. Analysis of panreactive markers36 
also detected increased expression of GFAP (Fig. 2.4c′). Identification of cellular sources of anti-
neurogenic and proinflammatory cytokines in the CNS via transcriptional analysis of ex vivo-
isolated astrocytes and microglia at 25 d.p.i. revealed astrocytes as the primary source of IL-1b, 
Caspase-1, and TNF (Fig. 2.4d). The purity of those cellular sources was confirmed by 
transcriptional analysis of cell type-specific markers, as previously reported39. Isolated astrocytes 
demonstrated significant enrichment of the astrocyte Gfap gene expression while isolated 
microglia show significant enrichment of microglial Cx3cr1 and Trem2 expression. Both ASCA-
2 positive astrocytes and CD11b positive microglia had negligible expression of the neuronal gene 
Rbfox3 (Fig. 2.10). Kinetic analysis of Il1b expression within hippocampi of WNV-NS5-E218A-
infected mice showed persistent elevation of this anti-neurogenic cytokine at 25 d.p.i. (Fig. 2.4e). 
Immunohistochemical analysis of mock- and WNV-NS5-E218A-infected tissue at 25 d.p.i. (Fig. 
2.4f) confirmed increases in numbers of activated, GFAP+ astrocytes (Fig. 2.4g) that are the 
primary cellular source of IL-1b protein expression in the recovering hippocampus (Fig. 2.4h, i). 
Taken altogether, these data indicate that WNND promotes the generation of A1 reactive 




Il1r1-/- mice resist alterations in cell fate of early progenitors 
To determine whether WNV-mediated reduction in neuroblast proliferation requires IL-1R1 
signaling, mock- and WNV-NS5-E218A-infected Il1r1-/- mice were administered BrdU during the 
peak of encephalitis, followed by flow cytometric evaluation of hippocampal neuronal progenitors. 
In contrast to the reduction in neuroblast proliferation observed in neurogenic zones of wild type 
animals, Il1r1-/- mice exhibited normal neurogenesis in both the hippocampus (Fig. 2.5a) and SVZ 
(Fig. 2.5b). In addition, Il1r1-/- mice did not undergo the substantial increase in proliferating 
astrocytes observed in wild-type animals (Fig. 2.5c). Immunohistochemical identification of 
Ki67+ proliferating neural progenitor cells in conjunction with Mash1, which identifies early 
neural progenitor cells with neurogenic potential40, within the DG revealed acute WNV-mediated 
decreases in wild-type animals, but not in animals deficient in IL-1R1 or Caspase 1 (Casp1-/-), 
which cleaves pro-IL-1b to produce mature IL-1b (Fig. 2.5d). Acute viral loads did not differ 
between wild-type and Il1r1-/- animals at 6 d.p.i. in various brain regions (Fig. 2.11a-c), and there 
was no difference in persistent viral RNA at 25 d.p.i. in the hippocampus (Fig. 2.11d), confirming 
that virologic control of WNV-NS5-E218A was intact in Il1r1-/- animals. In addition, flow 
cytometric analysis of cells isolated from the hippocampus demonstrated similar numbers of 
various subpopulations of resident and infiltrating CD45+ cells in WNV-NS5-E218A infected 
wildtype and Il1r1-/- animals (Fig. 2.11e-l).  These data support the notion that IL-1R1 signaling 
underlies derailment of neurogenesis during WNND. 
 
Il1r1-/- mice exhibit synapse recovery and normal spatial learning  
42 
 
Given that Il1r1-/- mice are protected from derailed neurogenesis following WNV infection, we 
hypothesized that IL-1R1-deficient animals would exhibit improved synapse recovery following 
infection with WNV-NS5-E218A. Both WNV-NS5-E218A-infected wild-type and Il1r1-/- mice 
exhibit acute loss of presynaptic terminals at 7 d.p.i. (Fig. 2.5e), and wild-type animals continued 
to show decreased numbers of presynaptic terminals at 25 d.p.i. In contrast, Il1r1-/- animals 
displayed recovery of synapses at this time point (Fig. 2.5f). Given that adult neurogenesis and 
synaptic plasticity are critical for spatial learning, we allowed WNV-NS5-E218A-infected, Il1r1-
/- mice to recover for a month beyond viral clearance (46 d.p.i.) and tested their ability to spatially 
locate and remember the location of a target hole in a Barnes maze over the course of 10 trials held 
twice daily for 5 days (Fig. 2.6a). While WNV-recovered, wild-type mice display significant 
deficits in spatial learning14 (Fig. 2.6b), the performance of WNV-recovered Il1r1-/- mice was 
indistinguishable from mock-infected animals (Fig 2.6c). Area under the curve (AUC) analysis for 
each animal, which allows a comprehensive view of how individuals within the group performed 
across all 5 days of testing on the Barnes Maze, demonstrated that wild-type animals recovering 
from WNND had more severe memory impairments than mock-infected wild-type controls and 
WNND recovered Il1r1-/- animals (Fig 2.6d). To assess differences in exploratory behavior that 
may affect performance on the Barnes Maze spatial learning task, we performed Open Field testing 
(OFT) at 45 d.p.i., 1 day prior to the Barnes Maze (Fig. 2.6a). While the number of lines crossed 
during OFT were similar for mock- and WNV-infected mice of both genotypes, mock-infected 
Il1r1-/- animals crossed fewer lines than mock-infected wild-type controls (Fig. 2.6e). No 
differences in the number of center crosses were observed between all groups (Fig. 2.6f). These 




IL-1R antagonism prevents WNV-induced spatial learning deficits 
In order to explore the potential for therapeutic intervention, we opted to test cognitive recovery 
in wild-type animals treated during acute infection with either vehicle or the IL-1R antagonist, 
Anakinra.  As synapse elimination14 and loss of neurogenesis occurs during acute infection, which 
is also when IL-1 expression was highest, we began treatment at 10 d.p.i., a time point during viral 
clearance14 when the blood brain barrier was still permeable (Fig. 2.12). Mock- or WNV-NS5-
E218A-infected animals received 5 daily intra-peritoneal doses of vehicle or Anakinra, and then 
recovered for 30 days prior to Barnes Maze testing at 46 d.p.i. (Fig. 2.7a). As expected, vehicle 
treated WNND recovered animals were significantly impaired in their ability to identify the 
location of the target hole during Barnes Maze testing (Fig. 2.7b). In contrast, animals treated with 
Anakinra were protected from WNV-induced spatial learning impairment (Fig. 2.7c). AUC 
analysis confirmed that WNND-recovered animals treated with Anakinra had improved 
performance on the Barnes Maze compared with vehicle treated animals (Fig. 2.7d). Finally, OFT 
at 45 d.p.i. demonstrated that there were no differences between any of the groups in exploratory 
behavior, locomotion, or number of center crosses (Fig. 2.7f). These studies identify a potential 
therapeutic target for the prevention of spatial learning defects that occur during recovery from 
WNND. 
2.4 Discussion 
The original designation of cytokines as immune modulators has expanded to include a variety of 
functions in nonlymphoid tissues, especially the CNS, where they play critical roles in 
neurodevelopment. Regulation of signaling by the gp130 family of cytokines through Janus 
Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) pathways maintains the 
pool of neural stem and progenitor cells (NPCs), promoting neurogenesis of the latter41. During 
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development, IL-1R1 is also expressed on proliferating NPCs and IL-1b exerts an anti-
proliferative, anti-neurogenic and pro-gliogenic effect on embryonic hippocampal NPCs in 
vitro42,43.  Studies of viral encephalitis have demonstrated critical roles for innate cytokines 
expressed by infiltrating immune cells in T cell-mediated clearance of pathogen. However, their 
impact on CNS recovery and repair after viral clearance via actions on NPCs has not been 
elucidated. Our findings suggest that during the acute phase of viral infection, myeloid cell-derived 
IL-1 (ref.10) alters the proliferation and differentiation fates of neural progenitor cells, leading to a 
shift from neurogenesis to astrogenesis. Proinflammatory astrocytes then become the predominant 
source of the cytokine, which continues to inhibit neurogenesis, after myeloid cells retreat from 
the CNS14. Accordingly, mice deficient in IL-1R signaling are resistant to both derailment of 
neurogenesis as well as spatial memory impairments, which are observed in wild-type WNV-
recovered mice. Because loss of neurogenesis is detected early in the course of infection, 
administration of IL-1R antagonist at 10 d.p.i., a time-point when the BBB is still permeable, was 
able to reverse the effects of IL-1 and improve spatial learning. Our data indicate that the 
combinatorial effect of synapse loss14 and reduced neurogenesis can negatively impact 
hippocampal spatial learning and memory long beyond the initial episode of infection via a shift 
in sources of cytokines to neural cells. 
 Other neurotropic flaviviruses, including Japanese Encephalitis and Zika Virus, have been 
shown to directly infect neural progenitors, causing apoptosis of progenitors and progeny44,45. In 
agreement with previous studies46, we found very few neural progenitor cells infected with WNV. 
However, transcriptional profiling detected altered expression of genes implicated in hippocampal 
neurogenesis during WNND recovery. These included increased expression of genes that encode 
CDKN1a, CDCA4, and CCND1, cell cycle progression inhibitors, and decreased expression of 
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genes that encode Epha5 and Sema6B, which regulate hippocampal axon pathfinding during neural 
development47,48, were detected during WNND recovery. We also detected alterations to the Wnt 
signaling pathway, which can impact neural progenitor cell proliferation and motility, but also 
regulates synapse formation49 and plasticity50, potentially contributing to the failure of mice to 
recover from both neurogenesis derailment as well as WNV-mediated synapse loss14. The genetic 
signatures present during WNV recovery describes an environment which both impedes neural 
progenitor cell proliferation and the ability of immature and mature neurons to form new synapses.  
While previous studies have detected IL-1R1 within the hippocampus51, recent research 
highlighting astrocyte heterogeneity has not identified these cells as a first target of IL-152. In 
contrast, numerous studies have implicated neural progenitor cells as a significant target of IL-1. 
IL-1a and IL-1b have both been shown to induce neural stem and progenitor cells to favor the 
astrocyte rather than neuronal lineage in vitro42. TNF, which is highly expressed in WNV-infected 
brains5 in an IL-1R-dependent manner10, has been shown in other contexts to direct neuronal 
progenitors towards an astrocyte fate via downstream STAT3 induction53, suggesting that these 
may be part of the same anti-neurogenic pathway.  In vivo studies using overexpression and stress 
models have shown that IL-1b decreases neurogenesis43,54,55, and influences synaptic plasticity56,57, 
processes that are vital for the development and retention of spatial memory. We found that 
abundance of IL-1b during acute infection altered lineage fate of neural stem cells within 
neurogenic zones of the CNS favoring astrocyte genesis. This led to a feed-forward cycle of 
inflammation, as astrocytes became the primary source of IL-1β in the recovering hippocampus. 
IL-1R1-deficient mice were protected from decreased neurogenesis following WNV infection, and 
retained the ability to learn a spatial memory task. Importantly, we demonstrated that the effect 
was specific to inflammasome-activated IL-1b by confirming that Casp1-/- animals were also 
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protected from decreased neurogenesis. In studies using cultured NPCs, IL-1b and TNF are both 
capable of altering lineage-fate to favor greater numbers of astrocytes and both of these pathways 
are dependent on downstream STAT3 activation58. While we focused on the role and necessity of 
IL-1R signaling, TNF, which was also upregulated by astrocytes at 25 d.p.i., may also contribute 
to the observed lineage fate-altering phenotype. 
 While multiple studies have described effects of cytokines released from astrocytes59 and 
microglia60 on memory and hippocampal neurogenesis, the precise contributions of each cell type 
in vivo remain ill-defined. In the current study, we found that astrocytes within WNV-recovered 
CNS express increased expression of Il1b, Casp1 and Tnf, whereas microglia increased expression 
of Ccl2. Astrocytes display a regional heterogeneity38,52, which can also reflect differences in 
homeostatic function, such as synaptogenesis52, and response to infection, where cerebellar 
astrocytes are poised to quickly mount antiviral programs61. In addition to developmentally 
determined sub-populations62,63, astrocytes display a remarkable plasticity and molecular identity 
determined in part by neuronal cues64. In response to different types of injury, reactive astrocytes 
can develop a recently described polarized phenotype termed A1 (infection induced, pro-
inflammatory astrocytes) or A2 (ischemia induced, promoting tissue repair) that are distinguished 
by distinct genetic signatures36. In this study, A1 astrocytes were induced in vivo by 
lipopolysaccharide injection and the combination of IL-1a, TNF, and C1q was observed to promote 
A1 polarization in vitro. Our model of viral infection also exhibits elevated production of IL-1, 
TNF, and C1q14. Consistent with this, we also observed the in vivo development and persistence 
of astrocytes with panreactive and A1 markers. As proinflammatory astrocytes lose the ability to 
phagocytose due to a decrease in mRNA expression of the phagocytic receptors Mertk and Megf10, 
and fail to support synaptogenesis in vitro due to decreases in expression of Gpc6 and Sparcl1, 
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factors that normally promote excitatory synapse formation36. Thus, the lack of recovery of 
synapses in our model could be explained by the generation of this subset of reactive astrocytes. 
Alternatively, lack of recovery could also be due to the loss of a specific astrocyte population that 
normally promotes synaptogenesis52. Although expansion of a synapse-promoting astrocyte 
population leads to seizures in the context of a reactive glioma52, this population may be crucial 
for CNS repair in the setting of the diverse array of diseases recently associated with loss of 
synapses in addition to WNV encephalitis, including Alzheimer’s disease19, schizophrenia20, and 
lupus65. Further studies are needed to more fully understand how homeostatic astrocyte 
populations respond to CNS injury, and whether this correlates with regional or functional identity. 
The discovery that newly derived, reactive astrocytes of a recently identified proinflammatory 
subset36 are responsible for persistently decreased adult neurogenesis during WNV recovery also 
suggests cell-type specific studies will be required to elucidate these pathways in disease models.  
 There is a growing body of experimental evidence demonstrating the importance of 
homeostatic neuroimmune interactions for normal cognitive function (recently reviewed by66,67). 
However, the effects of immune mediators on brain function depend on their levels and 
locations; this phenomenon was classically demonstrated as a U-shaped curve relating the effect 
of IL-1 signaling on cognitive function in which either overexpression or complete blockade of 
IL-1 signaling both negatively impacted spatial learning68. Thus, in the context of 
neuroinflammation, increased expression of immune molecules may similarly lead to altered 
cognitive performance.  Of note, we observed a trend towards recovery of neurogenesis in the 
SVZ that was absent in the hippocampus, an effect that has been reported previously in response 
to ionizing radiation69, suggesting a differential responses to injury in these neurogenic niches. 
Interestingly, in a study of hypoxia driven neuroinflammation, hippocampal neurogenesis 
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decreased, while SVZ neurogenesis increased, an effect that was linked to IL-6 signaling70. 
Further work addressing the mechanism underlying differential responsiveness to cytokine 
signaling in neurogenic niches could shed light on basic aspects of neural precursor cell biology. 
2.5 Methods 
Animals 
5-8 week-old male mice were used at the outset of all experiments. C57BL/6J mice were obtained 
from Jackson Laboratories. Il1r1–/– mice (> 10 generations backcrossed to C57BL/6) were 
obtained from Jackson Laboratories. Nestin-GFP mice (> 10 generations backcrossed to C57BL/6) 
were obtained from G. Enikolopov (Cold Spring Harbor Laboratories). All experimental protocols 
were performed in compliance with the Washington University School of Medicine Animal Safety 
Committee (protocol# 20140122). 
 
Mouse models of WNV infection 
Footpad: (WNV-NY99) The WNV strain 3000.0259 was isolated in New York in 2000 (Ebel et 
al., 2001) and passaged once in C6/36 Aedes albopictus cells to generate an insect cell–derived 
stock. 100 plaque-forming units (pfu) of WNV-NY99 were delivered in 50 ul to the footpad of 
anaesthetized mice. 
 
Intracranial: “WNV-NS5-E218A,” which harbors a single point mutation in the 2’O-methyl-
transferase gene, was obtained from M. Diamond (Washington University) and passaged in Vero 
cells as described previously41. Deeply anaesthetized mice were administered 104 pfu of WNV-
NS5-E218A or 10 pfu of WNV-NY99 in 10 ul of 0.5% FBS in HBSS into the brain’s third ventricle 
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via a guided 29-gauge needle. “Mock” infected animals were deeply anesthetized and administered 
10 ul of 0.5% FBS in HBSS into the brain’s third ventricle via a guided 29-gauge needle.  
 




Further analysis was performed on previously published hippocampal microarray gene expression 
data14 (Gene Expression Omnibus #GSE72139) from Mock-infected and WNV-NS5-E218A 
animals at 25 days post infection. Expression data from selected genes (P < 0.05 or P < 0.1 for 
italicized genes, Two-tailed Students t-test) were converted to Z-scores for each individual gene 
and animal and are displayed as colorimetric heatmaps. 
 
In vivo bromodeoxyuridine (BrdU) labeling. 
BrdU (Sigma Aldrich) in sterile PBS was injected intraperitoneally (IP) for all experiments. For 
acute Immunohistochemical studies (harvests day 7-8 post-infection) mice were given 150 mg/kg 
of BrdU at 48 h prior to tissue harvest. For flow cytometric analyses, mice were given 100 mg/kg 
of BrdU at 48 h and again at 24 h prior to tissue harvest. For neuronal BrdU labeling, mice were 
given 75 mg/kg every 12 h beginning at 3 days post-infection and ending at 7 days post-infection 





WNV (1:100 described previously8), NeuN (1:100, Cell Signaling, Cat 12943S, Clone D3S3I), 
BrdU (1:200, Abcam, Cat ab1893, polyclonal), CD45 (Biolegend, Cat 103114, Clone 30-F11), 
Doublecortin (1:150, Cell Signaling, Cat 4604S, polyclonal), GFAP (1:50 for flow cytometry; 1: 
200 for IHC, BD, Cat 561483, Clone 1B4), IL-1b (R&D, Cat AF-401, polyclonal), Mash1 (BD, 
Cat 556604, Clone 24B72D11.1), Ki67 (Abcam, Cat AB15580, polyclonal), Synaptophysin 
(1:250, Synaptic Systems, Cat 101004, polyclonal). Secondary antibodies conjugated to Alexa-
488, Alexa-555, or Alexa-647 (Invitrogen) were used at a1:400 dilution. 
 
Immunohistochemistry 
Following perfusion with ice-cold PBS and 4% paraformaldehyde (PFA), brains were immersion-
fixed overnight in 4% PFA, followed by cryoprotection in 2 exchanges of 30% sucrose for 72 h, 
then frozen in OCT (Fisher). 9 um-thick fixed-frozen coronal brain sections were washed with 
PBS and permeabilized with 0.1% Triton X-100 (Sigma-Aldrich), and nonspecific Ab was blocked 
with 5-10% normal goat serum (Santa Cruz Biotechnology) for 1 h at 23°C. Mouse on Mouse kit 
(MOM basic kit, Vector) was used per manufacturers protocol when detecting synaptophysin 
(mouse, DAKO) to reduce endogenous mouse Ab staining. After block, slides were exposed to 
primary Ab or isotype matched IgG overnight at 4°C, washed with 0.2% FSG in PBS and 
incubated with secondary Abs for 1 h at 23°C. Nuclei were counterstained with DAPI (Invitrogen) 
and coverslips were applied with vectashield (Vector). Immunofluorescence was analyzed using a 
Zeiss LSM 510 laser-scanning confocal microscope and accompanying software (Zeiss). For each 
animal, 6-8 images were taken from 2-3 different coronal sections spaced at least 50 um apart. 
Positive immunofluorescent signals were quantified using the public domain NIH Image analysis 





Cells were isolated from brains of WT mice at day 6, 15, or 30 days post-infection and stained 
with fluorescently conjugated antibodies to CD45, BrdU, and Doublecortin as previously 
described37. Briefly, animals were deeply anesthetized with a ketamine/xylazine mixture and 
perfused intracardially with ice cold dPBS (Gibco). Brains were aseptically removed, minced and 
enzymatic digested in HBSS (Gibco) containing collagenase D (Sigma, 50mg/ml), TLCK trypsin 
inhibitor (Sigma, 100 ug/ml), DNase I (Sigma, 100U/ul), HEPES ph 7.2 (Gibco, 1M), for 1hr at 
23°C while shaking. The tissue was pushed through a 70 um strainer and spun down at 500g for 
10min. The cell pellet was resuspended in a 37% percoll solution and spun at 1200g for 30min to 
remove myelin debris. Cells were washed in PBS, then resuspended in FACS buffer. Cells were 
blocked with TruStain fcX anti-mouse CD16/32 (Biolegend) for 5 min on ice, followed by 
incubation with fluorescently conjugated antibodies for 30 min on ice. Cells were then washed 2 
times in PBS, fixed with 4% PFA for 10 min at 23°C and resuspended in FACS buffer. Data 
collection was performed with LSR-II (BD Biosciences) and analyzed with Flowjo software.  
 
Ex vivo isolation of microglia and astrocytes with microbeads 
Animals were deeply anesthetized with a ketamine/xylazine mixture and perfused intracardially 
with ice cold dPBS (Gibco). Brains were aseptically removed, minced and enzymatic digested in 
HBSS (Gibco) containing collagenase D (Sigma, 50mg/ml), TLCK trypsin inhibitor (Sigma, 100 
ug/ml), DNase I (Sigma, 100 U/ul), HEPES 7.2 (Gibco, 1M), for 1hr at 23°C while shaking. The 
tissue was pushed through a 70 um strainer and spun down at 500g for 10min. The cell pellet 
was resuspended in a 37% percoll solution and spun at 1200g for 30 min to remove myelin 
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debris. Cells were washed in PBS then resuspended in MACS buffer. CD11b+ Microglia and 
ACSA-2+ astrocytes were isolated using manual MACS sorting according to the manufacturer’s 
instructions (Miltenyi Biotec). Non-specific labeling of CD11b+ microglia was prevented by 
incubating the cells with FcR blocking reagent prior to labeling the cells with ACSA-2 
antibodies for magnetic isolation. The purified microglia and astrocytes were processed for real-
time quantitative RT-PCR as described below. 
 
Real-time quantitative RT-PCR 
cDNA was synthesized using random hexamers, oligodT15, and MultiScribe reverse transcriptase 
(Applied Biosystems). A single reverse transcription master mix was used to reverse transcribe all 
samples in order to minimize differences in reverse transcription efficiency. The following 
conditions were used for reverse transcription: 25°C for 10 min, 48°C for 30 min, and 95°C for 5 
min. Real-time quantitative RT-PCR was performed as previously described14. 
 
Behavioral Testing 
Open field and Barnes Maze testing was performed as previously describe14. Briefly, mice were 
tested on the Barnes Maze over the course of 5 consecutive days, receiving two trials per day, 
spaced 30 minutes apart. For each trial, the mouse was given 3 minutes to explore the maze and 
find the target hole. Mice that did not enter the target hole within 3 minutes were gently guided 
into the hole. After each trial, the mouse remained in the target hole for exactly 1 minute, and then 
was returned to its home cage. The maze was decontaminated with 70% ethanol between each 
trial. The numbers of errors (nose pokes over non-target holes) were measured. One day prior to 
Barnes Maze testing, mice were tested via open field testing to monitor differences in exploratory 
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behavior. Each animal was given 5 minutes to explore an open field arena before returning to its 
home cage. Behavior was recorded using a camera (Canon Powershot SD1100IS), and a blinded 
experimenter scored the trials. 
 
Anakinra Treatment 
Anakinra (Kineret®, Sobi) was diluted in PBS to 10 mg/mL and animals were treated with 100 
mg/kg/day of Anakinra or Vehicle (PBS) for 5 consecutive days by intraperitoneal (ip) injection. 
Animals were weighed daily to monitor for weight loss or adverse events, none of which were 
observed during the course of treatment.  
 
Statistical Analysis 
Statistical analyses were performed using Prism 7.0 (GraphPad Software). All data were analyzed 
using an unpaired student’s t-test, one-way or two-way ANOVA with Bonferroni post-test to 
correct for multiple comparisons as indicated in the corresponding figure legends. A P value of < 
0.05 was considered significant.  
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Fig. 2.1. Gene transcripts that impact neurogenesis and markers of proinflammatory 
astrocytes are altered in WNV-recovered mice. (a-d) Heat maps show relative expression by 
z-score of altered genes generated by microarray analysis of hippocampal RNA collected at 25 
days post infection (d.p.i.) from Mock, and WNV-NS5-E218A infected, recovering mice. All 
genes listed in black font show significant fold change (P < 0.05 by two-tailed Student’s t-test) 
while those in green are trending toward significance (0.05 < P < 0.1 by two-tailed Student’s t-
Test). (e-h) Validation of microarray hits by QPCR in an independent sample of hippocampal 
RNA collected at 25 d.p.i. from mock and WNV-NS5-E218A infected, recovering mice. *, P < 
0.05; ** P < 0.01, *** P < 0.001, by two-tailed Student’s t-test. Each symbol represents an 
individual mouse; data are mean ± s.e.m. . Data are pooled from 2 independent experiments with 
4-10 mice per condition in each. Panels of gene-expression markers include genes that are pro 









Fig 2.2 Fewer new neurons are born within the dentate gyrus during WNV-NS5-E218A 
recovery. (a) Representative image of the dentate gyrus of Mock and WNV-NS5-E218A infected 
animals at 45 d.p.i., following in vivo BrdU labeling during acute infection. BrdU (red), NeuN 
(green), and DAPI (blue).  (b) Experimental design. Mice were given BrdU by intraperitoneal 
injection every 12 hours for 3.5 days (7 injections) beginning at 4 d.p.i., then animals were 
sacrificed at 45 d.p.i. for immunohistochemical analysis. (c, d) Quantification of BrdU+NeuN+ 
cells per section of dentate gyrus depicted in panel a (c), and normalized to the number of BrdU+ 
cells. *, P < 0.05 by two-tailed, Student’s t-test. ***, P < 0.001. Each symbol represents an 
individual mouse; small horizontal lines indicate the mean (± s.e.m). Data are representative of 



















Fig 2.3 Deficits in adult neurogenesis during WNV infection.  (a) Experimental design. Mock, 
WNV-NY99 or WNV-NS5-E218A mice were given an i.p. BrdU injection (100 mg/kg) at 24 
and 48 hours prior to harvest at 6, 15, or 30 d.p.i. (b) Cells were isolated from subventricular 
zone (SVZ) or hippocampus (HP) and proliferation rates of neuroblasts (% BrdU incorporation) 
was measured by flow cytometry. Representative plots showing BrdU+ cells after gating on 
doublecortin+ (DCX) cells (see Supplementary Fig. 1) in mock, WNV-NY-99 and WNV-NS5-
E218A intracranially infected animals. (c) Quantification of proliferating neuroblasts (%DCX+ 
cells labeled with BrdU) in the hippocampus and subventricular zone at 6, 15, and 30 d.p.i. 
following in vivo BrdU labeling as shown in a. (d) Representative images and quantification of 
immunostaining for proliferating neuroblasts in the SVZ and HP following footpad infection 
with WNV-NY99. *, P < 0.05, **, P < 0.005, ***, P < 0.001 by two-tailed student’s t-test. 
Quantification in c and d was normalized to age-matched mock-infected controls to compensate 
for age-related alterations in neurogenesis. Each symbol represents an individual mouse; small 
horizontal lines indicate the mean (± s.e.m.). Data are pooled from 2 independent experiments 










Fig 2.4. Greater numbers of astrocytes are born within the hippocampus during acute 
WNV encephalitis which adopt a proinflammatory phenotype and express IL-1b. (a,b) 
Mock, WNV-NY99 and WNV-NS5-E218A infected mice were given an i.p. BrdU injection at 
24 and 48 hours prior to harvest at 6 d.p.i. Cells were isolated from dissected hippocampi and 
stained for flow cytometry. Quantification of neurogenesis (BrdU+DCX+) and astrogenesis 
(BrdU+GFAP+) was normalized to mock. Gene expression analysis of (c) A1, and (c’) A2 and 
panreactive astrocyte markers in ex vivo isolated astrocytes from mock and WNV-NS5-E218A 
whole brains by qPCR. (d) Gene expression analysis of cytokines in ex vivo isolated microglia 
and astrocytes from WNV-NS5-E218A whole brains by qPCR, normalized to mock-infected 
samples of the respective cell types. (e) Gene expression of Il1b by qPCR of RNA isolated from 
hippocampal tissue collected at 7, 25, and 52 d.p.i. from mock and WNV-NS5-E218A infected 
animals. (f-i) Immunostaining for IL-1  in hippocampus of mock and WNV-NS5-E218A 
infected animals collected at 25 d.p.i. Representative images are shown in f, percent area of 
GFAP in g, percent area of IL-1  in h, and percent area of Il-1b +GFAP+ normalized to total IL-
1 + area in i.  *, P < 0.05, **, P < 0.005, ***, P < 0.001 by two-tailed student’s t-test. Each 
symbol represents an individual mouse; small horizontal lines or bar height represent the mean 
(± s.e.m.). Data are representative of one experiment (a,b,e-i), or pooled from three independent 






Fig 2.5. IL-1R1-/- mice resist WNV-mediated alterations in neuroblast proliferation and 
recover synapses earlier than wildtype controls. (a,b) Mock and WNV-NS5-E218A infected 
wild-type (WT) and Il1r1-/- animals were assessed for alterations in neurogenesis at 6 d.p.i. 
following in vivo BrdU labeling at 24 and 48 hours prior to harvest. Quantification of BrdU+DCX+ 
cells by flow cytometry are shown for the hippocampus (HP) in a and the subventricular zone 
(SVZ) in b, normalized to age-matched mock infected controls. (c) Mock and WNV-NS5-E218A 
infected Il1r1-/- animals were assessed for alterations in astrogenesis at 6 d.p.i. following in vivo 
BrdU labeling at 24 and 48 hours prior to harvest. Quantification of BrdU+GFAP+ cells by flow 
cytometry are shown for the hippocampus, normalized to age-matched mock infected controls. (d) 
Hippocampal neurogenesis in Mock and WNV-NS5-E218A infected WT, Il1r1-/-, and Caspase-1-
/- (Casp1-/-) was analyzed by immunohistochemistry (IHC) at 6 d.p.i. Quantification of the number 
of Mash1+Ki67+ cells per mm of dentate gyrus analyzed. (e-f) Immunostaining of synapses in 
mock and WNV-NS5-E218A infected WT at Il1r1-/- animals at 7 d.p.i. in e and 25 d.p.i. in f. 
Quantification shows percent area of synaptophysin in the CA3 of the hippocampus. 
Synaptophysin (red) and DAPI (blue).  *, P < 0.05, **, P < 0.005, ***, P < 0.001 by two-tailed 
student’s t-test. Each symbol represents an individual mouse; height of bar indicates the mean (± 
s.e.m.). Data are pooled from 2 independent experiments (a,b) or representative of one experiment 




Fig 2.6. Il1r1-/- WNV-NS5-E218A-infected mice are protected from virus-induced spatial 
learning deficits on the Barnes Maze behavior task. (a) Experimental design. Mock or WNV-
NS5-E218A infected wild-type (WT) and Il1r1-/- underwent behavioral testing beginning at 45 
d.p.i. Open field testing was performed at 45 d.p.i., followed by 5 consecutive days of Barnes Maze 
testing. (b) Barnes maze performance of WT mice, showing average errors per trial of each group 
for each day of testing. (c) Barnes maze performance of Il1r1-/- mice. (d) Barnes Maze 
performance of mock and WNV-NS5-E218A infected mice, quantified as area under the curve for 
each individual animal within each group. (e) Open Field testing showing the number of lines 
crossed in 5 minutes of testing for each animal. (f) Open Field testing showing the number of times 
an animal crossed the center of the arena in 5 minutes of testing for each animal. For Barnes Maze, 
ns = not significant (P > 0.05), *, P < 0.05 by two-way ANOVA for effect of WNV.  ns = not 
significant (P > 0.05), *, P < 0.05, **, P < 0.005 by one-way ANOVA with Bonferroni’s multiple 
comparisons test to compare groups. Each symbol represents an individual mouse; small horizontal 
lines or height of bars represents the mean (± s.e.m.). Data are pooled composite experiments with 












Fig 2.7. WNV-NS5-E218A-infected mice treated with Anakinra are protected from virus-
induced spatial learning deficits on the Barnes Maze behavior task. (a) Experimental design. 
Mock or WNV-NS5-E218A infected wild-type (WT) mice were treated with 5 consecutive doses 
of 100mg/kg/day of Anakinra or vehicle by intraperitoneal (ip) injection beginning at 10d.p.i. 
Animals were allowed to recover for an additional 30 days post treatment, followed by behavior 
testing at 45 d.p.i. Open Field testing was performed at 45 d.p.i., followed by 5 consecutive days 
of Barnes Maze testing. (b) Barnes maze performance of vehicle treated WT mice, showing 
average errors per trial of each group for each day of testing. (c) Barnes maze performance of 
Anakinra treated wildtype mice. (d) Barnes Maze performance of mock and WNV-NS5-E218A 
infected mice, quantified as area under the curve for each individual animal within each group. 
(e) Open Field testing showing the number of lines crossed in 5 minutes of testing for each 
animal. (f) Open Field testing showing the number of times an animal crossed the center of the 
arena in 5 minutes of testing for each animal. For Barnes Maze, ns = not significant (P > 0.05), 
*, P < 0.05 by two-way ANOVA for effect of WNV.  ns = not significant (P > 0.05), *, P < 0.05, 
**, P < 0.005 by one-way ANOVA with Bonferroni’s multiple comparisons test to compare 
groups. Each symbol represents an individual mouse; small horizontal lines or height of bars 
represents the mean (± s.e.m.). Data are pooled composites of 3 independent experiments, with at 










Fig 2.8 Flow cytometry gating strategy 
(a) Following isolation and staining with Dapi and antibodies to CD45, Doublecortin, and 
BrdU, doublets were excluded, and the CD45-negative population was utilized for further 
gates. b Percentage of BrdU+ neuroblasts, through expression of the marker, DCX, was 
calculated and example plots shown from Hippocampus (HPC), Hippocampus from an animal 
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Fig 2.9 WNV permissivity of DCX+ neuroblasts in vivo 
a 5 week old mice were infected via the footpad with 100 pfu of wild type WNV(NY99) and 
harvested for tissue collection on day 8 post infection. Immunohistochemistry is shown for 
West Nile antigen and the neuroblast marker, doublecortin (DCX) within the Dentate gyrus 
(DG) and Subventricular Zones (SVZ). Many WNV+ neurons can be seen within the granule 
cell layer (GCL) of the DG and the striatum neighboring the SVZ, however only 1 out of 4 
animals showed any WNV and DCX-double positive cells (shown by white arrowhead, Left), 
resulting in a mean % of infection of less than 1% of total DCX+ cells. Within the DG, 
infected DCX+ cells were always located within the GCL—indicating that they are more 
mature neuroblasts or immature neurons. bImmunostaining for GFP and GFAP in mock and 
WNV-NS5-E218A nestin-GFP reporter animals. Representative images of the dentate gyrus 
are shown on the left and quantification of Nestin+ transit amplifying (TA) and 
Nestin+GFAP+ neural stem cells (NSC) on the right. Nestin-GFP (green), GFAP (red) and 








Fig 2.10 Determination of astrocyte and microglia purity 
qRT-PCR analysis of expression of cell type specific astrocyte (GFAP), microglia (Cx3CR1, 
Trem2), and neuronal (RBFox3) transcripts in ex vivo isolated astrocytes (ASC2+ cells) and 















Fig 2.11 Lack of IL-1 signaling does not affect viral control of immune cell infiltrates to the 
CNS 
a-c Plaque assay of CNS tissue from WNV-NS5-E218A infected wildtype (WT) 
and Il1r1−/− animals at 6 d.p.i. d qPCR analysis of WNV envelope protein at 25 d.p.i. in 
hippocampus from WNV-NS5-E218A WT and Il1r1 −/− mice. e-l Flow cytometric analysis of 
stained single cell populations isolated from hippocampus of WT and Il1r1 −/− mice at 6 d.p.i. 













Fig 2.12 Blood brain barrier opening peaks at 6 dpi, and closes by 12 dpi 
a-c Relative blood brain barrier permeability of the frontal cortex, hippocampus, and 
cerebellum at 3, 6, 9, and 12 d.p.i. was assessed by an in vivo sodium fluorescein assay to 





















Chapter 3: T cells promote microglia-
mediated synaptic elimination and cognitive 
dysfunction during recovery from 
neuropathogenic flaviviruses 
 
This chapter is adapted from a manuscript published in Nature Neuroscience: 
Garber C, Soung A, Vollmer LL, Kanmogne M, Last A, Brown, J, Klein RS. T cells promote 
microglia-mediated synaptic elimination and cognitive dysfunction during recovery from 
neuropathogenic flaviviruses. Nat Neurosci. 2019;22(8):1276-1288. doi:10.1038/s41593-
019-0427-y. 
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performed experiments. C.G., A.S., L.L.V., M.K., and R.S.K analyzed the data. R.S.K., C.G., 
and A.S. wrote the paper. All authors read and edited the manuscript. 
 
3.1 Abstract 
T cells clear virus from the CNS and dynamically regulate brain functions, including spatial 
learning, through cytokine signaling. Here we determined whether hippocampal T cells that 
persist after recovery from infection with West Nile virus (WNV) or Zika virus (ZIKV) impact 
hippocampal-dependent learning and memory. Using newly established models of viral 
encephalitis recovery in adult animals, we show that in mice that have recovered from WNV or 
ZIKV infection, T cell-derived interferon-γ (IFN-γ) signaling in microglia underlies spatial-
learning defects via virus-target-specific mechanisms. Following recovery from WNV infection, 
mice showed presynaptic termini elimination with lack of repair, while for ZIKV, mice showed 
extensive neuronal apoptosis with loss of postsynaptic termini. Accordingly, animals deficient in 
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CD8+ T cells or IFN-γ signaling in microglia demonstrated protection against synapse 
elimination following WNV infection and decreased neuronal apoptosis with synapse recovery 
following ZIKV infection. Thus, T cell signaling to microglia drives post-infectious cognitive 
sequelae that are associated with emerging neurotropic flaviviruses. 
 
3.2 Introduction 
Among the most debilitating consequences of arboviral infections of the CNS is impairment in 
cognitive function that occurs despite recovery from acute encephalitis. Mosquito-borne 
infections with flaviviruses, in particular and including WNV and Japanese encephalitis virus, 
are linked to significant long-term cognitive sequelae, including decreases in psychomotor speed 
and in verbal and visuospatial learning, which not only persist but also worsen for years after 
recovery from encephalitis1. In addition, the recently emerged and related flavivirus ZIKV may 
cause a range of neurological complications in adults, including encephalopathy, and 
meningomyelitis or encephalomyelitis, which may be associated with defects in memory and 
cognition with unknown long-term outcomes for survivors2. In the adult CNS, WNV targets fully 
differentiated neurons3, whereas Japanese encephalitis virus targets immature neurons4 and 
ZIKV may additionally target microglia5 and neural progenitors6 depending on the strain. That 
recovery from infection with these viruses may all correlate with reduced learning abilities, 
despite their differential tropism for neural cell subtypes, suggests that events triggered acutely 
may be generalizable for a broader category of memory disorders. 
The formation and consolidation of memories occur primarily in the hippocampus and depends 
on the integrity of a trisynaptic circuit between the entorhinal cortex, the hippocampal dentate 
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gyrus (DG) and the cornu ammonis (CA). In particular, excitatory connections between CA3 
pyramidal neurons support the formation of spatial memories in adult rodents7. Accordingly, 
memory disorders, including those associated with Alzheimer’s disease (AD), Parkinson’s 
disease, and post-viral encephalitis cognitive sequelae, are all associated with disruptions in 
circuit integrity via synapse elimination or neuronal loss within the hippocampus8–10. Microglial 
function is critical for synaptic plasticity and for maintenance of adult neurogenesis within 
neurogenic niches11,12. While mechanisms contributing to hippocampal dysfunction are 
incompletely understood, recovery from WNV infection clearly involves alterations in the 
homeostatic functions of microglia and astrocytes. This is because reactive changes in these cells 
persist for weeks after clearance of the infectious virus, which lead to complement-mediated 
synapse elimination within the CA3 region10and interleukin-1 (IL-1)-mediated inhibition of 
synaptic repair13. 
Activation of microglia and astrocytes in the acutely infected CNS promotes the parenchymal 
entry of antiviral T cells, which exert virological control via cytokine-mediated, non-cytolytic 
mechanisms. T cell cytokines such as IFN-γ may also influence microglial biology. In brain 
tissues of patients with multiple sclerosis, Parkinson’s disease, or AD, infiltrating T cells are 
found in proximity to activated microglia14–16, and transition into AD dementia correlates with 
increased numbers of microglial majorhisto-compatibility complex II (MHCII)+ cells17. IFN-γ 
influences social interactions18, synapse formation19, neurogenesis20, and learning and memory21, 
primarily through regulatory mechanisms. Thus, IFN-γ-deficient animals show increased rates of 
hippocampal neurogenesis and synapse formation and hyperconnectivity in the pre-frontal 
cortex18,19, all of which are partially reversed by an injection of recombinant IFN-γ into the 
cerebrospinal fluid. Such effects suggest that IFN-γ dynamically influences circuit plasticity in 
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adult animals. Resident memory T (Trm) cells, which reside in non-lymphoid tissues at sites of 
prior antigen exposure, produce IFN-γ to coordinate rapid recall responses following re-
challenge22. Although there is evidence to indicate that IFN-γ+ T cells may induce microglial 
activation, the functional implications of a parenchymal population of T cells that persist in the 
CNS after clearance of viral infections remain unknown. 
In this study, we demonstrate that antiviral T cells that persist within the hippocampus after 
recovery from flaviviral infection are the most proximal trigger of spatial-learning defects. Using 
newly established in vivo models of recovery from flaviviral encephalitis caused by either a 
mutant WNV (WNV-NS5-E218A) or ZIKV (Zika-Dakar virus) infection, we determined that 
CD8+ T cell-derived IFN-γ is required for microglial activation and impaired spatial learning in 
the post-infectious CNS. We show that WNV and ZIKV differentially target forebrain regions 
within adult mice, especially with regard to the hippocampus, which exhibited dramatic 
differences in neuropathology. However, while both flaviviruses led to the persistence of IFN-
γ+CD8+ T cells and microglial activation in the hippocampus following recovery, WNV infection 
was associated with the elimination of presynaptic termini, while ZIKV promoted the loss of 
neuronal nuclei and postsynaptic termini. Subpopulations of these T cells expressed CD 103, a 
marker associated with the formation of brain Trm cells, which suggests that the newly formed 
Trm cells might contribute to these effects. Although IFN-γ receptor (IFNGR)-deficient mice 
(Ifngr1−/−) infected with either WNV or ZIKV exhibited no acute defects in CNS virological 
control, spatial learning was preserved. Ifngr1−/− and Cd8−/− mice exhibited early recovery of 
presynaptic termini expressing synaptophysin during recuperation from WNV infection. For 
ZIKV, Ifngr1−/− and Cd8−/− mice exhibited decreased neuronal apoptosis with recovery of 
postsynaptic termini that was most pronounced in the CA regions following viral clearance. 
75 
 
Microglial-specific deletion of IFNGR protected mice against spatial-learning deficits and 
blocked alterations in synapses or neuronal numbers induced during recovery from infection with 
either virus. These results indicate that T cell and microglial interactions are critical for 
triggering post-infectious cognitive dysfunction through effects on hippocampal circuitry. 
 
3.3 Results 
ZIKV preferentially targets the adult hippocampus.  
To address the mechanisms of cognitive recovery from neuroinvasive infection with ZIKV, we 
developed a model of ZIKV infection recovery in adult mice. Direct intracranial inoculation of 
8-week-old C57BL/6J (wild-type (WT)) mice with ZIKV-Dakar (Dakar 41525, Senegal, 1984), 
which shows increased pathogenicity, including higher levels of inflammatory cytokine 
induction in mice, compared with Asian strains23, led to weight loss but 100% survival (Fig. 
3.1a,,b).b). This was comparable to our established recovery model of infection with a mutant 
WNV10, a strain in which a point mutation in NS5, a nonstructural protein that encodes a 2’-O-
methyltransferase, prevents viral recognition by tetratricopeptide repeats 1 (IFIT1), which 
normally acts to block translation of virion-delivered virus-specific RNAs24. ZIKV replicated to 
high levels in the hippocampus and cortex, and, to a lesser extent, in the cerebellum (Fig. 3.1c). 
Quantitative PCR (qPCR) analysis of hippocampal tissue during acute ZIKV infection and 
recovery demonstrated robust induction of Cxcl10, Tnfa, and Il1a (Fig. 3.1d), which are 
molecules known to play important roles during WNV infection of the CNS25. Detection of 
ZIKV or WNV envelope protein (E) mRNA via in situ hybridization revealed dramatic 
differences in viral tropism within forebrain regions. Robust levels of ZIKV E mRNA were 
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detected within all regions of the hippocampi of all animals examined. By comparison, E mRNA 
in WNV-infected mice was variably detected in multiple areas throughout forebrain and 
hindbrain regions (Fig. 3.1e; Fig. 3.9a,b). Immunohistochemical (IHC) detection of viral proteins 
within cellular targets of both viruses revealed that both WNV and ZIKV primarily targeted 
mature neurons (Fig. 3.1f; Fig. 3.9c,d); however, ZIKV E protein was also detected within 
NeuN+ cells near the neurogenic subgranular zone of the DG, suggesting that there is additional 
targeting of immature neurons (Fig. 3.9e,f). These data suggest that direct intracranial infection 
with ZIKV leads to high viral titers in the hippocampus and induces a neuroinflammatory 
immune response in animals that survive infection, providing a robust model for recovery from 
neurotropic viral infection. 
 
ZIKV infection of the adult CNS is associated with loss of neurons. 
Expression of cytokines and chemoattractant molecules within the virally infected CNS 
promotes the recruitment and activation of antiviral T cells, which may persist after viral 
clearance with unknown consequences26. A transcriptional microarray analysis of hippocampal 
gene expression during recovery of WNV (25 days post-infection (d.p.i.)) indeed identified 
pathways associated with adaptive immune responses. Genes involved in antigen processing and 
presentation and in chemokine signaling10 were identified, which suggests that cytokines and 
chemoattractant molecules persist beyond acute infection. Indeed, flow cytometry analysis of 
CD45+ cells in the hippocampus during acute infection and after recovery from ZIKV and WNV 
encephalitis revealed a large population of infiltrating lymphocytes (CD45hiCD11b−), which 
were primarily CD8+ T cells, that persisted despite viral clearance (Fig. 3.10). Intraparenchymal 
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T cells and activated astrocytes and microglia were detected robustly at all time points within the 
hippocampus during recovery from ZIKV infection (Fig. 3.2a,c), whereas these cells were at the 
highest levels at 25 d.p.i. with WNV (Fig. 3.2b,d). Consistent with prior work10, WNV infection 
did not lead to neuronal loss in the hippocampus (Fig. 3.2b,d), although ZIKV infection led to a 
significant decrease in NeuN+ cells during acute infection that plateaued by 25 d.p.i. (Fig. 
3.2a,c). These data suggest these flaviviruses exert distinct immunopathological effects during 
recovery. 
 
Antiviral CD8+IFNg+ T cells associate with microglia in the post-infected hippocampus. 
An analysis of infiltrating CNS T cells in mice at 25 d.p.i. with WNV or ZIKV revealed 
significantly increased percentages of CD8+ T cells expressing the integrin CD103, which has 
been associated with CNS Trm cell formation26 (Fig. 3.2e,f). Percentages of 
CD45midCD11b+CX3CR1+CCR2− microglia expressing MHCII, a marker associated with 
microglial activation that is induced by the T cell cytokine IFN-γ, were also significantly 
increased (Fig. 3.2g,h). Consistent with this, the qPCR analysis revealed that 
hippocampal Ifng expression increased following WNV and ZIKV infection, and remained 
significantly elevated during recovery (Fig. 3.3a,c). An analysis of IFN-γ-YFP (yellow 
fluorescent protein) reporter mice at 25 d.p.i. demonstrated that CD3+ T cells expressed the bulk 
of IFN-γ in hippocampus at this time point, with IBA1+ microglia representing an additional 
source (Fig. 3.3b,d). Flow cytometry analysis of CD45+IFN-γ+ cells isolated from the 
hippocampus of IFN-γ-Thy1.1 reporter mice at 25 d.p.i. confirmed that ~15% of the cells were 
CD45midCD11b+ microglia, while ~80% were CD45hiCD11b− lymphocytes, specifically CD8+ T 
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cells (Fig. 3.3e–g). An analysis of CD8+IFN-γ +cells confirmed that a subpopulation of these 
cells expressed CD103, while detection of NS4B, the predominant CD8 epitope in WNV-
infected mice27, via tetramer staining confirmed virus specificity (Fig. 3.3f,g;  Fig. 3.11). In 
addition, IFN-γ+CD8+ T cells were observed in close proximity to CX3CR1+ microglia at 25 
d.p.i. (Fig. 3.3h,i). An additional flow cytometry analysis of mice at 52 d.p.i. confirmed that 
CD8+IFN-γ+ T cells persisted in the hippocampus 1 month after viral clearance (Fig. 3.11). These 
data show that antiviral T cells reside in the hippocampus following flavivirus infection, and may 
influence the reactivity of resident neural cell populations through cytokine signaling. 
 
ZIKV- and WNV-infected mice show IFN-g-mediated deficits in spatial learning post 
recovery. 
While IFN-γ is critical for virological control within the CNS, it is also a dynamic regulator of 
circuit plasticity18. Thus, we hypothesized that IFN-γ signaling between T cells and resident CNS 
cells may underlie post-infectious cognitive sequelae. Mock, WNV, or ZIKV infection 
of Ifngr1−/−and WT mice did not reveal significant differences in survival, weight loss, or clinical 
score between these animal models (Fig. 3.12a–f). Consistent with the clinical course, the 
kinetics of infectious viral replication in most brain regions of the CNS were similar between 
WT and Ifngr1−/− mice following WNV and ZIKV infection (not shown), with the exception of 
the cerebella in Ifngr1−/− animals, for which WNV clearance was significantly delayed, but 
cleared in both genotypes by 24 d.p.i. (Fig. 3.12g–i). Mock-, WNV-or ZIKV-
infected Ifngr1−/−and WT mice underwent cognitive behavioral testing 1 month following viral 
clearance (Fig. 3.4a). WT mice exhibited spatial-learning deficits on the Barnes maze following 
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WNV infection, as previously described10,13, as did those recovering from ZIKV infection, 
while Ifngr1−/− mice were protected, showing similar learning curves to mock-infected controls 
(Fig. 3.4b,c). To control for alterations in anxiety or movement that could impact performance in 
hippocampus-dependent tasks, we also performed open-field tests (OFTs). While WNV infection 
did not alter exploratory or anxiety-like behaviors during the OFT in WT or Ifngr1−/− mice (Fig. 
4e,g), ZIKV-infected WT and Ifngr1−/− mice crossed more lines during the OFT than mock-
infected controls (Fig. 3.4d), but did not show differences in anxiety (Fig. 3.4f). As this increase 
in locomotion was observed in both genotypes, this change in behavior is unlikely to explain the 
difference in the Barnes maze deficits observed between WT and Ifngr1−/− mice.  
T cell-derived IFN-γ is required to achieve an antiviral state following antigen re-exposure22, 
which is an important functional outcome for Trm cell generation. Of interest, we found that there 
was decreased expression of the Trm cell marker CD103 in a subpopulation of 
CD45hiCD11b−CD8+ T cells in the hippocampus of Ifngr1−/− animals post recovery from 
infection compared with WT controls, with minimal CD103 expression in CD4+ T cells (Fig. 
3.13a,b). We also found high levels of CCR2 on a subpopulation of CD45hiCD11b−CD8+ T cells 
in the hippocampus of mice that had recovered from infection, the expression of which did not 
change in the absence of IFN-γ signaling (Fig. 3.13c,d). Importantly, CCR2 expression by 
CD3+ T cells has been demonstrated in human spinal cord tissue from cases of WNV 
encephalomyelitis28; however, the functional consequence of CCR2 expression by T cells in the 
CNS remains unknown. Together, these data suggest that IFN-γ signaling negatively affects 
cognitive recovery from neurotropic viral infections, which is unlikely to be due to differences in 




IFNGR signaling is required for neuronal apoptosis during recovery from ZIKV infection. 
Given the dramatic hippocampal targeting and neuronal loss observed following ZIKV infection 
(Figs. 3.1 and 3.2), we determined whether the altered survival of neural cells might underlie 
spatial-learning deficits. At 25 d.p.i. with ZIKV, Ifngr1−/− and Cd8−/− mice exhibited 
significantly higher levels of NeuN compared with similarly infected WT animals, in which 
levels were reduced by ~30% of mock-infected controls (Fig. 3.5a–c). In comparison, 
WT, Ifngr1−/−, and Cd8−/− mice had similar levels of detection of NeuN following recovery from 
WNV infection (Fig. 3.5e–g). Consistent with prior studies10, we observed no ongoing neuronal 
loss in WT animals post recovery from WNV infection (Fig. 3.5e–g). Consistent with the 
observed loss of NeuN+ cells, TdT-mediated dUTP nick end labeled (TUNEL)+ cells in the DG, 
CA3, and CA1 regions of the hippocampus of ZIKV-infected WT animals were significantly 
increased post recovery compared with mock-and ZIKV-infected Ifngr1−/− animals post recovery 
(Fig. 3.5h). Of note, levels of apoptosis within the DG were considerably lower and more 
variable than that observed in other hippocampal regions (Fig. 3.5a,d,h). Within the CA3, which 
is a region critical for spatial learning, detection of NeuN+TUNEL+ cells was significantly lower 
in ZIKV-infected Ifngr1−/− and Cd8−/−mice compared with similarly infected WT animals after 
viral clearance (Fig. 3.5i,j). ZIKV did not target GAD67+ GABAergic neuronal populations, 
which suggests that the virus may not target interneurons (Fig. 3.14a). In contrast, there were no 
significant differences in NeuN+TUNEL+ cells in the hippocampus of WT and Ifngr1−/− mice 
post recovery from mock infection or WNV infection (Fig. 3.5k). ZIKV also did not alter the 
number of new neurons born within the DG during recovery from infection, which suggests that 
impairment in neurogenesis is not a contribution to long-term deficits (Fig. 3.14b). However, 
increased neuronal loss and apoptosis persisted up to 52 d.p.i. in ZIKV-infected WT mice post 
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recovery compared with mock-and ZIKV-infected Ifngr1−/− mice post recovery (Fig. 3.5l;  Fig. 
3.14d). These data indicate that WNV and ZIKV lead to differential effects on neurons, 
including pathology, that contribute to defects in spatial learning. 
 
IFNGR is required for synapse elimination during recovery from WNV infection via IL-1. 
Prior studies have demonstrated that WNV infection leads to acute and chronic loss of 
synaptophysin+ presynaptic terminals, but preservation of Homer1+ postsynaptic terminals, 
which ceased by 52 d.p.i.10. In addition, expression of IL-1β by reactive astrocytes inhibits the 
recovery of presynaptic termini and is associated with spatial-learning deficits during recovery 
from WNV infection13. Given the synapse recovery observed in Ifngr1−/− mice and the 
demonstration that IFN-γ influences IL-1β expression29, we examined levels of this cytokine in 
WNV-infected Ifngr1−/− mice post recovery. Consistent with prior studies13, we detected 
increased IL-1β expression by GFAP+ astrocytes in the hippocampus of WNV-infected WT mice 
post recovery, which was significantly decreased in Ifngr1−/− animals at 25 d.p.i. (Fig. 3.6a). As 
previously reported10, WNV-infected WT animals showed decreased synaptophysin+ presynaptic 
terminals within the CA3 at 7 and 25 d.p.i., while WNV-infected Ifngr1−/− and Cd8−/− animals 
demonstrated limited evidence of synapse elimination at either time point (Fig. 3.6b,c;  Fig. 
3.14e). This result suggests that IFNGR is required for synapse elimination during WNV 
infection. In contrast, and consistent with acute and chronic loss of NeuN+ perikarya, ZIKV 
infection led to loss of Homer1+ post-synaptic terminals in WT and Ifngr1−/− animals at 7 d.p.i., 
with preservation of synaptophysin + and vGlut+ presynaptic terminals (Fig. 3.14c,f,g). ZIKV-
infected WT animals continued to exhibit decreased numbers of Homer1+ postsynaptic terminals 
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within the CA3 at 25 and 52 d.p.i., while ZIKV-infected Ifngr1−/− animals exhibited recovery of 
postsynaptic termini by 52 d.p.i. (Fig. 3.6d,e). ZIKV-infected WT and Ifngr1−/− animals also both 
displayed significantly increased IL-1β expression by GFAP+ astrocytes in the hippocampus 
compared with mock-infected controls post recovery (Fig. 3.15a). Of note, IL-1β expression was 
not detected within IBA1+ cells at 25 d.p.i. (not shown). These data suggest that persistent 
alterations in postsynaptic termini contribute to spatial-learning deficits in ZIKV-infected mice 
independent of IL-1β signaling. 
 
IFNGR signaling potentiates microglial engulfment of postsynaptic termini and perikaryal 
in ZIKV-infected animals. 
Phagocytic roles for microglia are well established and include removal of both apoptotic 
newborn cells in the neurogenic niche of the hippocampus and non-apoptotic TBR2+ neural 
progenitors in the developing cerebral cortex, in addition to synapse pruning and elimination, the 
latter of which requires the upregulation of markers of microglial activation30. We therefore 
wondered whether T cell-derived IFN-γ signaling is required for synapse elimination or neuronal 
loss following WNV or ZIKV infection, respectively, via specific effects on microglia. Indeed, 
both WNV and ZIKV infection led to increased expression of IBA1 at 25 d.p.i. in WT mice, 
which did not occur in similarly infected Ifngr1−/− animals (Fig. 3.7a,b). Importantly, no 
differences in numbers of CD45hiCD11b+CX3CR1+CCR2− microglia cells or expression of 
TMEM119, a recently described homeostatic marker for microglia, were observed in WNV-and 
ZIKV-infected WT and Ifngr1−/−animals post recovery (Fig. 3.15b–e). This result is consistent 
with prior data demonstrating that viral infections do not promote microglial proliferation10. 
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Flow cytometry analysis of CD45midCD11b+CX3CR1+CCR2− microglia revealed increased 
expression of MHCII in WNV-and ZIKV-infected WT animals post recovery; this increased 
expression was significantly attenuated in Infgr1−/− animals (Fig. 3.15f,g). This finding confirms 
that IFN-γ contributes to microglial activation in the post-infectious CNS. Three-dimensional 
reconstructions of IBA1+ cells from sections of ZIKV-infected mice at 25 d.p.i. revealed 
Homer1+ puncta (Supplementary Video 1) and NeuN+ nuclei (Supplementary Video 2) within 
microglia. Colocalization of Homer1 or NeuN, lysosomal-associated membrane protein 1 
(LAMP1), and IBA1 revealed increased numbers of postsynaptic termini within the lysosomes of 
IBA1+ cells, which were significantly reduced in Ifngr1−/− mice at 25 d.p.i. (Fig. 3.7c–f). These 
data suggest that microglia may be critically involved in responses to T cell-derived IFN-γ that 
drive cognitive impairment after infection with either WNV or ZIKV. 
 
Micrgolial-specific deletion of IFNGR protects animals against spatial-learning defects. 
Given the shared alteration in microglial activation observed in both WNV-and ZIKV-infected 
animals post recovery in the absence of IFN-γ signaling, we utilized a conditional deletion 
paradigm to determine whether IFN-γ signaling within microglia of mice post recovery was 
responsible for the observed spatial-learning deficits. Cx3cr1CreERIfngrfl/fl (referred to as 
Cre+hereafter) animals and Cx3cr1CreERIfngrfl/fl (referred to as Cre− hereafter) litter-mate controls 
were mock-infected or infected with WNV or ZIKV, and then treated with tamoxifen 1 week 
after infectious viral clearance (at 19 and 21 d.p.i.). Animals were allowed to recover for 3 weeks 
to achieve specific deletion of Ifngr in long-lived microglia while allowing time for short-lived 
CX3CR1-expressing myeloid populations to turnover31 (Fig. 3.16a–d), at which time cognitive 
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behavior testing was performed (Fig. 3.8a). Similar to WT animals, tamoxifen-treated 
Cre−animals displayed significant spatial-learning deficits on the Barnes maze following WNV 
and ZIKV infection (Fig. 3.8b,c). In contrast, tamoxifen-treated Cre+ animals performed 
similarly to mock-infected controls (Fig. 3.8b,c). OFTs confirmed no differences in locomotor 
activity or anxiety between experimental groups, with the exception of an increase in activity in 
ZIKV-infected WT animals, as previously shown (Fig. 3.8d–g). Importantly, microglial-specific 
deletion of Ifngr after viral clearance was sufficient to prevent elimination of 
synaptophysin+ presynaptic termini and neuronal apoptosis in WNV-and ZIKV-infected mice, 
respectively (Fig. 3.8h,i). A lack of increased microglial MHCII expression was also observed in 
WNV-and ZIKV-infected Cre+ mice post recovery (Fig. 3.16e,f), confirming that IFN-γ 
signaling in microglia during recuperation promotes their continued activation. Together, these 
data suggest that IFN-γ signaling in microglia contributes to microglial activation and spatial-
learning deficits following clearance of infectious WNV and ZIKV from the CNS. 
 
3.4 Discussion 
Antiviral T cells persist within the CNS for months to years after neurotropic viral infections26. 
The extent to which these tissue-resident cells impact on normal brain function is unclear; 
however, studies of acutely infected mice suggest that CD8+ T cells may damage neuronal 
structures, such as dendrites, during viral clearance32. Here, we developed a novel murine model 
to evaluate mechanisms of cognitive decline following adult ZIKV infection. We found that 
ZIKV preferentially targets and induces the loss of neurons throughout the hippocampus, which 
was also associated with the loss of postsynaptic Homer1+ termini. In contrast, the related WNV, 
which infects neurons throughout the CNS, led to elimination of synpato-physin+ presynaptic 
85 
 
termini, which was most pronounced within the CA3 region of the hippocampus, as previously 
described10,13. Survival after infection with either virus was associated with the recruitment of 
antiviral CD4+ and CD8+ T cells, the latter of which persisted in the virus-cleared CNS, 
expressed CD103, and became a predominant source of IFN-γ. While IFN-γ+CD4+ T cells also 
persisted, targeted deletion of IFN-γ signaling or CD8 was sufficient for reversing the effects of 
WNV and ZIKV infection on synapses and apoptosis, respectively. IFN-γ signaling was required 
for synapse elimination during WNV infection and for the loss of neuronal cell bodies and 
recovery of synapses after ZIKV infection. Levels of IFN-γ remained elevated after viral 
clearance, and IFN-γ signaling was required for microglial activation and cognitive dysfunction 
during recovery from infection with either virus. Microglia-specific deletion of Ifngr prevented 
the development of WNV-or ZIKV-induced hippocampal-dependent learning and memory 
deficits, suggesting that T cell signaling to microglia is a pivotal event in the development of 
post-infectious cognitive dysfunction after recovery from flavivirus encephalitis (Fig. 3.17). We 
used an inducible CX3CR1-Cre line (Cx3cr1 -CreERT) and administered tamoxifen 1 week after 
viral clearance (~20 d.p.i.), when macrophages are no longer present in the CNS (Fig. 3.10). We 
therefore designed this experiment to limit the possibility that non-microglial myeloid cells were 
participating in the process. Nevertheless, as CXC3R1 is not a specific microglial marker, non-
microglial cells could possibly contribute to the results obtained. 
Infection with ZIKV appears to target the hippocampus in our model. The pathogenesis of ZIKV 
infection is poorly understood, and there is considerable debate regarding the putative receptors 
that enable ZIKV infection of various cell types. Several entry receptors, including the innate 
immune receptor DC-SIGN, the transmembrane protein TIM-1, and TAM receptors (Tyro3, Axl, 
and Mertk), a family of phosphatidylserine receptors, have been extensively studied for their 
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potential role as flavivirus entry receptors33. However, a more recent study investigating different 
infection routes of ZIKV, including subcutaneous, transplacental, vaginal, and intracranial 
infections in WT and TAM receptor null mice, showed no difference in viral titers34. TAM 
receptors, at least in mice, are therefore not essential for ZIKV infection, but may play roles in 
viral tropism. Studies examining Tyro3 expression in the rodent CNS, however, have 
demonstrated that it is specifically expressed within the neocortex, especially within the 
hippocampus35. Thus, although Tyro3 is not required for ZIKV infection, the high level of 
hippocampal expression of this receptor could potentially contribute to ZIKV targeting this CNS 
region. ZIKV also led to extensive and ongoing neuronal apoptosis in the hippocampus, which 
was attenuated in the absence of IFN-γ. This is consistent with studies of mice with CNS 
autoimmune disease, in which IFN-γ is observed to directly induce apoptosis of 
oligodendrocytes36. Alternatively, activated microglia can promote apoptosis by inducing 
phosphatidylserine exposure and subsequent phagocytosis of neurons by Mertk37. The 
differential extent of neuronal apoptosis and recovery in ZIKV-infected WT, Ifngr1−/−, 
and Cd8−/− mice supports reports that a threshold number of neurons may be needed to achieve 
spatial learning38. Resolution of neuroinflammation may involve FasL-mediated apoptosis of T 
cells39, which may explain the increased numbers of TUNEL+ cells that are not neurons. 
The persistence of presynaptic termini after ZIKV infection suggests that synaptic boutons of 
injured axons of hippocampal neurons may be resistant to the rapid loss incurred by other 
cortical neurons40. This also suggests that microglial activation following viral infection does not 
universally lead to elimination of presynaptic termini, even among closely related virus family 
members, and that mechanisms leading to microglial-mediated phagocytosis of synapses or 
neuronal nuclei may be distinct41. Elimination of presynaptic termini following WNV infection 
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requires the complement component C3 and its receptor C3aR10. Astrocytic C3 induces C3aR-
mediated phagocytosis in a model of AD, but this is attenuated with prolonged exposure to C3 
(ref. 42), which may explain the lack of elimination of presynaptic termini in the setting of the 
observed robust and persistent ZIKV-induced astrogliosis. 
Loss of IFN-γ signaling also led to attenuation of astrocyte activation during recovery from 
WNV, but not ZIKV, infection. The lack of astrocyte activation in Ifngr1−/− animals protected 
animals against astrocyte IL-1β production13, which limits synapse repair during recovery from 
WNV infection13. This effect could be caused by a direct loss of IFN-γ signaling in astrocytes, or 
it could be secondary to the lack of microglial activation43. In our model, the latter explanation is 
more probable given that specific deletion of Ifngr in microglia was sufficient to protect animals 
against spatial-learning deficits, and prior work has demonstrated that in Csflr−/− mice, which 
lack microglia, lipopolysaccharide injection fails to activate astrocytes44. These studies suggest 
that signaling between microglia and astrocytes critically regulates ongoing neuroinflammation 
following viral clearance. That spatial learning is preserved in ZIKV-infected Ifngr1−/− animals 
post recovery despite widespread astrocyte reactivity and IL-1β production, which is pathogenic 
in WNV-infected animals post recovery, adds to the growing body of work demonstrating that 
heterogeneity in astrocyte reactivity can promote or prevent CNS repair in a disease-specific 
manner44. 
Although the full spectrum of clinical complications after infection with ZIKV remains unclear, 
the incidence of neurological manifestations is increasing, including reports of cognitive 
sequelae45,46. Our study also detected increased motor activity in ZIKV-infected mice post 
recovery. Of interest, neuropsychiatric symptoms, including hyperactivity and hypomania, have 
been reported in a young adult presenting with ZIKV encephalitis46. This finding suggests that 
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ZIKV targeting of the hippocampus may influence cognitive functions beyond spatial learning. 
Cognitive dysfunction after recovery from WNV infection was first reported in the United States 
approximately 8 years after its emergence in the New York area47, and numerous clinical studies 
since that time have documented persistent psychological and cognitive sequelae following 
WNV infection1. Moreover, the induced cognitive sequelae may worsen over time1. In humans, 
male sex is independently associated with developing neuroinvasive disease and death, 
especially in older individuals48. While no studies have addressed sex differences in cognitive 
outcomes, higher survival rates of female patients could impact potential findings. In our study, 
we used both male and female animals in numbers powered to assess cognitive dysfunction but 
not sex differences. Further studies of both humans and rodents are needed to examine sexually 
dimorphic features of neurological sequelae after flavivirus encephalitis. 
The differential effect of global versus cell-specific deletion of IFNGR on locomotor activity in 
ZIKV-infected mice suggests that cell-specific roles for this receptor in motor activity may occur 
during recovery. In addition to microglia, IFNGR is also expressed by astrocytes, neurons, and 
brain microvasculature, which may each exhibit regional differences in their levels of expression 
and/or signaling pathways. Given that ZIKV also targets axons in the pyramidal tract (Fig. 3.1e), 
it is possible that effects on motor activity are mediated by any of these cell types within this 
brain region. As microglial-specific deletion of IFNGR abolished hyperactivity, it is possible that 
IFNGR signaling in microglia specifically limits the effects of the virus on motor function. As 
the effect was not abolished in mice with global IFNGR deletion, it is possible that IFNGR 
signaling of other cell types might override the effects of microglia. Additional studies 
examining regional and cell-specific differences in IFNGR signaling are needed to determine the 
mechanism of this effect. 
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In summary, our studies demonstrate that re-establishing circuit integrity through recovery of 
lost synapses or neurons is critical for restoring hippocampal function after injury, and identify 
IFN-γ signaling to microglia as a proximal regulator of this repair in the post-infectious CNS. 
Given the recent association of herpesviral infections49 and T cells50 within the CNS parenchyma 
of patients with AD, the mechanisms uncovered in our study could have implications for other 




Male and female mice (8–10 weeks old) were used for each experiment. C57BL/6J, Ifngr1−/−, 
Ifngrfl/fl and CX3CR1-CreERT mice were obtained from Jackson Laboratories. Transgenic animals 
were backcrossed more than ten generations to C57BL/6 mice at Jackson Laboratories. IFN-γ-
YFP (C57BL/6 background) and IFN-γ-Thy1.1 (C57BL/6 background) were obtained from H. 
Shin at Washington Univeristy in St. Louis. CX3CR1GFPCCR2RFP mice were obtained from R. 
Ransohoff and the Lerner Research Institute and crossed in-house to Ifngr1−/− mice to 
generate Ifngr1−/−CX3CR1GFPCCR2RFP reporter mice. All experiments followed the guidelines 
approved by the Washington University School of Medicine Animals Safety Committee (protocol 
no. 20170064). 
 
Mouse models of WNV infection. 
WNV-NS5-E218A and ZIKV-Dakar strains utilized for intracranial infections were obtained from 
M. Diamond at Washington University in St Louis. WNV-NS5-E218A contains a single point 
mutation in the gene encoding 2’-O-methyltransferase. Mice were deeply anesthetized and 
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intracranially administered 1 X 104 plaque-forming units (p.f.u.) of WNV-NS5-E218A or ZIKV-
Dakar. Viruses were diluted in 10 μl of 0.5% fetal bovine serum in Hank’s balanced salt solution 
(HBBS) and injected into the third ventricle of the brain with a guided 29-guage needle. Mock-
infected mice were intracranially injected with 10 μl of 0.5% in HBSS into the third ventricle of 
the brain with a guided 29-guage needle. BHK21 cells were used for viral plaque assays to 
determine stock titers of both viruses (described below). 
 
Measurement of viral burden. 
WNV-or ZIKV-infected mice were killed and tissues were collected, weighed, homogenized with 
zirconia beads in a MagNA Lyser instrument (Roche Life Science) in 500 μl of PBS, and stored 
at −80 °C until virus titration. Thawed samples were clarified by centrifugation (2,000 × g at 4 °C 
for 10 min), and then diluted serially before infection of BHK21 cells. Plaque assays were overlaid 
with low-melting point agarose, fixed 4 days later with 10% formaldehyde, and stained with crystal 
violet. Viral burden was expressed on a log10 scale as p.f.u. per gram of tissue. During initial 
development of the adult ZIKV infection and recovery model (Fig. 3.9), viral burden was 
determined by qPCR with reverse transcription (qRT-PCR). RNA was extracted using a RNeasy 
Mini kit (Qiagen). ZIKV levels were determined by one-step qRT-PCR on an Applied Biosystems 
ViiA7 Real-Time PCR system using standard cycling conditions. A standard curve was produced 
using serial tenfold dilutions of ZIKV RNA, and viral burden was expressed as viral RNA 






Mice were anesthetized and perfused with ice-cold Dulbecco’s PBS (Gibco) followed by ice-cold 
4% paraformaldehyde (PFA). Brains were post-fixed overnight in 4% PFA followed by 
cyroprotection in 30% sucrose (three exchanges for 24 h), then frozen in OCT compound (Fischer). 
Coronal tissue sections (10 μm) were washed with PBS and permeabilized with 0.1–0.3% Triton 
X-100 (Sigma-Aldrich). Nonspecific antibodies were blocked with 5% normal goat serum (Sigma-
Aldrich) at room temperature for 1 h. To reduce endogenous mouse antibody staining when 
detecting ZIKV, a Mouse on Mouse kit (MOM basic kit, Vector) was used as per the 
manufacturer’s instructions. Slides were then incubated in primary antibody (described below) or 
isotype-matched IgG overnight at 4 °C. Following washes in PBS, slides were then incubated in 
secondary antibodies at room temperature for 1 h, and nuclei were counterstained with 4,6-
diamidino-2-phenylindole (DAPI; Invitrogen). Coverslips were applied with ProLong Gold 
Antifade Mountant (Thermo Fisher). Immunofluorescent images were acquired using a Zeiss LSM 
880 confocal laser scanning microscope and processed using software from Zeiss. 
Immunofluorescent signals were quantified using the software ImageJ. 
 
Antibodies for immunohistochemistry. 
The following primary antibodies were used for IHC analyses: WNV (1:100, polyclonal25), ZIKV 
(1:50; gift from M. Diamond (St. Louis, MO), ZV-13), NeuN (1:1,000; Cell Signaling, cat no. 
12943S, clone D3S3I), BrdU (1:200; Abcam, cat. no. ab1893, polyclonal), doublecortin (1:125; 
Cell Signaling, cat. no. 4604S, polyclonal), GFAP (1:250; Thermo, cat. no. 13–0300, clone 
2.2B10), IL-1β (1:100; R&D, cat. no. AF-401, polyclonal), CD3 (1:250; R&D, cat. no. MAB4841, 
clone 17A2), CD11c (1:50; Novus, cat. no. NB110– 97871, clone AP-MAB0806), GFP (1:500; 
Abcam, cat. no. ab13970, polyclonal), IBA1 (1:200; Wako, cat. no. 019–19741, polyclonal), 
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TMEM119 (1:200; Abcam, cat. no. ab209064, clone 28–3), TUNEL (Roche In situ Cell Death kit 
Red), and synaptophysin (1:250; Synaptic Systems, cat. no. 101004, polyclonal). Secondary 
antibodies conjugated to Alexa-488 (Invitrogen, cat. no. A-21206, polyclonal) or Alexa-555 
(Invitrogen, cat. no. A-21435, polyclonal) were used at a 1:400 dilution. 
 
Three-dimensional reconstruction of confocal z-stack images. 
Confocal z-stack images were taken using a Zeiss LSM 880 laser scanning microscope with 
Airyscan at ×63 magnification, and consisted of at least eight images. Images were transformed 
into three-dimensional reconstruction videos using the image analysis software Volocity 3D 
image. 
 
RNAscope in situ hybridization. 
Mice were anesthetized and perfused with ice-cold PBS. Brains were then immersion-fixed 
overnight in 4% PFA followed by three exchanges of 30% sucrose for 24 h. Brains were 
embedded in OCT compound (Fischer) and 10-μm sagittal tissue sections were prepared. 
RNAscope 2.5 HD Assay-Brown was performed as per the manufacturer’s instructions. Probes 
against WNV and ZIKA mRNA (ACD) were used. Viral tropism was analyzed using a ZEISS 





Cells from the hippocampus and cortex of mice were isolated at indicated d.p.i. and stained with 
fluorescence-conjugated antibodies (described below) as previously described13. Briefly, mice 
were anesthetized and perfused with ice-cold Dulbecco’s PBS (Gibco). Hippocampal and cortex 
brain tissue were dissected out, minced, and enzymatically digested at room temperature for 1 h 
with shaking. The digestion buffer contained collagenase D (Sigma, 50 mg ml−1), TLCK trypsin 
inhibitor (Sigma, 100 μg ml−1), DNase I (Sigma, 100 U μl−1), HEPES buffer, pH 7.2 (Gibco, 1 M) 
in HBSS (Gibco). The tissue was then pushed through a 70-μm strainer and pelleted by a 500 
× gspin cycle for 10 min. To remove myelin debris, cells were resuspended in 37% Percoll and 
spun at 1,200 × g for 30 min. Cells were then resuspended in FACS buffer. TruStain fcX anti-
mouse CD16/32 (BioLegend, cat. no. 101320, clone 93) was used to block the cells for 5 min at 4 
°C, followed by cell surface staining for 15 min at 4 °C. Cells were washed twice in FACS buffer, 
fixed with 4% PFA, and resuspended in 2% PFA for data acquisition. Data were collected using a 
Fortessa X-20 instrument and analyzed with the software Flowjo. 
 
Antibodies for flow cytometry. 
The following antibodies were used for flow cytometry: CD45 (PE/Cy7, BioLegend, cat. no. 
103114, clone 30-F11), CD11b (Brilliant Violet 605, BioLegend, cat. no. 101257, clone M1/70), 
I-A/I-E (MHC-II, APC/Cy7, BioLegend, cat. no. 107628, clone M5/114.15.2), CD4 (Alexa Fluor 
700, BioLegend, cat. no. 100536, clone RM4–5), CD8 (PerCP/Cy5.5, BioLegend, cat. no. 
100734, clone 53–6.7), NK1.1 (Brilliant Violet 421, BioLegend, cat. no. 108741, clone PK136), 
CD103 (APC, BioLegend, cat. no. 121414, clone 2E7), Thy1.1 (PE, BioLegend, cat. no. 202524, 
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clone OX-7), CD119 (IFNGR, Biotin, BD Biosciences, cat. no. 558771, clone GR20), and 
streptavidin (PE, BD Biosciences, cat. no. 554061). 
 
Behavioral testing. 
Animals underwent open-field and Barnes maze testing as previously described13. Briefly, mice 
were given 3 min to explore the Barnes maze platform and to find the target hole. If a mouse did 
not find the target hole within the test period, it was gently guided in the hole. At the end of a 
trial, the mice remained in the target hole for 1 min before being placed back into their home 
cage between trials. Each mouse received two trials per day over the course of five consecutive 
days. The number of errors (or number of nose pokes over non-target holes) was recorded. 
Before Barnes maze testing, animals performed the OFT as a measure of exploratory behavior. 
Each mouse was given 5 min to explore an empty arena before being placed back into its home 
cage. Both the Barnes maze platform and the open-field arena were decontaminated with 70% 
ethanol between trials and/or mice. All trials were video recorded using a camera (Canon 
Powershot SD1100IS) and scored by experimenters blinded to the treatment conditions. 
 
Statistical analysis. 
Unpaired Student’s t-test or one-way or two-way analysis of variance (ANOVA) with 
appropriate post-test to correct for multiple comparisons, in which the means of all groups were 
compared pairwise, were performed as indicated in the figure legends. Prism 7.0 (GraphPad 
Software) was used for generating graphs and statistical analyses. P values of ≤0.05 were 
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considered significant. To determine sample sizes for virological and immunological studies, a 
power analysis was performed using the following values: probability of type I error = 0.05, 
power = 80%, fivefold hypothetical difference in mean, and population variance of 25-fold 
(virological studies) or 12-fold (immunological studies). Sample sizes for behavioral testing 
experiments were predetermined by the power analysis. For all experiments, animals were 
randomly assigned to mock, WNV or ZIKV infection. Investigators were blinded to group 
allocation during data collection and analyses. 
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Figure 3.1. ZIKV targets the hippocampus. 
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a-d, Establishing a mouse model of adult ZIKV infection and recovery. a, ZIKV infection did 
not cause lethality in adult mice. b, ZIKV infection led to weight loss, expressed as the 
percentage of day 0 body weight. Data were pooled from two independent experiments (n = 10 
mice per group; P< 0.0001). c, ZIKV replicated in the CNS of WT mice. Viral burden was 
quantified via standard plaque assays (n = 5 mice per group; P = 0.0001 for the frontal corext 
and hippocampus). P.f.u., plaque-forming units. d, ZIKV infection induced cytokine responses in 
the hippocampus. qPCR analysis of indicated mRNA isolated from the hippocampus at the 
indicated d.p.i. (n = 5 mice per group). Cxcl10 (left to right), P= 0.0048 and 0.0007; Tnfa, P< 
0.0001; Il1a (left to right), P = 0.0010 and 0.0002. e,f, ZIKV and WNV target different regions 
of the CNS during acute infection, but similarly infect mature neurons in the hippocampus. e, In 
situ hybridization for viral RNA at 7 d.p.i. revealed dramatic differences in the neurotropism of 
WNV and ZIKV. ZIKV consistently targeted the hippocampus, with sparse infection of the 
cortex and striatum. Conversely, WNV RNA was present throughout the CNS, including the 
olfactory bulb, cortex, hippocampus, and cerebellum. Representative images shown (n = 4 mice 
per group) here, with additional images shown in Supplementary Fig 1. Scale bars,1,000 μm. f, 
ZIKV and WNV target mature neurons in the hippocampus. Representative immunostaining of 
the CA3 region of the hippocampus for NeuN (green), viral antigen (red), and DAPI (blue). Data 
are representative of one independent experiment. Scale bar, 20 μm. For b-d, data represent the 
mean ± s.d. and were analyzed by two-way (b) or one-way (c and d) ANOVA, and corrected for 







Figure 3.2. ZIKV induces neuroinflammation and neuronal loss in the hippocampus.  
a-d, ZIKV and WNV induce differential neuropathology in the hippocampus of WT mice. IHC 
analysis revealed that the number of microglia (IBA1+), astrocytes (GFAP+), and T cells (CD3+) 
increases in the hippocampus after infection with either virus, but the number of neurons 
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(NeuN+) decreases following ZIKV infection. a,b, Representative images shown. Scale bars, 20 
μm. c,d, The number of cells were quantified as indicated. For c, n = 3 (0 d.p.i.) or 5 (7, 25 
d.p.i.) mice per group. IBA1, P = 0.0051 (0 versus 7d.p.i.) and P= 0.0001 (0 versus 25d.p.i.); 
GFAP, P = 0.0086 (0 versus 7d.p.i.) and P = 0.0008 (0 versus 25 d.p.i.); CD3, P = 0.0001 (0 
versus 25 d.p.i.); NeuN, P = 0.0342 (0 versus 7d.p.i.) and P= 0.0046 (0 versus 25 d.p.i.). 
For d, n = 3 (0,25) or 4 (7d.p.i.) mice per group. IBA1, P = 0.0125; CD3, P = 0.0367. e-h, T 
cells persist in the hippocampus after viral clearance, and microglia demonstrate persistent 
activation. Flow cytometry analysis of cells isolated from the hippocampus of 
CC3CR1GFPCCR2RFPreporter animals at the indicated d.p.i. (gating strategy shown 
in Supplementary Fig 2). Data are representative of two independent experiments. e,f, ZIKV (e) 
and WNV (f) infection leads to increased expression of CD103 in CD45hiCD11b−CD8+ T cells 
(n = 3 mice per group; P<0.0001). g,h, CD45midCD11b+Cx3CR1+CCR2− microglia isolated from 
the hippocampus of ZIKV-infected (g) and WNV-infected mice (h) express high levels of 
MHCII at 25 d.p.i. (n = 3 mice per group; P= 0.0035 (g) and P = 0.0023 (h)). For c-h, data 
represent the mean±s.d. and were analyzed by two-way ANOVA, corrected for multiple 




















Figure 3.3. T cells express IFN-g in the post-infected hippocampus. 
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 a,c, qPCR analysis of Ifng expression in the hippocampus at the indicated d.p.i. For a, n = 4 (0, 
7 d.p.i.) or 5 (25, 52 d.p.i.) mice per group. For c, n = 4 (0, 25d.p.i.), 3 (7 d.p.i.), or 5 (52 d.p.i.) 
mice per group. For a (left to right), P = 0.0001 and P= 0.0376. For c (left to right), P = 
0.0021, P= 0.0001, and P = 0.0145. b-g, IFN-γ is primarily expressed by CD3+CD8+ T cells at 
25 d.p.i. b,d, Immunostaining (left) and quantitation (right) of hippocampi at 25d.p.i. from IFN-
γ-YFP reporter mice for IFN-γ (YFP) and cell-type-specific markers for neurons (NeuN), 
astrocytes (GFAP), microglia (IBA1), and T cells (CD3) to identify the source of IFN-γ in the 
hippocampi of infected mice post recovery. Images in the upper panel are magnifications of the 
boxed area in the corresponding images in the lower panel. Scale bars, 20 μm. For b, n = 5 mice 
per group; P = 0.0143 (NeuN versus GFAP) and P< 0.0001 (for other comparisons). For d, n = 4 
mice per group; P = 0.0439 (NeuN versus GFAP) and P< 0.0001 (for other comparisons). e-g, 
CD45+IFN-γ+ cells isolated from the hippocampus of IFN-γ-Thy1.1 reporter mice at 25d.p.i. e, 
Gating strategy. Cells were gated via CD45 and CD11b to identify putative microglial (P1: 
CD45midCD11b+), macrophage (P2: CD45hiCD11b+), and lymphocyte (P3: CD45hiCD11b−) 
populations among IFN-γ-expressing cells. Population P3 was further analyzed for CD4, CD8, 
and NK1.1 expression. IFN-γ+CD4+ and IFN-γ+CD8+ T cells were further analyzed for CD103 
expression, and IFN-γ+CD8+ T cells were analyzed for virus specificity via NS4B tetramer 
staining. f,g, Quantification of indicated populations (n = 4 mice per group). For f, P = 0.0402 
(P1 versus P2), P< 0.0001 (for other comparisons), P= 0.0011 (P3: CD4 versus CD8), and P = 
0.0006 (CD103+: CD4 versus CD8). For g, P< 0.0001 (for other comparisons) and P = 0.0002 
(CD103+: CD4 versus CD8). Full gating strategy and absolute numbers are provided 
in Supplementary Fig 3. h,i, IFN-γ+CD8+ T cells are closely associated with microglia in the 
post-infectious CNS. Representative immunostaining of the CA3 region of the hippocampus for 
IFN γ, CD8, IBA1, and DAPI. Data are representative of one independent experiment. For a-d, f, 
and g, data represent the mean±s.d. and were analyzed by one-way ANOVA and corrected for 












Figure 3.4 Loss of IFN-g signaling protects animals against spatial-learning deficits. 
 a-g, WT mice display spatial-learning deficits 1 month after viral clearance. lfngr1−/− animals 
are protected against these deficits. Data were pooled from four independent experiments, with 
the sample size for each group indicated in b and c. a, Schematic of the model of viral infection 
and recovery. b,c, Average errors on the Barnes maze (sample sizes are indicated). For b, P = 
0.0012 (WT mock versus ZIKV) and P = 0.0381 (lfngr1−/− mock versus ZIKV). For c, P<0,0001 
(WT mock versus ZIKV) and P= 0.0186 (lfngr1−/− mock versus ZIKV). d-g, Open-field data to 
assess locomotor activity (lines crossed; d,e) and anxiety (center crosses; f,g) in 5 min when 
exploring an open-field arena (for sample sizes, see the corresponding colors in b and c). 
For d (left to right), P = 0.0032 and P= 0.0059. For b-g, data represent the mean±s.e.m. and were 












Figure 3.5 IFN-g promotes neuronal apoptosis in ZIKV-infected animals post recovery. 
a-h, ZIKV, but not WNV, infection leads to decreased numbers of hippocampal neurons at 25 
d.p.i. More neurons were found in infected Ifngrl−/− and Cd8−/− mice post recovery. a-c,e-g, 
Representative images (a,e) and quantitation (b,c,f,g) of neurons in the hippocampus. Data were 
pooled from two to three independent experiments. For b, n = 4 (WT mock, WT 
ZIKV, Ifngrl−/− ZIKV) or 5 (Ifngr7−/− mock) mice per group. For c, n = 5 (WT mock) or 4 (WT 
ZIKV, Ifngrl−/− mock, Ifngrl−/− ZIKV) mice per group. For f, n = 5 (WT mock, Ifngr7−/− mock), 
7 (WT WNV), or 3 (Ifngr1−/− ZIKV) mice per group. For g, n = 5 (WT mock, WT ZIKV), 4 
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(Ifngrl−/− mock), or 3 (Ifngrl−/− ZIKV) mice per group. For b(left to right), P= 0.001, P= 0.0111, 
and P = 0.0214. For c, P= 0.0032. Scale bars, 200μm. d,h, Quantitation of TUNEL+ cells in 
multiple regions of the hippocampus at 25 d.p.i. following ZIKV and WNV infection of WT 
and Ifngrl−/− mice. Note that levels of apoptosis were much lower in WNV-infected animals post 
recovery. Data were pooled from two independent experiments (n = 4 mice per group). 
For d (left to right), P = 0.0009, P = 0.0001, and P = 0.0001. For h (left to right), P = 
0.0138, P= 0.0002, and P = 0.0068. i,j, ZIKV infection leads to significant increases in 
TUNEL+NeuN+ cells, which is not observed in Ifngrl−/− or Cd8−/− mice post recovery. Data were 
pooled from two independent experiments. For i, n = 5 mice per group; P = 0.0049 and P = 
0.0134 (left to right). For j, n = 4 mice per group; P = 0.0014 and P = 0.0081 (left to right). k, 
Quantitation of TUNEL+NeuN+ cells at 25 d.p.i. with WNV. Data were pooled from two 
independent experiments (n = 5 (WT mock, Ifngrl−/− mock), 7 (WT WNV), or 3 (Ifngrl−/− WNV) 
mice per group). l, Quantitation of TUNEL+NeuN+ in ZIKV-infected WT versus Ifngrl−/− mice at 
52d.p.i. Data were pooled from two independent experiments (n = 4 mice per group; P< 0.0001). 
Scale bars, 20 μm. For b-d, f-l, data represent the mean±s.d. and were analyzed by two-way 












Figure 3.6 IFNGR is required for repair of presynaptic and postsynaptic termini in 
flavivirus-infected animals post recovery. 
a-c, WNV infection induces astrocyte IL-1β production, which leads to delayed recovery of 
synapses in the hippocampus at 25 d.p.i. in WT mice, but Ifngrl−/− and Cd8−/− animals display 
early recovery of presynaptic termini. a, Representative immunostaining (left) and quantitation 
(right) of the hippocampus. Data were pooled from three independent experiments (n = 9 (WT 
mock), 6 (WT WNV, Ifngrl−/− mock), or 4 (Ifngrl−/− WNV) mice per group; P<0.0001 (left) 
and P= 0.0040 (right)). Scale bar, 50 μm. b,c, Representative immunostaining (left) and 
quantitation (right) of the hippocampus at 25d.p.i. Data were pooled from three independent 
experiments. For b, n = 9 (WT mock), 6 (WT WNV, Ifngrl−/− mock), or 4 (Ifngrl−/− WNV) mice 
per group; P = 0.0311 (left) and P = 0.0169 (right). For c, n = 5 (WT mock), 3 (WT WNV), or 
4 (Ifngrl−/− Mock, Ifngrl−/− WNV) mice per group; P = 0.0048 (left) and P = 0.0157 (right). Scale 
bars, 50 μm. d,e, ZIKV infection leads to chronic loss of Homer1+ postsynaptic terminals at 25 
and 52 d.p.i. in WT mice, but Ifngrl−/− animals display recovery. d, Representative 
immunostaining (left) and quantitation (right) of the hippocampus at 25d.p.i. Data were pooled 
from two independent experiments (n = 4 mice per group; P= 0.0011 (left) and P = 0.0311 
(right)). Scale bar, 10μm. e, Representative immunostaining (left) and quantitation (right) of the 
hippocampus at 52 d.p.i. Data were pooled from two independent experiments (n = 6 (WT 
mock), 4 (WT WNV, Ifngrl−/− WNV), or 7 (Ifngrl−/− Mock) mice per group). Scale bar, 10 μm. 
For all panels, data represent the mean±s.d. and were analyzed by two-way ANOVA, and 
















Figure 3.7. IFN-g potentiates microglial engulfment of postsynaptic termini and neurons in 
ZIKV-infected animals post recovery.  
a,b, WNV or ZIKV infection induces increased expression of IBA1 in the hippocampus at 
25d.p.i., which is significantly reduced in Ifngrl−/− mice. Representative immunostaining (left) 
and quantitation (right) of the hippocampus at 25d.p.i. Data were pooled from two independent 
experiments. For a, n = 4 mice per group; P=0.0001 (left) and P = 0.0102 (right). For b, n = 4 
(WT mock, WT WNV, Ifngrl−/−WNV) or 6 (Ifngrl−/− mock) mice per group; P< 0.0001 (left) 
and P = 0.0010 (right). Scale bars, 50 μm. c,e, IBA1+ microglia engulf postsynaptic termini at 
25d.p.i., which is significantly reduced in Ifngrl−/−mice. Representative immunostaining, with 
single-channel images on the right (c) and quantitation (e) of the hippocampus of infected mice 
post recovery. Data were pooled from two independent experiments (n= 3 (WT 
Mock, Ifngrl−/− Mock), 5 (WT ZIKV), or 4 (Ifngrl−/− ZIKV) mice per group; P= 0.0011 (left) 
and P = 0.0209 (right)). Scale bars, 10 μm. d,f, IBA1+ microglia engulf NeuN+ perikarya at 
25d.p.i., which is reduced in Ifngrl−/− mice. Representative immunostaining, with single-channel 
images on the right (d) and quantitation (f) of the hippocampus of infected mice post recovery. 
Data were pooled from two independent experiments (n = 4 (WT Mock, Ifngrl−/− ZIKV), 5 (n = 
WT ZIKV), or 3 (Ifngrl−/−Mock) mice per group; P = 0.0190). Scale bars, 10μm. For a, b, e, 
and f, data represent the mean±s.d. and were analyzed by two-way ANOVA, corrected for 















Figure 3.8 Loss of IFN-g signaling in microglia during recovery protects animals against 
spatial-learning deficits. 
a-g, Specific deletion of IFNGR in microglia after viral clearance is sufficient to protect animals 
against WNV-or ZIKV-induced spatial-learning deficits. a, Experimental 
design. Cx3cr1CreERIfngrfl/fl (Cre+) animals were generated, and Cx3cr1CreERIfngrfl/fl (Cre−) 
littermates were used as controls. Mice were challenged intracranially with mock, WNV, or 
ZIKV at 8 weeks of age. All mice were treated with tamoxifen at 19 and 21 d.p.i. to induce Cre-
recombinase expression and achieve deletion of Ifngr in CX3CR1+ microglia. Behavioral testing 
began on 45 d.p.i. with OFTs, followed by 5 consecutive days of Barnes maze testing. b,c, 
Average errors on the Barnes maze. Data were pooled from four independent experiments, and 
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sample sizes are as listed. For b, P= 0.0011 (Cre− mock and ZIKV) and P = 0.0073 (Cre+ mock 
and ZIKV). For c, P = 0.003 (Cre− mock and ZIKV) and P= 0.0207 (Cre+ mock and ZIKV). d-g, 
OFT data to assess locomotor activity (lines crossed; d,e) and anxiety (center crosses; e,g) in 5 
min when exploring an open-field arena. Data were pooled from four independent experiments 
(for sample sizes, see the corresponding colors in b and c); P = 0.0146 (d). h,i, Specific deletion 
of Ifngr in microglia after viral clearance is sufficient to protect animals against WNV-or ZIKV-
mediated synapse and neuronal loss, respectively. Cre+ and Cre− littermates were infected with 
mock, WNV, or ZIKV and treated with tamoxifen as described above, but tissue was collected at 
25 d.p.i. for IHC analysis of synaptophysin or NeuN and TUNEL positivity. Data were pooled 
from two independent experiments. For h, n = 7 (Cre− Mock), 4 (Cre− WNV, Cre+ WNV), or 5 
(mock Cre+) mice per group. For i, n = 4 (Cre− mock, Cre− ZIKV, Cre+ mock) or 5 (Cre+ ZIKV) 
mice per group. Scale bars, 20 μm. Data represent the mean±s.e.m. (b and c) or mean±s.d. (d-i) 
and were analyzed by two-way ANOVA, and corrected for multiple comparisons (a-i). *P<0.05, 



















Figure 3.9. ZIKV targets the hippocampus. 
(a,b) ZIKV preferentially targets the hippocampus (white box). Additional representative images 
of in situ hybridization for viral RNA (RNA-ISH) at 7 dpi as in Fig 1e, (n=4 mice per group). 
(c,d) Neither WNV nor ZIKV targets astrocytes (GFAP+) or microglia (IBA1+) in the CA3 
region of the hippocampus. (e,f) Neither WNV nor ZIKV targets neural progenitor cells (DCX+) 













Figure 3.10. Kinetics of immune cell infiltration to the hippocampus.  
Cx3CR1GFPCCR2RFP reporter animals were infected with WNV or ZIKV at 8 weeks old. Cells 
were isolated from the hippocampus at indicated dpi. (a) Gating strategy to identify putative 
microglia (P1: CD45midCD11b+), macrophage (P2: CD45hiCD11b+), and lymphocyte (P3: 
CD45hiCD11b-) populations. (b,c) Quantification of indicated populations at 0, 7, and 25 dpi 
revealed infiltration of putative macrophage and lymphocyte populations by 7 dpi, the latter of 
which persisted in the hippocampus at 25 dpi. Data are representative of two independent 
experiments (n=3 mice per group, mean + SD). (d) Additional gates were applied to P1 and P3 
populations to assess MHC-II expression in CD45midCD11b+Cx3CR1+CCR2- microglia 
populations and CD103 expression in CD45hiCD11b- CD8+ T cells (quantification in main Figure 
2). (e,f)  CD45hiCD11b- CD8+ T cells (identified by gating strategy in a,d) enter the hippocampus 
by 7 dpi and persist to 25 dpi (n=3 mice per group, mean + SD). Data was analyzed by two-way 
(b,c) or one-way (e,f) ANOVA, and corrected for multiple comparisons. *,P<0.05, **, P<0.005, 






Figure 3.11 IFN-g+ T cells persist in the hippocampus. 
Most of the IFNg+ cells in the hippocampus during recovery are CD8+ T cells, and these persist 
in the hippocampus for at least a month after viral clearance. IFNγ-Thy1.1 reporter mice were 
infected with ZIKV or WNV and cells were isolated from the hippocampus at 25 or 52 dpi for 
flow cytometric analysis. (a) Representative gating strategy to identify CD45+IFNg+ cells, which 
were further analyzed according to the gating strategy shown in main Figure 3. (b,c) Data from 
main Figure 3f,g represented as number of cells (n=4 mice per group, mean + SD). (d,e) 
Analysis of CD45+IFNγ+ cells at 52 dpi showed that CD45hiCD11b- CD8+ T cells persist in the 
hippocampus at least one month after viral clearance. Data are representative of two independent 
experiments (n=3-4 mice per group, mean + SD). Data was analyzed by one-way ANOVA, and 





Figure 3.12 Ifngr1-/- mice display similar clinical course and viral burden as WT mice. 
(a-f) Loss of IFNγ signaling does not affect survival, weight loss, or clinical score. (a,d) Survival 
analysis (n indicated in the figure). (b,e) No difference in weight loss following infection, 
expressed as % of day 0 body weight (b: n=4 WT (mock), 10 WT (WNV), 5 Ifngr1-/- (WNV); e: 
n=20 WT (mock), 15 WT (ZIKV), 16 Ifngr1-/- (ZIKV); mean + SD). (c,f) No difference in 
clinical score following infection (n as in b,e; mean + SD). (g-i) Loss of IFNγ signaling does not 
influence replication or clearance of infectious virus, with the exception of slight delay in the 
cerebellum. Viral burden was quantified via standard plaque assays. Data are pooled from two 
independent experiments (n=5-15 mice per group; mean + SD). Data was analyzed by log rank 










Figure 3.13 Ifngr1-/- mice have slight decrease in CD103+CD8+ T cells, which express high 
levels of CCR2. 
(a,b) Loss of IFNγ signaling led to a small but significant decrease in CD103 expression of 
CD45hiCD11b-CD8+ T cells isolated from the hippocampus at 25 dpi. Flow cytometric analysis 
of cells isolated from the hippocampus of Cx3CR1GFPCCR2RFP or Ifngr1-/-Cx3CR1GFPCCR2RFP 
animals as in Fig. 2e-f (gating strategy in Supplementary Fig 2). Data are pooled from two 
independent experiments (n=3-8 mice per group; mean + SD). (c,d) Loss of IFNγ signaling did 
not influence CCR2 expression, which was high increased in CD45hiCD11b-CD8+ T cells 
isolated from the hippocampus at 25 dpi. Flow cytometric analysis of cells isolated from the 
hippocampus of Cx3CR1GFPCCR2RFP or Ifngr1-/-Cx3CR1GFPCCR2RFP animals as in Fig. 2e-f 
(gating strategy in Supplementary Fig 2). Data are pooled from two independent experiments 
(n=3-8 mice per group; mean + SD). Data was analyzed by two-way ANOVA and corrected for 








Figure 3.14 Decreases in post-synaptic terminals and increase in apoptotic neurons are 
observed during ZIKV acute infection and long-term recovery. 
(a,c) ZIKV infection does not target glutamatergic termini (Vglut1) or GABAergic (GAD67) 
neurons at 25 dpi. Data are pooled from two independent experiments (n=4-8 mice per group, 
mean ± SD). (c) No difference in new neurons within the DG during recovery. Representative 
images of recovered hippocampus at 52 dpi, assessed after BrdU labeling during acute infection; 
BrdU (red), NeuN (green), DAPI (blue). Data from one experiment (n=4 mice, mean ± SD). 
Scale bar 50 µm. (d) ZIKV infection leads to decreased number of neurons at 52 dpi. More 
neurons were found in Ifngr1-/- recovered mice. Representative images of the recovered 
hippocampus, NeuN (green). Data are pooled from two independent experiments (n=4-5 mice 
per group, mean ± SD). Scale bar 20 µm. (e) WNV infection leads to the acute loss of 
synaptophysin+ pre-synaptic terminals. Data are pooled from 2 independent experiments (n=4 
mice per group, mean ± SD). Scale bar 20 µm. (f-g) ZIKV infection leads to acute loss of 
homer1+ post-synaptic terminals, but preservation of synaptophysin+ pre-synaptic terminals (f) 
Representative immunostaining in the hippocampus at 7 dpi; Synaptophysin (red), DAPI (blue). 
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Data are pooled from 2 independent experiments (n=4 mice per group, mean ± SD). Scale bar 10 
µm. (g) Representative immunostaining in the hippocampus at 7 dpi; Homer1 (green), DAPI 
(blue). Data are pooled from 2 independent experiments (n=4 mice per group, mean ± SD). Scale 
bar 10 µm. Data was analyzed by two-way ANOVA and corrected for multiple comparisons (a-












Figure 3.15 Significant differences in numbers of microglia in the hippocampus of WT and 
Ifngr1-/- WNV and ZIKV-recovered mice. 
(a) Astrocyte expression of IL-1b was similarly elevated in WT and Ifngr1-/- mice. 
Representative immunostaining in the hippocampus; GFAP (green), IL-1b (red), DAPI (blue). 
Data are pooled from 3 independent experiments (n=4-8 mice per group, mean + SD). Scale bar 
50 µm. (b-e) ZIKV- and WNV-recovered animals demonstrate similar numbers of microglia in 
the hippocampus at 25 dpi. (b,c) No differences in the number of 
CD45midCD11b+Cx3CR1+CCR2- microglia were observed in cells isolated from the ZIKA- or 
WNV-recovered hippocampus of reporter mice at 25 dpi. Representative plots of 
CD45midCD11b+ cells. Data are representative of two independent experiments (n=3 mice per 
group, mean ± SD). (d,e) No differences in the number of Tmem119+ microglia were observed 
in the hippocampus of WT and Ifngr1-/- infected animals at 25 dpi. Representative 
immunostaining of Tmem119 (green) and DAPI (blue) in the hippocampus. Data are pooled 
from two independent experiments (n=4-8 mice per group, mean ± SD). Data was analyzed by 
unpaired t test (a-d). (f,g) WNV or ZIKV infection induces increased expression of MHC-II in 
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hippocampal microglia at 25 dpi. Representative plots from flow cytometric analysis of MHC-II 
expression in CD45midCD11b+Cx3CR1+CCR2- microglia isolated from the recovered 
hippocampus of infected WT and Ifngr1-/- animals. Data are pooled from two independent 
experiments (n=8 mice per group, mean ± SD). Data was analyzed by two-way ANOVA and 












Figure 3.16 Conditional deletion of IFNGR in Cx3CR1+ microglia 
Specific deletion of IFNGR in microglia was achieved as in Fig. 8a-g. (a,b) Flow cytometric 
analysis of CD45midCD11b+ microglia isolated from the hippocampus of Cx3CR1CreERIfngrfl/fl 
(Cre +) mice and Cx3CR1Cre-Ifngrfl/fl (Cre-) littermate controls after behavioral testing 
demonstrated significant deletion of IFNGR in Cre+ mice. Data are pooled from two 
independent experiments (n=4-7 mice per group, mean + SD). (c) Analysis of peripheral myeloid 
cells isolated from the blood (PBMCs) and spleen revealed no difference in IFNGR expression 
between Cre+ and Cre- mice. Data are representative of two independent experiments (n=4 mice 
per group, mean + SD). (d) Tamoxifen treatment did not alter IFNGR expression in 
CD45hiCD11b-CD8+ or CD45hiCD11b-CD4+ T cells isolated from the hippocampus of Cre+ and 
Cre- mice. Data are representative of two independent experiments (n=4 mice per group, mean + 
SD). (e,f) Conditional deletion of IFNGR in microglia during recovery led to significant 
attenuation of MHC-II expression in microglia isolated from the hippocampus of Cre+ but not 
Cre- mice after behavioral testing. Data are pooled from two independent experiments (n=4-7 
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mice per group, mean + SD). Data was analyzed by two-way ANOVA and corrected for multiple 















Figure 3.17 T cell-derived IFNg targets microglia to mediate neurocognitive dysfunction 
during recovery from WNV and ZIKV infection. 
(a) WNV infects neurons throughout the CNS. Anti-viral T cells that persist in the CNS after 
viral recovery produce IFNγ. IFNγ targeting of microglia leads to the elimination of presynaptic 
termini, most prominently in the CA3 region of the hippocampus, and the development of spatial 
learning and memory deficits. (b) ZIKV preferentially targets neurons in the hippocampus. Like 
WNV, IFNγ producing T cells persist in the CNS after ZIKV recovery. Targeting microglia, 
IFNγ induced apoptosis of neurons and the elimination of post-synaptic termini throughout the 








Chapter 4: Conclusions and future directions 
4.1 Astrocytes, neurogenesis and synapse recovery 
This work has explored the fundamental processes which prevent cognitive recovery 
following neuroinvasive disease with West Nile virus. We found that in the case of West Nile 
Virus, reactive astrocytes prevent recovery of synapses and lead to decreased neurogenesis 
through IL-1b signaling. Blocking this pathway through genetic deletion of the receptor for IL-1 
(Il1r1-/-) or pharmacologic treatment with the IL1R1 antagonist anakinra was sufficient to 
protect animals from WNV-induced spatial learning deficits.  
In earlier work we demonstrated that after WNV infection, activated microglia cause 
synapse elimination in the hippocampus through complement mediated phagocytosis1, providing 
a pathological basis for the spatial learning deficits we observed. Synapses are lost during acute 
infection, but what prevents synaptic repair? In the ventral spinal cord, depletion of region-
restricted astrocytes led to differential loss of excitatory and increase of inhibitory synapses. 
Astrocytes from developmentally distinct regions did not migrate into the depleted area, and thus 
could not replace the cells that were lost2. This raises two important points which may be 
relevant for understanding the mechanisms underlying synaptic recovery following viral 
infection.  
First, in addition to their developmental role of promoting synaptogenesis astrocytes may 
also be important for maintaining synaptic connections. In vivo imaging studies have 
demonstrated that synaptic connections are formed and lost in a dynamic way even under normal 
conditions3. Thus, during recovery from infection reactive astrocytes may lose the ability to 
perform homeostatic maintenance of synapse formation and loss. Indeed, recent work has 
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demonstrated that reactive astrocytes were unable to promote synapse formation in vitro, 
although resting astrocytes readily performed this function4.  
Second, astrocytic patterning during development may be an important determinant of the 
functional capabilities and the region-restricted areas in which they divide. Indeed, depletion of 
astrocytes in a restricted region of the spinal cord led to loss of those astrocytes without 
infiltration of astrocytes from an adjacent region2. Thus, as reactive astrocytes lose their 
homeostatic functions following WNV infection, it is unlikely that neighboring astrocytes will be 
able to migrate into the region to fill the functional void.  
However, there are several important caveats to this second line of reasoning. First, 
although patterning has been demonstrated for the spinal cord2, no studies have explored whether 
hippocampal astrocytes derive from a developmentally restricted region. Second, in vivo imaging 
studies have shown that during development, differentiated astrocytes locally proliferate and 
integrate into functional networks5, and the daughter cells do not appear to migrate tangentially2. 
In the neurogenic zone of the hippocampus, newly generated astrocytes may also contribute to 
reactive astrogliosis following infection. Indeed, we observed an increase in proliferating 
astrocytes and a decrease in proliferating neuroblasts. Why these newly generated astrocytes are 
unable to perform homeostatic functions remains unknown, although it is likely that the 
inflammatory environment promotes a reactive phenotype. In vivo imaging of the astrocyte 
response to infection could address 1) the dynamics of synapse formation and retraction during 
recovery and 2) the contribution of local proliferation and/or migration to reactive astrogliosis.  
We also observed decreases in the number of proliferating neuroblasts in the subgranular 
zone of the dentate gyrus and the subventricular zone of the lateral ventricles following WNV 
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infection6. This loss of neural progenitor cells was not due to direct viral targeting, but rather due 
to cytokine mediated alteration in lineage fate. During development, neurogenesis precedes 
astrogenesis. The ‘gliogenic switch’, when neural stem cells switch from making new neurons to 
making new glia, is mediated in part by JAK-STAT signaling7. It is possible that developmental 
pathways leading to gliogenesis are activated when neural stem cells residing in the dentate 
gyrus, which typically make new neurons that integrate into the hippocampal circuitry, are 
exposed to a cytokine milieu following infection. In addition to the effects of reactive 
astrocytosis on synaptogenesis discussed above, the loss of newborn neurons may also contribute 
to spatial learning deficits.  
Studies in rodents have identified several ways by which adult neurogenesis in the 
hippocampus contributes to spatial learning and memory. Adult-born new neurons are integrated 
into the hippocampus during spatial learning8, and ablation of neural stem cells or young neurons 
prevents learning9,10. Thus, following infection decreases in the proliferating neural precursor 
pool, may lead to a decrease in the number of new neurons generated and integrated into the 
hippocampal circuitry. Injecting BrdU, which labels dividing cells, at various days post infection 
during recovery, in combination with staining for early activation genes could help to identify 
whether there is indeed a decrease in the number of newborn neurons incorporating into the 
hippocampal circuit during a hippocampal-based memory paradigm.  
Although initially dismissed, the hypothesis that neurogenesis exists in the adult human 
brain has been widely accepted for many years due to mounting evidence that precursor cells can 
be found in restricted neurogenic regions. However, two papers published recently have revived 
the debate. Sorrell et. al analyzed human tissue from birth to 77 years and found a sharp decline 
in the number of proliferating progenitor cells in the dentate gyrus beginning around 1 year, and 
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very few cells in any of the later time points. They also found a similar decrease in neural 
progenitors with age in non-human primates11. On the other hand, Boldrini et al analyzed human 
tissue ranging from 14-79 years of age, using stereologic techniques to quantify and extrapolate 
the number of newborn neurons in the hippocampus. They identified neural progenitor cells and 
found a stable population during aging12. These studies arrived at different conclusions but raise 
several important points. First, rodent studies are important and useful for testing mechanistic 
hypotheses, but have recognized limits in translating findings to humans due to fundamental 
differences in physiology. Second, human studies utilizing post-mortem tissue are an important 
step to validate hypotheses generated in rodent studies, but have additional challenges due to an 
increasing number of variables, including prior exposures and post-mortem interval, which are 
difficult to fully control. Finally, the ability to determine whether neurogenesis continues during 
adulthood is limited by the identification and availability of lineage defining markers. 
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